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Abstract 
Novel and complementary routes for the selective preparation of either the 2,11 b-cis (B) 
or trans (C) series of functionalised benzo[a]quinolizidines have been developed and 
reported in close collaboration with the Bosch group. 1 The common aromatic core, chiral 
p-aminoalcohol (A), allows access to either (B) or (C) via judicious choice of substrate 
sub-structure for lactamisation. The key cyclisation step in both instances involves the 
attack of a pendent aromatic nucleophile onto an N-acyliminium intermediate. 
MeO OH Mea 
0 MeO~OH 0 Mea .. 10 NH • Mea MeO 2 
"-(8) C0 2Me (A) (C) 
Also described in this thesis is the first asymmetric synthesis of the 
dodecahydrobenz[a]indolo[3,2-h]quinolizine ring system (E), a common sub-structure of 
several bioactive indole alkaloids.2 Our approach furnishes the pentacyclic indole core of 
the manadomanzamine skeleton with complete control over the relative and absolute 
stereochemistries at the three contiguous chiral centres at positions 1, 10 and 24. 
~OH ~)) ~H? N 2 
H 
(D) 
o 
The source of indole and chiral auxiliary, (S)-tryptophanol (D) has also been elaborated 
towards a functionalised analogue (F) with a synthetic 'handle' for further derivatisation. 
Synthetic routes towards the tetracycline class of compounds have also been investigated. 
1 AIIin, S. M.; Duffy, L. J.; Page, P. C. B.; McKee, V.; Edgar, M.; McKenzie, M. 1.; Amat, M.; Bassas,O.; 
Santos, M. M. M. and Bosch, 1. Tetrahedron Lelt. 2006, 47, 5713. 
2 AIlin, S. M.; Duffy, L. J.; Page, P. C. B.; Mckee, V. and McKenzie, M. J. Tetrahedron Lelt. 2007, 48, 4711. 
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CHAPTER ONE: 
POLYCYCLIC ALKALOIDS 
INTRODUCTION 
1.0 N-Acyliminium Ions 
1.1 Brief History 
Significant progress in the enhancement of the chemo-, regio- and stereoselectivity of 
both classical and modern reagents in the last few decades has been paralleled by 
advances in organic synthesis.! Both Mannich reagent (1), and amidoalkylating reagent 
(2), also known as an N-acyliminium ion and primarily designed to facilitate Mannich-
type condensations2, have proved versatile synthetic tools. With respect to the latter, an 
impressive number of synthetic applications have been demonstrated utilizing 
intermolecular processes.3, 4 In contrast, examination of the intramolecular carbon-carbon 
bond forming reactions of the N-acyliminium ion has demonstrated a new dimension in 
the reactivity and selectivity tendencies of amidoalkylating reagents. 
(1) 
1.1.1 Generation of N-Acyliminium Ions and Synthesis of their Precursors 
The first detailed account on the generation of the N-acyliminium ions and synthesis of 
their precursors was reported by Zaug and MartinS in 1965. In subsequent years these 
methods have been refined and new methods added, resulting in five principle synthetic 
pathways to arrive at N-acyliminium ions as illustrated in Scheme 1. 
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Scheme 1 
Route a) Oxidation of Amides 
The key step in this method is the removal of hydride from the a-carbon of an amide 
which formally leads to an N-acyliminium ion. Several research groups have developed 
an extremely efficient electrochemical method to facilitate this transformation.6-8 The 
mechanism (Scheme 2) involves initial removal of an electron from the lone pair on 
nitrogen to generate cation radical (4). The subsequent removal of a proton and further 
electron affords the corresponding N-acyliminium ion (5). This electrochemical oxidation 
is carried out in the presence of a nuc1eophile, usually methanol, in order to immediately 
trap the N-acyliminium ion to yield a-methoxyalkyl amide (6). The scope of the reaction 
encompasses a wide structural variety of ami des and carbamates and a more 
comprehensive study has since been reported.9 
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Scheme 2 
Route b) Electrophilic Addition to Enamides 
Lenz10 reported that acylation of an imine (7) with either an acid chloride or anhydride, 
followed by elimination of HX generates the en amide (8). Protonation of the enamide 
furnishes the corresponding N-acyliminium ion (9) (Scheme 3). 
~j RtX H X / Jyhl(R -t+}-R - HX • • -
0 0 
(7) (8) I H' 
~I. :;--NI(R 
0 
(9) 
Scheme 3 
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Route c) N-Protonation of N-Acylimines 
This particular method carries more mechanistic rather than synthetic interest due to the 
relative instability of N-acylimines (rapidly tautomerize to corresponding enamide if 
possible). Wurthwein and co-workers ll investigated the protonation of imine (10) and 
produced convincing evidence for the N-acyliminium ion structure (11), as shown in 
Scheme 4. 
HSbCle 
.. 
(10) 
Scheme 4 
Route d) N-Acylation of Imines (Schiff Bases) 
Ph 0 
PhA~)lMe 
H 
(11 ) 
SbCle 
Imines are easily obtainable in high yields by condensation of the corresponding 
aldehydes or ketones with primary amines. 12 Their acylation with suitable reactive 
carboxylic acid derivatives such as acid chlorides or anhydrides was reported as early as 
1914 by James and Judd.13 The N-acylation of benzaniline (12) with benzoyl chloride 
(13) furnished the crystalline precursor (14), which was readily hydrolysed in water to 
give benzaldehyde (16) and benzanilide (17) (Scheme 5). The lability of the carbon-
chlorine bond illustrates the tendency for the N-acyliminium ion (15) to be formed in this 
system. 14 
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0 C\- 'ph Hr- ,Ph -Ph~N .... Ph 
+ PhACI • H N 
-N Cl 
PhTPh Ph TPh 
0 0 
(12) (13) (14) (15) 
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Ph, -f H\- ,Ph PhCHO • H N HN + PhTPh 
Ph 0 
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Scheme 5 
Route e) Heterolysis of Amides 
Heterolysis of a-substituted amides is the most frequently employed method for the 
generation of synthetically useful N-acyliminium ions. In the majority of cases the 
leaving group is an oxygen substituent, but can also be a sulfur, nitrogen, phosphorus or 
halogen substituent. In order to generate the N-acyliminium ion (19) from the a-oxyalkyl 
amide precursor (18) where R is alkyl or hydrogen (Scheme 6), a Bronsted or Lewis acid 
activator is generally employed. 14 In the case where R is acetyl or methanesulfonyl, no 
such catalyst is required. 
Acid or Heat 
(18) (19) 
Scheme 6 
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1.1.2 Structure and Reactivity of N-Acyliminium Ions 
It has been well established throughout the last two decades that the Mannich 
intermediate (20) can be made considerably more reactive via substitution with electron 
withdrawing groups at nitrogen, thus enhancing its cationic character. Of these modified 
cations, the N-acyl derivative (21) and the carbamate (22) have been the most widely 
exploited. Examples of other electronegative substituents such as the amide (23) and N-
tosyl (24) cations have been reviewed to a lesser extent. Numerous cyclic and linear 
forms can be distinguished, depending on the type of RI, R 2 and R 3 and new variations 
such as the hydrazonium (25) have arisen. 15 
20 R = H, alkyl 
21 R = acyl 
22 R = COOR 
23 R = CONR2 
24 R = Tos 
25 R = NR2 
It is expected that the imino carbon atom in the amidoalkylating agent (21) is more 
electron-poor than in Mannich reagent (20) due to the presence of the strongly electron 
withdrawing carbonyl group. A study by Wurthweinll et al. of iminium salts (26) and 
(27) revealed that substitution of an N-methyl by an N-acetyl group produces an 
approximate downfield shift of 5 ppm with respect to the imino carbon absorption. This 
spectral evidence is indicative of N-acyliminium ions being more electrophilic than 
iminium ions, hence more reactive. 
184.6 189.7 
Ph,) + ,Me PhJ +O}-
p=N, C=N I \ 
Ph H Ph H 
-
SbCls SbCls 
(26) (27) 
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1.1.3 Mechanistic Aspects 
Reactions between N-acyliminium ions and nucleophiles (also termed amidoalkylation 
or Mannich-type condensations) have been frequently employed to introduce substituents 
at the a-carbon of an amine. The general schematic for the mechanism by which most 
amidoalkylations proceed is shown below (Scheme 7).16 Acidic catalysis generates 
equilibrium between precursor (28) and N-acyliminium ion (2). Substituted product (29) 
is obtained when N-acyliminium ion (2) reacts in an irreversible process with a 
nucleophile. 
Acidic catalyst 
.. 
Nucleophile 
• 
(28) (2) (29) 
Scheme 7 
This scheme closely resembles that of an SNl process. A study by Zaugg and Martin17 led 
to the establishment of two extreme kinetic situations; (i) the formation of the N-
acyliminium ion is rate limiting and (ii) the reaction of the nucleophile is rate limiting. 
The former situation implies that a more stable N-acyliminium leads to a faster reaction, 
whereas the latter case implies the opposite to be true. Other factors which influence the 
rate of amidoalkylation include the nature of the leaving group and the solvent. 
An important side reaction in the chemistry of the N-acyliminium ion is the loss of a 
proton to give the corresponding enamide. In an acidic medium, this process may be 
reversible but this is not always the case. Dimeric structures can arise when enamides 
react as a nucleophile with the N-acyliminium ions still present. The problem of enamide 
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formation and subsequent side reaction can arise if the N-acyliminium ion is not trapped 
fast enough by the nucleophile. The four main factors that facilitate such problems are: 
• There is too much steric hindrance 
• Stereoelectronic factors are unfavourable (intramolecular case) 
• A medium or large sized ring is to be formed 14 
• The nucleophile is not very reactive 
1.1.4 Detection of N-Acyliminium Ion Intermediates by NMR Spectroscopy 
Whereas iminium salts are frequently isolable, their N-acyliminium counterparts are 
seldom isolated due to both limited stability and high reactivity, and are almost always 
generated in situ. As a result, there have only been two reports in the literature of 
transient N-acyliminium intermediates being observed by dynamic NMR. Yamamoto and 
Nakada18 demonstrated that treatment of alkoxycarbamate (30) at _55°C with Lewis acid 
in the presence of TfzO produces a clean l3C NMR spectrum of the corresponding N-
acyliminium ion intermediate (31) as shown in Scheme 8. 
(30) (31 ) 
Scheme 8 
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In a more recent study, it was found that the bis(homoallyl) hydroxylactam (32) could be 
treated with BF3·0Et2 at 25°C to produce a clean 13C NMR spectrum of the N-
acyliminium ion (33).19 The slow cyclisation (1 h) of this intermediate to fluoro 
compound (34) highlighted unexpected stability, which may be explained by the greater 
electron withdrawing ability of the amide carbonyl compared to the carbamate. 
(32) (33) (34) 
1.2 Intramolecular N-Acyliminium Amidoalkylations 
1.2.1 Iminium Cyclisations versus Acyliminium Cyclisations 
Cyclisations involving iminium cations such as the venerable Mannich reaction2o, the 
Bischler-Napieralski reaction21 and the Pictet-Spengler reaction22 are well reviewed and 
established. In contrast, a more recent development has been the emergence of 
cyclisations that proceed via N-acyliminium species (Scheme 9). Both types of 
intermediates have been extensively employed in the synthesis of alkaloidal and related 
systems, including several early uses of N-acyliminium ions in amidoalkylation reations? 
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+ 
• H • 
Hel 
Scheme 9 
1.2.2 Cyclisation of Benzenoid Nucleophiles 
NuH 
+ 
-H 
Mannich amidoalkylation 
R2yO 
NUyNH 
R1 
N-acyliminiu m 
amidoalkylation 
The reactions of N-acyliminium ions with tethered 1t bonds have proved a most versatile 
and important tool for the construction of complex nitrogen containing heterocycles. The 
first example of this kind was reported by Von Braun et aP3 while investigating the ring 
closure of sulfonamide glycine derivatives by A1Ch catalysed decarbonylation (Scheme 
10). 
Scheme 10 
The major breakthrough in synthetic application of intramolecular amidoalkylations 
occurred in the early 1950s, when the reaction was applied in alkaloid synthesis. l1 
Interest in this field was stimulated by the pioneering work of both Belleau24 and 
Mondon25 on the synthesis of Erythrina alkaloids by ring closure of N-acyliminium ions 
(35a) (RI = 0, R2 = H2) and (35b) (RI = H2, R2 = 0). 
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(35) 
The genus Erythrina is widely distributed in tropical and subtropical regions of the world 
and has traditionally been used in indigenous folk medicine.26 Extracts from the flowers, 
seeds, and bark of the genus have yielded a family of Erythrinan alkaloids which exhibit 
numerous pharmacological effects including sedative, hypotensive and neuromuscular 
blocking. The vast majority of naturally occurring Erythrina alkaloids possess the 
common tetracyclic framework and substitution pattern of (36). 
RO 
Z 
(36) 
X or Z =0 
R= Me 
x 
MeO 
o 
(-)-3-Demethoxyerythratidinone 
Allin and J ames27 reported a novel, stereos elective approach to a fused tetracylclic ring 
core of the Erythrinane system in 92 % yield via an asymmetric, intramolecular N-
acyliminium mediated cyclisation. Treatment of bicyclic lactam (37) with the Lewis acid 
TiCl4 gave the target core (38) presumably from the N-acyliminium ion (39) (Scheme 
11). 
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MeM Meo~ 
Me0'r;r:&oH 
r-\ TiCI4 \ I \ ___ 2.-_.... .0 N 0 
ONO DC~o~8 QC MeO (". __  (~ r---
0T' 0 
~O 
(37) (38) 
Scheme 11 
1.2.3 Cyclisation of Indole Nucleophiles 
MeO Meo~ < 
LA -o"----\'' + 
~NyO &-~ 
(39) 
Of equal importance in initiating studies in this field was the synthesis of yohimbine by 
Van Tamelen et al.,28 which incorporated a critical acid-catalyzed ring closure of the N-
acyliminium ion (40). The reaction proceeded remarkably easily thus highlighting the 
reactivity of an electron-rich aromatic pyrrole ring in such cyclisations. 
(40) 
Indole type cyclisations via an intermediate N-acyliminium ion have been used in the 
synthesis of many indole alkaloids. The highly reactive nature of the indole 1t-nucleophile 
makes this category stand out as a unique collection of illustrative examples. The 
synthesis of tetrahydro[12H]pyrroloazepinoindole as reported by Wawzonek and 
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Maynard29 was facilitated by a key cyclisation of this type. The hydroxylactam precursor 
(41) was subjected to acid activation in order to generate the N-acyliminium ion (42), 
which gave direct access to the tetracyclic product (43) via an intramolecular cyclisation 
(Scheme 12). 
\1: KO HO Ph Ph 
Hel 
.. 
.. 
MeOH 
HN 
(41 ) (42) (43) 
Scheme 12 
More recently, Allin and Thomas demonstrated both a novel and facile asymmetric 
approach to both enantiomers of the indole alkaloid deplancheine.3o The key ring forming 
step in the construction of the indolo[2,3-a]quinolizine framework involved cyclisation of 
an indole nucleophile onto an acid-induced N-acyliminium ion (46). Simple treatment of 
a mixture of bicyclic lactams (44a!b) with 2M HCI furnished indolo[2,3-a]quinolizine 
target (45) as a single diastereoisomer in 97 % yield (Scheme 13). 
o 
vrlO 
H 0 N 
H 
(44a1b) 
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2M Hel, EtOH .. 
rt, 20 h 
(45) 
Scheme 13 
OH 
o 
o 
Vj'(O 
HO N H 
(46) 
13 
1.2.4 Cyclization of Pyrrole, Imidazole and Pyridine nucleophiles 
N-Substituted pyrroles linked to an N-acyliminium ion via the pyrrole a-position react 
cleanly at the a-position as shown previously (Scheme 13).30 Similarly, N-acyliminium 
ions linked to the pyrrole nitrogen undergo cyclisation at the a-position to generate five, 
six, seven and even eight-membered rings.3! Scheme 14 highlights the difficulty in 
forming a five-membered ring, as signified by the low yield of (48), but also the 
possibility of N-acyliminium cyclisation at the a-position. 
0 0 
cGN\ HC02H • .0 N 3 days 
OH Q 
(47) (48)(27 %) 
Scheme 14 
Scheme 15 gives a clear indication of the high reactivity of the pyrrole nucleus for N-
acyliminium cyclisations. In this case, cyclisation involving the phenyl nucleophile in 
order to generate a five-membered ring does not occur; rather, the pyrrole nucleophile 
attacks to furnish a new eight-membered ring (50)?2 It is a remarkable feat to form an 
eight-membered ring in such high yield (92 %) and under such mild conditions (23°C, 1 
h) (Scheme 15). 
on ~~-N~ 
Et OH 
(49) 
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TFA, 
(2 drops) 
DCM,1 h 
Scheme 15 
o 
N)O Et \ 8 
~ N 
(50) (92 %) 
14 
The role of other heterocyclic nucleophiles in the cyclisation of N-acyliminium ions has 
been reviewed.31 There is a reported example of an N-acyliminium cyclisation onto an 
imidazole.33 Reaction of histamine with 4-oxodecanoyl chloride in pyridine affords a 
mixture of amide (51) and tricyclic structures (52) and (53) which are acid catalysed 
cyclisation products of (51). Prolonged heating in 10 % aqueous acetic acid gave 
essentially pure (53) (Scheme 16). 
AfI N~N N C6H1~O 
(51 ) (52) (53) 
Scheme 16 
In contrast to the pyrrole nucleus, which has been shown to be a highly reactive 
nucleophile for N-acyliminium cyclisations e.g. Scheme 15, one would expect an 
electron-deficient heterocycle such as pyridine to be unreactive. Indeed, this can explain 
the limited depth of examples of pyridine in cationic 1t-cyclisation reactions in the 
literature, despite its frequent occurrence in a plethora of biologically active heterocycles. 
However, N-acyliminium reactions do proceed when the pyridine nucleus is activated at 
the 2-position as highlighted in Scheme 17.34 
«O~ I N-f' N=( ~ OMe 
OH 
(54) 
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,rTsOH 
benzene, reflux 
Scheme 17 
.. 
OMe 
(55) 
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The 2-methoxy substituted lactam (54) failed to undergo cyclisation in the presence of a 
wide range of Lewis acids including TiCI4, SnCl4 and BF3·OEtZ, with only starting 
material recovered in each case. Refluxing the lactam in the presence of a catalytic 
amount of protic acid in benzene, however, furnished the target tetracycle (55) in 70 % 
yield. 
1.2.5 Effect of Substituent on the Iminium Ion 
In N-acyliminium ion cyclisations, the nature of the substituent either on the carbon or 
nitrogen of the iminium unit generally has negligible effect on the reaction outcome. 
There are instances however, in which more reactive N-acyliminium species have a 
significant impact. Intermediates that bear an electron-withdrawing group on the carbon 
atom, or those devoid of steric hindrance at the carbon atom, or those with more electron-
deficient N-acyl groups, may result in higher yields and/or allow for milder conditions. 
It has been demonstrated that for certain hydroxyisoindolinones with standard 
substituents such as phenyl or hydrogen, disparate reactivity exists, especially with ring 
strain in the cyclisation (Scheme 18).35 
00 o=/~ 
R OH 
n=1 
(56) R = Ph 
(57) R = H 
n=2 
(58) R = Ph 
(59) R = H 
PPA 
.. 
135°C,4h 
Scheme 18 
n=1 
R = Ph (75 %) 
R = H (0 %) 
n=2 
R = Ph (65 %) 
R = H (84 %) 
In the case of (56) where the iminium carbon bears an electron withdrawing phenyl group 
and where n = 1, cyclisation proceeds in high yield in stark comparison to the analogous 
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hydrogen substituent compound (57), which fails to cyc1ise. Since the corresponding 
cyc1isations to six-membered rings supply good yields irrespective of substituent, it 
appears that the substituent effect is directly accentuated by ring strain. 
Okano et aZ?6 demonstrated that if the electrophilicity of the iminium carbon is 
sufficiently enhanced, then the reactivity of the nuc1eophile can be lessened with no great 
effect (Scheme 19). 
~~CI 
R OH 
(60) 
CF3S0 3H 
DCM 
23°C, 7 d 
Scheme 19 
.. 
X 
(61) X = Cl; Y = H 
(62) X = H; Y = Cl 
(100% 61162 = 9:1) 
The presence of a trifluoromethyl group at the iminium carbon of (60) results in a 
quantitative yield of cyc1ised pyrroloisoquinolines (61162), even though the arene 
nuc1eophile is a less reactive chlorophenyl group. 
1.2.6 Formation of Five-Membered and Seven-Membered Rings 
The formation of five-membered rings by N-acyliminium ion cyc1isation can be 
problematic as highlighted previously (Scheme 18). This difficulty is illustrated by the 
failure of (63) and (64) to cyc1ise under various acidic conditions (Scheme 20)?7 
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of cq- x .. 
OEt 
(63) 
~F X .. 
Ph OH 
(64) 
Scheme 20 
On the other hand, five-membered rings are formed more readily from spirocyclisation of 
N-acyliminium species as highlighted by the cyclisation of N-arylglycinamide based ions 
to 3-aminoindolin-2-ones (Scheme 21).38 
J3 TFA .. reflux N, 
0 0 Me 
(69 %) 
Scheme 21 
Formation of seven-membered rings in cyclisations can be troublesome but there are 
several successful examples.33 One prevalent example is illustrated in Scheme 22 where 
there are competing phenyl and thiophene 1t-nucleophiles. Upon subjection of (65) to 
trifluoroacetic acid, cyclisation occurred exclusively on the phenyl ring in 80 % yield. No 
cyclisation took place on the thiophene ring (at the 4-position) thus reflecting the 
difficulty in forming a new five-membered ring, especially for a 5,5-fused product.39 
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O<N~ 
OH 
o 
TFA .. 
(65) (66) (80 %) (67) 
Scheme 22 
Another notable example of seven-membered ring generation utilizing an N-acyliminium 
precursor was reported by Nakatsuka et al.4o Azepinoindoles were prepared as 
exemplified in Scheme 23. 
.. 
(68) 
Scheme 23 
o 
Ph
6di 
~02Me 
I ~ ~ 
.0 N 
Me 
(69) 
(89 % from Z-68) 
(87 % from E-68) 
Rather interestingly, enamide (68) as either the Z or E isomer, cyclised exclusively at the 
indole 4-position to furnish (69). This is in spite of the reactive indole 2-position being 
available for six-membered ring formation. 
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1.3 Unsaturated Bicyclic Lactams 
Bicyclic lactams provide an extremely versatile chiral, non-racemic tool for the 
generation of a plethora of optically pure carbocycles and heterocyc1es. Their application 
to total synthesis has demonstrated that lactams provide access to a wide variety of 
structural features with excellent stereocontrol. 41 The preparation of (l,~-unsaturated 
carbonyl compounds is an important transformation, allowing further functionalisation of 
substrates. The predominant method to access such compounds involves the oxidative 
elimination of an appropriate selenoxide as developed by Reich.42 The (l-
phenylselenocarbonyl compound (70) can be accessed via an appropriate lithium enolate 
and phenyl selenyl bromide. Oxidative conditions promotes elimination to yield the (l,~­
unsaturated product (71) and phenyl selenic acid as a by-product (Scheme 24). 
~ • 
(71 ) 
+ 
PhSeOH 
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2. PhSeBr 
.. 
Scheme 24 
Cl /( I~~ 
PhSe 
(70) 
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1.3.1 Conjugate Additions 
1.3.1.1 Organocuprate Conjugate Addition 
The conjugate addition of organocuprates to electrophilic olefins has scarcely been 
utilised in a chiral sense.43 House et al. carried out the addition of organocuprates on 
unsaturated lactam (72) in order to investigate any diastereoselective pattern and hence 
address the task. Rapid enone reduction was observed on attempting the addition of 
Gilman-type cuprates to yield saturated lactam (73) (Scheme 25).44 
PhJ:~H Me2CuLi ,.co Me H+ PhJ:~e • Ph N~ • 
0 0 0 
(72) (73) 
Scheme 25 
Diels-Alder cycloadditions to the bicyclic lactam were found to only be successful when 
an a-carboalkoxy group was introduced.45 Subsequent addition of the standard 'Gilman 
reagent' to the same bicyclic lactam template (74) furnished the B-substitued lactam (75) 
in a 3:1 (trans:cis) diastereomeric ratio. Further studies revealed that the use of a lower 
order cyanocuprate produced a diastereomeric ratio >95:5 (trans:cis) (Scheme 26), 
(Table 1). It is rationalised that the angular methyl group effectively blocks the 
approaching cuprate on the B face thus promoting the endo addition that is observed. 
PhJ:~e 
'rC02Me 
o 
(74) 
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Scheme 26 
(0 Me , 
,J-- ~"R Ph N 
C02Me 
o 
(75 a-d) 
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a 
Product R' Yield (%)a 
75a Me 84 
75b Vinyl 84 
75c Phenyl 76 
75d n-butyl 80 
I The d.r. of all the products was >95.5 as determmed by H NMR 
Table 1 
The removal of the carbomethoxy group used initially to activate the addition, from the 
~-substituted lactam (75), has proved problematic. The viability of the procedure was 
limited by the rapid epimerisation noted upon alkaline hydrolysis to give the 
decarboxylated product.46 This disadvantage was ultimately overcome by changing to a 
benzyl ester (76), which could be easily removed via hydrogenolysis followed by 
decarboxylation in refluxing toluene to give (77) (Scheme 27). Pyrrolidine system (7S) 
was obtained via reductive removal of the auxiliary over two steps.46 
,c~( o R' PhjN~"'R R' R Ph N " a), b) c), d) HO' .. .. C02Bn 
0 0 
(76) (n) (78) 
Reagents: a) Pd/C, H2 b) reflux c) A1H3d) N~ ~C02-' Pd/C 
Scheme 27 
More recently, Bosch et al.47 have established that unsaturated lactams (SOa) and (SOb), 
derived from the same chiral inductor, (R)-phenylglycinol, undergo conjugate addition of 
cyanocuprates with opposite facial selectivity. The resulting C-7/C-8a trans isomers 
(Sla) and (SIb) arise due to the difference in configuration at the C-8a stereocentre 
(Scheme 2S). 
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Ph, 
h 
0+)0 
Bn02C 
PhSe 
(79a) 
(79b) 
(80a) 
(80b) 
Scheme 2S 
Ph, 
h 
iii) RCuCNLi 0xyo 
.. Sa 
7 
Bn02C : 
R 
(81a) 
Ph, 
h 
iii) RCuCNLi 0:yN ".0 
• 
", 
Bn02C 
R 
(81 b) 
The stereochemical outcome was explained by considering the difference in the 
conformation of the piperidine ring for lactams (SOa) and (SOb), with nucleophilic attack 
of the cyanocuprate proceeding via stereoelectronic control, axial to the electrophilic 
carbon of the enone. Rather interestingly, the same group also discovered that y-
substitution of C-7/C-8a trans lactam (S1b) with an ethyl group facilitates entry to C-7/C-
8 cis isomers through similar additions (S3a/b) (Scheme 29). This allowed for entry to 
enantiopure cis-3-alkyl-4-arylpiperidines (S4a1b),48 with the stereochemical outcome of 
the conjugate additions to y-substituted a,p-unsaturated o-lactam (S2) being in stark 
contrast to the trans isomers usually formed.49 
RCuCNLi 
(82) 
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Ph, 
h °l~:fO 
· Bno,c/!~ 
R 
(83a) R = Ph 
(83b) R = Me 
Scheme 29 
H 
steps X1N) 
· · Bno,e/Ai 
R 
(84a), R = Ph, X = 0 
(84b), R = Ph, X = H,H 
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1.3.1.2 Enolate Conjugate Addition 
In contrast to the cup rate additions summarised in the previous section, the conjugate 
addition of stabilised anions to a,p-unsaturated carbonyl compounds is a reversible 
process. This gives rise to thermodynamic control for the addition, which could result in a 
different stereochemical outcome than for that observed for the irreversible addition of a 
cyanocuprate. Amat et aI.50 investigated the addition of the enolate derived from ethyl 
1,3-dithiolane-2-carboxylate to the diastereomeric lactams trans (S6a) and cis (S6b), 
(Scheme 30). 
Ph, 
i) KH, PhS02Me h 
THF, reflux • ~UN S 0 
iO Na2C03' toluene "-"-
reflux 
X2Et 
Ph, S S 
LJ h 
LDA 01)0 • 
THF, HMPA 
Et02ct5 
(8Sa) (86a) (87a) 
Ph, 
i) KH, PhS02Me h 
THF, reflux • 0UN ~"O 
ii) Na2C03' toluene "-
reflux 
C02Et 0 Ph, h 
LDA 09",0 • 
EtO,C s5 
THF, HMPA 
(8Sb) (86b) (87b) 
Scheme 30 
It was found that without the presence of an ethyl group at the y-position, addition occurs 
with the same stereoselectivity as the addition of cyanocuprates to the related trans and 
cis lactams (SOa) and (SOb) (Scheme 2S). The conjugate addition of the enolate of ethyl 
1,3-dithiolane-2-carboxylate to the y-ethyl substituted derivative of (S6b), cis (SS), took 
place with high facial selectivity to give a cis relationship at C-7/C-8a (Scheme 31). 
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Ph, 
~2Et 
Ph, SLJS f\ f\ o~ LDA o~ ~ THF 
Et02C-r--S 
SvJ 
(88) (89) 
Scheme 31 
The dramatic influence exerted by the y-ethyl substituent on the stereochemical outcome 
of the conjugate addition of enolates is exemplified by comparison of (89) with the C-
7/C-8a trans relationship observed for the same addition to related desethyl cis lactam 
(87b), (Scheme 30). The resulting C-7/C-8 trans product (89) is the thermodynamically 
more stable isomer and its formation is facilitated by the reversible nature of the enolate 
addition. This is complementary to the C-7/C-8 cis products (83a/b), (Scheme 29), which 
were accessed via kinetically controlled addition of a cyanocuprate to unsaturated lactam 
(82). The additional activating alkoxycarbonyl group incorporated into (82) was 
subsequently removed by employing a hydrogenation/decarboxylation sequence. 
1.3.1.3 Epoxidation by Conjugate Addition 
The versatility of unsaturated a,~-unsaturated lactam (74) was further demonstrated by 
Van Rheenan et al. who reported oxygen addition to the template using tertiary amine N-
oxides.51 The Upjohn process for the dihydroxylation of unsaturated systems (catalytic 
OS04, N-methylmorpholine oxide) was employed, and the a-epoxide (90) isolated in high 
yield rather than the expected diol. The stereochemical outcome of this reaction was 
consistent with blocking of the ~-face by the methyl substituent as a-face entry was 
exclusively observed (Scheme 32). Further studies revealed that osmium tetroxide was 
unnecessary and that NMO could be replaced with triethylamine-N-oxide. Epoxidation of 
the a-face of a variety of doubly activated a,~-unsaturated bicyclic lactams proved 
successful. 52 
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0504 (cat) 
• NMO 
Scheme 32 
Amat has shown that epoxidation of the a,~-unsaturated bicyclic lactam is not limited to 
the bicyclo [3.3.0] system. The a,~-epoxy lactam (94) has been obtained from the [4.3.0] 
bicyclic lactam (91) via treatment of the intermediate a-selenyl bicyclic lactam (92) with 
m-CPBA (Scheme 33).53 It was reasoned that the a,~-unsaturated lactam (93) would be 
formed as an elimination product of the selenoxide of (92). This was followed by 
epoxidation with m-CPBA to furnish ~-epoxide (94). 
PhJ;6 
o 
(91) 
LiHMDS, CIC0 2Me (O}+H 
• Ph';-N 
SePh 
o C02Me 
(92) 
PhJpO 
o C02Me 
(94) 
+ 
Scheme 33 
I m-CPBA 
PhJQ 
o C02Me 
(93) 
The facial selectivity appears to be governed by the angular substituent present, with the 
presence of an angular hydrogen allowing for ~-epoxidation. In the case where oxidation 
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of the intermediate selenide was achieved with ozone, the corresponding a,p-unsaturated 
lactam (93) was exclusively isolated.46 
1.3.1.4 Amines Conjugate Addition 
High facial selectivity has also been observed for the addition of amines to the a,p-
unsaturated lactam (72) (Scheme 34). In order to facilitate efficient amine addition, two 
crucial conditions have been identified; (a) the presence of water to drive amine addition 
to completion and (b) reaction with 8 equivalents of the amine.54 
o Me PhJ9 + R'R'NH 
o 
(72) 
• 
Scheme 34 
Upon changing to a secondary amine i.e. increasing steric bulk, the selectivity of the 
endo-exo addition increased from 19:1 to >98:2 (Scheme 35), (Table 2). This indicated 
that the bulkier nucleophiles were sensitive to facial selectivity (Entries 1, 5). When the 
angular substituent of the lactam was changed from a methyl to a phenyl group (Entries 2 
and 4), the selectivities for the reaction with the same primary amine changed from 19:1 
to >98:2.46 
amine 
o R1 ~3 J >C""N'R2 
Ph Ny 
o 
Scheme 35 
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Entry RI Amine Yield (%) d.r. 
1 Me PhCH2NH2 84 95:5 
2 Me 
H2N,-/Ph 
83 95:5 
Me 
3 Me 
H2Ny Ph 85 95:5 
Me 
4 Ph 
H2N,-/Ph 
89 98:2 -
Me 
5 Me HN0 89 98:2 
Table 2 
1.4 Polyfunctionalised Bicyclic Lactams 
In contrast to the previous section (1.3) which describes the functionalisation of 
unsaturated bicyclic lactams via conjugate addition reactions, this section examines the 
incorporation of functionality prior to lactamisation. Bosch et aI.55 have extensively 
studied the formation of polysubstituted bicyclic lactams from chiral 1,3 and 1,2 
aminoalcohols, for example, (95) and (96, 97) respectively, with racemic or prochiral 8-
oxoacid derivatives (98-104) (Figure 1). 
(1 
H3C11 ("( 
NH2 OH 
(95) 
(98) R = H 
(99) R = Et 
Meo,c0CH, 
R 
(100) R = H 
(101) R = Et 
(96) (97) 
Me02y~ MeO,c~C02Me 
Me02C (102) R = H (104) 
(103) R = Et 
Figure 1 
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All of the cyclocondensation reactions undertaken involved a dynamic kinetic resolution 
(DKR) and/or differentiation of enantiotopic or diastereotopic ester groups effected by 
aminoa1cohols (95-97). The study encompassed a wide range of o-oxoacid derivatives 
including unbranched aldehydes (98) and ketones (100), racemic aldehydes (99) and 
racemic ketones (101). Prochiral aldehydo-diesters bearing enantiotopic ester groups 
(102, 104) and racemic aldehydo-diesters containing diastereotopic ester groups (103) 
were also screened with the results summarised in Table 3.56 
Rl R2 R3 Yield a:b Synthons Products 
(%) ratio 
rac-(95) + (98) N N rac-(105) H H - 90 " -rac-(95) + (99) H3C" :::,... H3C" :::,... rac-(106) H Et - 80 1:13 
rac-(95) + (100) on° + 0:0::0 rac-(107) CH3 H - 80 " I I 1 I I 1 -R R 
9: I" rac-(95) + (101) a R2 b IIR2 rac-(108) CH3 Et - 45 
(96) + (98) ~"H ~'H (109) H H H 70 4:1 (96) + (99) (110) H Et H 87 7:5:3b (96) + (102) 0y . o~o (111) H H X 78 4:1 (96) + (100) I I 1 R1 (112) CH3 H H 99 1:10 R 
" 2 b = R2 (96) + (101) a R (113) CH3 Et H 74 1:8c R3 R3 
(97) + (99) Ph, ,,-OR4 Ph ,,""":OR4 (114) H Et H 78 1:9 
(97) + (102) h ',-\: (115) H H X 86 1:14 O~l °UO (97) + (103) + 1 (116) H Et X 77 1:15d R 
(97) + (104) IIR2 = R2 (117) H Y H 80 1:20 
a R3 b R3 
(97) + (101) R4 = CHPH2 (118) CH3 Et H 81 3:2 
-
.. . . 0, •• X = CH2C02Me, Y (CH2)2C02Me. "Trace amounts of epImer at pIpendme a-poSItIon detected. a.b.c 
ratio (c is the epimers of b at piperidine a-position). cTrace amounts of epimer at piperidine p-position 
detected. dMinor amounts of epimer at piperidine 'Y-position isolated. 
Table 3 
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For the reaction of aminophenol rac-(95) with racemic aldehyde (99), no stereoselectivity 
was observed, whereas condensation with racemic ketone (101) furnished the 
corresponding tricyclic lactams rac-(108) with good stereoselectivity (aIb diastereomeric 
ratio 9:1). The moderate yield attained for rac-(108) (45 %) was accounted for by the 
isolation of considerable amounts of 2-vinylphenol. 
The application of conformationally rigid cis-l-amino-2-indanol (96) in the 
cyclocondensation reactions proved more successful, particularly with ketones (100, 
101). Tetracyclic lactams (109) and (111) were generated as the major products in good 
yield from aldehydes (98) and (102) respectively, with a stereoselectivity similar to that 
previously observed with phenylglycino1.57 However, in the case of racemic aldehyde 
(99), no dynamic kinetic resolution (DKR) was observed. Interestingly, formation of 
enantiopure lactam (111) involved the enantioselective desymmetrisation of two 
enantiotopic ester groups. 
In contrast, reaction of (96) with both prochiral ketone (100) and racemic ketone (101) 
gave much higher stereoselectivity than for the analogous reactions with 
phenylglycino1.57 The dynamic kinetic resolution of the isomerisable stereocentre a to the 
ketone carbonyl is highlighted by the formation of enantiopure lactam (113b), isolated in 
61 % following column chromatography. 
The use of aminoa1cohol (97) resulted in optimal yields and stereoselectivities for the 
cyclocondensation reactions involving aldehyde substrates (99) and (102-104). The 
reaction of (97) with racemic aldehyde (99) gave a 1:9 aIb stereoisomeric mixture of 
lactams (114) in 78 % yield, clearly indicating the occurrence of a DKR. The analogous 
condensation with racemic ketone (101) however, proceeded with low stereos electivity 
(3:2 118a1b) and hence it was concluded that no DKR had taken place. 
The prochiral aldehydo-diesters (102) and (104) produced 1:14 and 1:20 aIb 
stereo isomeric mixtures of the respective lactam esters (115) and (117) in excellent yield, 
indicating highly enantioselective desymmetrisations during condensation with (97). In 
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correlation with these findings, racemic oxodiester (103) underwent highly 
stereoselective condensation with aminoalcohol (97) to furnish one of the eight possible 
stereo isomeric lactams (116b), which was isolated in 69 % yield. This example rather 
impressively demonstrates the construction of three stereo genic centres with a well-
defined absolute configuration in only a single step. The highly stereoselective process 
involves DKR, with epimerization of the configurationally labile stereocentre in the 
substrate and also the desymmetrisation of two diastereotopic acetate chains. 
1.5 The Benzoquinolizidine Alkaloids 
1.5.1 Stereoselective Synthesis of the Tetrahydroisoquinoline Ring System 
The benzo[a]quinolizidine class of Alangium alkaloids are based on a fused tricyclic 
tetrahydroisoquinoline core (ABC ring) comprising of benzyl and piperidine subunits 
with 3,4-disubstitution at piperidine unit, C (119). 
MeO 
MeO 
(119) 
The potential of phenyl containing 5,6-bicyclic lactams derived from chiral amino 
a1cohols as precursors to functionalized benzo[a]quinolizidine alkaloids has yet to be 
fully explored. Protoemetinol (120) is an attractive synthetic target primarily due to its 
biological activity58 but also as a synthetic base unit for related alkaloids (122) and (123). 
Chapter 1 Introduction 31 
MeO 
MeO 
R 
( 
OH 
(120) R = H 
(121) R = OH 
~'" -,'-'::: .0 OMe 
OR 
(122) R = H 
(123) R = Me 
Protoemetinol and one of its analogues, ankorine (121), have potent anti-inflammatory 
properties. Such characteristics offer scope for the treatment of chronic inflammatory 
diseases such as tuberculosis and rheumatoid arthritis. They have been traditionally 
employed as a medicinal herb in China and can be extracted from the leaves of Alangium 
lamarckii.59 Psychotrine (122) and O-methylpsychotrine (123) have been demonstrated 
clinically to be potent inhibitors of the HIV transcriptase60 enzyme thus preventing 
multiplication of the virus. Both alkaloids can be extracted from species within the 
Alangiaceae plant family. Alangine (124), a recently isolated natural product also from A. 
lamarckii differs stereo chemically from compounds (120)-(123) in that it has trans 
relative stereochemistry at positions 2 and Ilb.61 
MeO 
HO 
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H 
~H 
(124) 
Figure 2 
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Allin and Vaidya utilised chiral bicyclic lactam substrates as precursors in a 
stereos elective approach towards the tetrahydroisoquinoline ring system.62 The approach 
allows the introduction of asymmetry during the key ring-closing step; the stereos elective 
cyclisations of a bicyclic lactam substrate (125) via an N-acyliminium intermediate (127) 
(Scheme 36). 
MeO Meo~ I 0 
MeO #ODH DeM, -10°C 20 h 
MeO 
(125) 
I + 0 Meo)(LC ,LA 
MeO h-oU 
(127) 
Scheme 36 
(126) 
OH 
o 
The desired tricyclic tetrahydroisoquinoline ring system (126) was isolated as a single 
diastereoisomer in 68 % yield. The use of bicyclic lactams derived from p-amino alcohols 
containing fused 5,5_63 and 5,6_41 ring systems in asymmetric synthesis has been 
extensive. This is believed to be the first application of the corresponding fused 5,6 
system (125) as a precursor in an N-acyliminium mediated cyclisation leading to the 
tetrahydroisoquinoline ring system. 
1.5.2 Stereoselective Synthesis of Benzoquinolizidine Alkaloids 
Hirai et al. have reported on the stereoselective synthesis of the Ipecac alkaloid (-)-
protoemetino1.64 The key step in the efficient synthesis involves a stereos elective 
intramolecular Michael reaction (Scheme 37). 
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Meom MeO I ~ :N Br- a) .. 
MeO ~ MeO 
oJ 
C02Et 
MeO 
c) 
MeO 
d)J C02Et C02Et 
MeO MeO 
0 e) 0 MeO .. MeO 
,,( 
"I 
0 C02Et C02Et 
MeO 
MeO 
"
1
,/ 
(120) OH 
Scheme 37 
Reagents: a) ethyl 4-bromobut-2-enoate, Zn dust, CH3CN, rt. b) 20 % oxalic acid, MeOH. c) 4-
methyleneoxetan-2-one, (C2Hs)20, rt. d) NaOEt, MeOH, rt. e) i) ethanedithiol, TFA, reflux ii) raney nickel, 
EtOH f) LiAIHt. 
1.5.3 Related Synthetic Targets 
(+)-Tetrabenazine (128) used clinically for the management of movement disorders, 
functions to deplete brain mono-amine levels via inhibition of the vesicular monoamine 
transporter type 2 (VMAT2).65 In humans, tetrabenazine (128) is rapidly and extensively 
metabolized by reduction of the 2-keto group, producing u- and B-dihydrotetrabenazine 
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(129). These alcohols also have high in vitro affinity for the VMAT2, and are likely the 
pharmacologically active agents in the mammalian brain.66 
MeD 
MeD 
o 
(93) 
1.6 The Manadomanzamine Alkaloids 
1.6.1 Background Information 
MeD 
MeD 
OH 
(94) 
Since the mid 1980s there has been a dramatic re-emergence of cases of tuberculosis 
around the world, with the WHO estimating that one-third of the world's population is 
current! y infected, with 3.1 million deaths annually. 67 The rapidly increasing threat posed 
by tuberculosis globally, particularly to women, adolescents and AIDS victims has 
stimulated a renewal of interest in discovering novel antituberculosis agents. 
In 2003, Hamann and co-workers identified two novel manzamine based alkaloids as 
potential marine-derived anti-infective leads.68 Indeed, both manadomanzamine A (130) 
and manadomanzamine B (131), isolable from the Indonesian sponge 
Acanthostrongylophora sp., exhibit significant activity against Mycobacterium 
tuberculosis (Mtb). Impressive MIC values of 1.9 and 1.5 flglml were attained for (130) 
and (131) respectively, and significant activities against both human immunodeficiency 
virus (HIV -1) and AIDS opportunistic infections (0 Is) were also documented. 
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Manadomanzamine A, 2213-H (130) 
Manadomanzamine S, 22 a-H (131) 
Figure 3 
1.6.2 Proposed Biogenetic Pathway of Manadomanzamines A and B 
Manadomanzamines A (130) and B (131) represent an unprecedented rearrangement of 
the manzamine skeleton and thus the alkaloids are suggested to derive from the more 
prevalent manzamines (Scheme 38).68 
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reduction .. oxidation .. 
(132) (133) (134) 
hydrolysis I 
(1301131) (136) (135) 
Scheme 38 
Manzamine B (132) is first reduced to tetrahydromanzamine B (133) and then oxidation 
of C-22 to form the imine (134) is followed by hydrolysis of the C-22-N-21 bond to 
furnish aldehyde (135). The aldehyde is, in turn, condensed with N-2 to construct the new 
ring (136), and N-21 attacks at C-12 leading to ring opening of the epoxide. The non-
stereoselective addition of the 2-ketopropyl is thought to occur either before the cleavage 
of the C-22-N-21 bond or after forming the C-22-N-2 bond. 
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1.6.3 Racemic Preparation of the Dodecahydrobenz[a ]indolo[3,2-h ]quinolizine 
System 
The pentacyclic dodecahydrobenz[a]indolo[3,2-h]quinolizine ring system, sometimes 
referred to as an 'inside yohimbane' has previously been prepared in racemic fashion by 
Morrison et al.69 The system was accessed via condensation of tryptamine (137) with 2-
formy1cyclohexaneacetic acid (138) and with subsequent LiAI~ reduction of the lactam 
carbonyl functionality (Scheme 39). 
o H Qn O"",!OH 0 - \ + H+ N NH2 ~ 
H 
(137) racemic (138) (139a) (139b) 
I j 
(140a) (140b) 
Scheme 39 
Fractional crystallization of the crude lactam afforded a 60 % yield of two trans epimers 
assigned as (139a) and (139b). It was proposed that reduction of these lactams gave the 
trans series of inside yohimbanes (140a) and (140b), as earlier preparation of (138) had 
revealed a significant trans bias.7o 
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1.7 Steresoselective Synthesis of Indole Alkaloids 
The indolo[2,3-a]quinolizidine ring system (141) is a common core of a plethora of 
highly bioactive indole alkaloids and has thus generated great interest as a target 
heterocycle. 
(141 ) 
Deplancheine (142) is an alkaloid isolated from the New Caledonian plant Alstonia 
deplanchei.71 Geissoschizine (143) is a pivotal biosynthetic intermediate for many 
monoterpenoid indole alkaloids and is of the corynantheoid class.72 Vellosimine (144), a 
sarpagine alkaloid, has been associated with curare-like activity.73 
CHO 
(142) (143) (144) 
Recent examples of the construction of this heterocycle include the use of the asymmetric 
Pictet-Spengler reaction74 in the synthesis of (+)-geissoschizine (143), and the 
diastereoselective vinylogous Mannich reaction employed by Martin75 , similarly towards 
(143). Other approaches of note include a Fischer indole synthesis undertaken by 
Montgomery76 and an application of the Bischler-Napieralski reaction, also by Martin et 
al.77 
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Allin et al. have recently developed a stereos elective synthesis of the indolo[2,3-
a]quinolizidine scaffold utilizing an indole nucleophile in a N-acyliminium cyclisation as 
previously described (Scheme 13).30 
The hydroxymethyl auxiliary group was removed via a series of oxidative steps, 
culminating in a tin mediated decarbonylation of the phenyl seleno ester (146) (Scheme 
40).30 
(145) 
DCM, 
o °C to rt, 
18 h 
Scheme 40 
.. 
(146) 
n-Bu3SnH, j Toluene, 
AIBN 80°C, 2 h 
o 
The presence of the lactam carbonyl moiety in the key BOC-protected building block 
(147) allows for divergence towards a range of natural product targets via selective 
chemistries (Scheme 41). 
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a) LOA, MeCHO 
b) Et3N, MsCI, OBN 
c) TBAF, THF 
(147) (148) 
(142) 
~ a) LOA, PhSeBr 
b) NaI04, NaHC03 
n-BuLi! THF 
.. 
0 C02Me 0 
sAs 
LJ 
s-t"C02Me H 1 ~s 
(149) (150) (151) OH 
Scheme 41 
In route 1, the ethylidene moiety was inserted through a three-step procedure, 
commencmg with generation of the lithium enolate of (147) and subsequent aldol 
reaction with acetaldehyde. Hydroxyl group activation was achieved by mesitylation and 
then followed by DBN-induced elimination to give BOC-protected (148). TBAF was 
employed in order to liberate the indole nitrogen and finally the lactam carbonyl group 
removed as previously reported by Martin.78 The desired target, (R)-( + )-deplancheine 
(142) was isolated with an ee of >95 %.30 
The alternative route towards the indole alkaloid derivative (+ )-12b-epidevinylantirhine 
(route 2) begins with the introduction of a,p-unsaturation in order to facilitate Michael 
addition at the 2-position. A suitable nuc1eophile, in this case 1,3-dithiolane-2-
carboxylate was lithiated and added to afford key intermediate (150) as a single 
diastereoisomer in 47 % yield. Desulfurisation of the dithioacetal with nickel boride was 
followed by formic acid deprotection of the indole nitrogen. Finally, global reduction of 
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the methyl ester and lactam carbonyl with lithium aluminium hydride furnished the 
desired target (151) in 50 % yield.79 
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CHAPTER TWO: 
POL YCYCLIC ALKALOIDS 
RESULTS AND DISCUSSION 
2.0 Stereos elective Synthesis of Polycyclic Alkaloid Templates 
2.1 Stereoselective Synthesis of the Tetrahydro-1H-pyrido[2,1-a]isoquinoline 
Ring System 
Access to the tetrahydroisoquinoline core of the benzo[a]quinolizidine class of alkaloids 
is now well established within our group. Methodology developed by Allin and Vaidya62 
allowed access to (152) and (126) in reasonable yield and with excellent 
diastereoselectivity. More recently, Allin and Thomas3o have successfully manipulated 
the indolo[2,3-a]quinolizidine template in order to furnish both enantiomers of the indole 
alkaloid deplancheine (Scheme 41). It was envisaged that a coupling of these 
methodologies would facilitate novel entry to the biologically active 
benzo[a]quinolizidine family of alkaloids (Figure 4). 
Q:&0H MeO OH 
.0 N 0 MeO 0 
H 
(152) (126) 
MeO MeO 
MeO HO 
(120) (124) 
Figure 4 
(+ )-Protoemetinol (120) and alangine (124) differ in the type of carbon substituents on 
the heterocyclic ring with the key point being that they exhibit the opposite relative 
stereochemistry at the 2 and 11 b positions. 
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The three step procedure employed to obtain the benzo[a]quinolizidine derivative (152) 
from (S)-phenylalaninol is illustrated in Scheme 42. 
uiOH LiBH4' Me3SiCI • VXOH Anhydrous THF ~ NH2 RT, 24 h ~ NH2 
(153) (154) 
Dean-Stark &e Toluene 
48 h (155) 
"'=0 
-fJ C5(5oH o ~ h ~ N 0 TiCI4 (1.5 eq) Cr~"H H DCM, -10°C 
(152) (156a/b) 
Scheme 42 
The synthesis began with the reduction of the readily available (S)-phenylalanine (153) 
using lithium borohydride and chlorotrimethylsilane8o to yield enantiomerically pure ~­
amino alcohol (154). It is hypothesised that the reduction proceeds via a borane-
tetrahydrofuran complex (157) with chlorotrimethylsilane assisting to act as the reducing 
agent (Scheme 43). The amino alcohol was obtained in 95 % yield and required no 
further purification. 
THF 
----.:...;....;..;...--. LiCI + Me3SiH + BH3.THF 
(157) 
Scheme 43 
The ~-aminoalcohol was condensed under Dean-Stark conditions with the appropriate 
keto-ester (155) for 48 hours to give a 4: I diastereomeric ratio (with respect to the 
protons on C-2 and C-5 of (156» in 50% yield. The major isomer (156a) has syn relative 
stereochemistry as confirmed by ID NOE experiments (Figure 5).62 
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o ~ h ;;P Q~"H 
H 
syn-(156a) 
(major isomer) 
Figure 5 
With syn-(156a) isolated, focus was directed toward the intramolecular N-acyliminium 
cyc1isation. Treatment of syn-(156a) with 1.5 eq of TiCl4at -10 QC in anhydrous DCM for 
20 hours resulted in the isolation of cyclised product (152) as a single diastereoisomer in 
65 % yield.81 Interestingly, it was also found that subjecting anti-(156b) to identical 
reaction conditions produced the same diastereoisomer, irrelevant of the stereochemistry 
before the planar iminium was formed. Thus, in subsequent synthesis of (126), the 
chromatographic separation of bicyclic lactam diastereoisomers (125a) and (125b) was 
deemed unnecessary and the crude mixture of (125) was carried forward to the TiCl4 
mediated cyc1isation reaction (Scheme 44). 
2.2 Stereoselective Synthesis of the Dimethoxy-tetrahydro-1H-pyrido[2,1-
a]isoquinoline Ring System 
To prepare the dimethoxy derivative of previous tricyclic ring system (152), the synthetic 
steps as detailed in Scheme 44 were employed. 
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MeO 
MeO~ I" /"-- )lOH 
MeoU ~H2 
(126) 
(158) 
OH 
o TiCI4 (3 eq) 
DCM, -78°C 
THF 
rt, 24 h 
Meo~OH 
Meo~ NH2 
(159) 
Dean-Stark 
Toluene 
48h 
OMe 
)loMe ~O 
(155) 
o ~ )IN-- .. ·H JlN ,,'H ~O l;i",o 
H (125a) H (125b) 
Scheme 44 
OMe 
The synthesis began with the acid catalysed transesterification of o-valerolactone (160) 
with methanol to produce the ring-opened target, methyl-5-hydroxypentanoate (161), in 
quantitative yield (Scheme 45). This was not purified as relactonisation is known to 
occur readily during distillation or aqueous work Up.82 
0 
U + ~e H ,MeOH .. reflux, 5 h OH 
(160) (161 ) 
Scheme 45 
The alcohol (161) was subsequently oxidised to the corresponding aldehyde methyl-5-
oxopentanoate (155), using pyridinium chlorochromate in 68 % yield (Scheme 46). The 
aldehyde was taken forward to the cyclocondensation reaction with no further 
purification required.82 
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0 0 
~e pec, DCM ~e .. 2h 
"'0 OH 
(161) (155) 
Scheme 46 
Keto-ester (155) was condensed with amino alcohol (159) under Dean-Stark conditions to 
furnish a 6: 1 (syn/anti) mixture of isolable bicyclic lactam diastereoisomers syn-(125a) 
and anti-(125b) in a reasonable combined yield of 62 %.81 
As previously mentioned, both syn-(156a) and anti-(156b) led to the formation of the 
same, enantiomerically pure tricyclic product (152). Based on this knowledge, a crude 
mixture containing the syn and anti epimers of (125) was carried forward to the TiCl4 
mediated cyclisation. As expected, the reaction proceeded cleanly to the formation of a 
single diastereoisomer (126) in considerably higher yield (79 %) than (152) (62 %). 
Assuming that the condensation reaction to produce the cyclised target (126) proceeds via 
the N-acyliminium intermediate (127), the mechanism would be that suggested in 
Scheme 46a. The enhanced nucleophilic character imparted on the aryl ring by the 
electron donating methoxy groups is believed to result in a more efficient ring closing 
onto the N-acyliminium ion (127). 
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MeO~OH c. 
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.. 
H 
j ~~ 
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MeO 
OH 
o 
Scheme46a 
Single crystal X-ray analysis was employed to confirm the stereochemical outcome of the 
cyclisation i.e. the syn relationship between the C-15 hydroxymethyl auxiliary and the C-
5 proton (Figure 6).81 Furthermore, ID NOE studies revealed no signal enhancement of 
H-15 when irradiating the H-5 signal and vice versa. 
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Figure 6 
2.3 Rationalisation for the Stereochemical Outcome of the Cyclisation Reactions 
Felkin-Anh-like conformational models can be invoked in order to rationalise the 
stereochemical outcome of the cyclisation reactions of bicyclic lactams (125a!b) and 
(156a/b). The largest substituent of the stereocentre is positioned perpendicular to the 
carbonyl group to give two very distinct conformations. The conformational mode of the 
N-acyliminium ion (127) that arises from the TiCl4 activation of the bicyclic lactam 
substrates (125a!b) and (156a/b) is depicted in Figure 7.83 
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___ .... (152), (126) 
syn exclusively 
R 
R=H,OMe 
---_a Anti not obsereved 
Figure 7 
In the case of conformation A, which leads to the favoured products (126) and (152), the 
carbonyl moiety is 'eclipsed' in a 1,3-fashion by the relatively small hydrogen atom at the 
J3-amino alcohol chiral centre. The steric positioning of the Lewis acid-complexed 
oxymethyl group here is favoured as the angular hydrogen atom at the imino carbon atom 
provides no sufficient steric bulk to interfere. 
The alternative conformation B would give rise to the anti-epimers of (126) and (152) i.e. 
the minor products but neither is observed. In this case the benzyl group is positioned as 
the larger substituent leading to an unfavourable 1,3-destabilising interaction between the 
carbonyl group and the more bulky Lewis acid-complexed oxymethyl group. It is also 
thought possible that as TiCl4 is capable of multipoint coordination, some degree of 
chelation control i.e. complexation of the Lewis acid-complexed oxymethyl group to the 
carbonyl oxygen could occur. 
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2.4 Manipulation of the Dimethoxy-tetrahydro-1H-pyrido[2,I-a]isoquinoline 
Ring System 
Having developed a synthetic route to the dimethoxy-tetrahydro-lH-pyrido[2,1-
a]isoquinoline core, which forms the synthetic base of several biologically interesting 
benzo [a]-quinolizidine alkaloids, we decided to investigate template functionalisation. 
The presence of a reactive carbonyl group on the C ring provides a handle for 
derivatisation e.g. enolate derivatisation and potential conjugate addition to ring C 
(Figure 8). The presence of asymmetry in the molecule, set up by the cyclisation 
reaction, could provide stereocontrol for the aforementioned functionalisation reactions. 
It was reasoned that investigation of these elaborative procedures would determine the 
suitability of our template as an intermediate in the synthesis of target alkaloids. 
MeO 
MeO 
(126) 
OH 
o -----
H 
potential al~lic /' 
functionalisation 
OH 
o 
~ enolate alkylation 
~ , introduction of 
a,~ unsaturation 
potential conjugate addition 
Figure 8 
2.4.1 Removal of the Hydroxymethyl Substituent 
It was first decided to investigate the possibility of efficient removal of the 
hydroxymethyl 'handle' as it is not present in any of the benzo[a]quinolizidine alkaloid 
targets. This would also allow for investigation of C ring elaboration in an equivalent 
manner to protecting the hydroxymethyl group, which will also be examined. Our 
proposed route for removal of the hydroxymethyl group from (126) consisted of a four-
step tin-mediated radical decarbonylation strategy (Scheme 47). 
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MeO MeO OH 
0 
IBX1 DMSO • 0 
MeO rt, 24 h MeO 
(126) (162) 
NaCI02 
CH3CN 
t-BuOH 
NaH2P04 H2O 1-methyl-1- o °C to rt 
cyclohexene 17 h 
MeO 
(PhSe)2 
MeO PBU3 
.. 
DCM 
0 0 
MeO reflux, 20 h Mea 
(164) (163) 
n-Bu3SnH Toluene 
AIBN 80°C, 24 h 
Mea 
MeO 
o 
(165) 
Scheme 47 
The initial step involved oxidation of (126) to produce the corresponding aldehyde (162). 
The aldehyde was obtained as a single diastereoisomer with the use of either Dess-Martin 
periodinane or its precursor IBX in yields of 63 % and 70 % respectively. The reagent of 
choice was IBX, not only due to the higher yield attained, but also owing to its facile 
formation from the cheap and readily available starting materials 2-iodobenzoic acid and 
potassium bromate.84 The aldehyde (162) was oxidised with sodium chlorite85 in 
straightforward fashion as previously demonstrated by the group on indole-based 
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templates, and acid (163) was isolated in a respectable 86 % yield. Initial attempts to 
synthesise the phenyl seleno ester (164) with diphenyl diselenide and tri-n-butyl 
phosphine proved successful but in extremely poor yields (ca. 20-30 %) under similar 
conditions to those employed by Martin.86 Yields were improved significantly by 
refluxing the reaction for 20 h, and acyl selenide (164) was isolated in 76 % yield. 
The phenyl seleno ester (164) was subjected to tin-mediated radical decarboxylation 
conditions in order to afford target (165) in similar fashion to previous examples by 
Martin.86 The target compound was isolated in excellent 81 % yield having successfully 
demonstrated the removal of the hydroxymethyl substituent via an overall 
decarboxylation process. 
2.4.2 Introduction of a,p-Unsaturation 
The introduction of (l,p-unsaturation was undertaken following methodology developed 
by Jones, Mundy and Whitehouse, whereby olefins can be readily accessed via syn 
elimination of the corresponding selenoxide.87 The procedure described by Reich to 
effect such a transformation was modified as detailed in Scheme 48.88 
LDA (3 eq) MeO 
0 
PhSeBr (1.5 eq) 
0 .-
THF MeO 
-78°C to rt 
19 h SePh 
(165) (166) 
NOT ISOLATED 
NaI04 ] MaOH, H,o 
NaHC03 rt, 20 h 
MeO 
0 
MeO 
(167) 
Scheme 48 
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The enolate of the decarboxylated product (165) was generated using LDA (3 eq) and 
trapped with phenylselenyl bromide (1.5 eq) at -78 QC to produce selenide (166). The 
selenide was not purified but directly treated with sodium metaperiodate to promote 
selenoxide syn elimination to give the desired a,p-unsaturated target (167) in 61 % yield 
over 2 steps. 
2.4.3 Conjugate Addition Study 
With the a,p-unsaturated compound (167) in hand, our attention turned to the possible 
conjugate addition of a nucleophile which in turn could be further elaborated towards the 
desired alcohol chain. The nucleophile of choice was vinyl magnesium bromide as this 
has been previously highlighted as a suitable precursor for such a conversion via 
hydroboration.89 The l,4-addition was effected by addition of vinylmagnesium bromide 
in the presence of stoichiometric amounts of CuCN and trimethylsilyl chloride as an 
accelerator (Scheme 49). 
MeO 
o 
MeO 
(167) 
VinylMgBr (15 eq) 
CuCN (7.5 eg) 
TMSCI (7.5 eq) 
THF, -78°C to 0 °C 
then -78°C, 24 h 
Scheme 49 
MeO 
• o 
The addition product (168) was isolated in 67 % yield and as a single diastereoisomer, 
with the relative stereochemistry revealed by ID NOE studies to be as shown in Figure 
9. No positive NOE interaction was observed between the protons at positions 2 and lIb 
and, due to the formation of (168) as a single diastereoisomer, it was not possible to 
perform comparative NOE studies. We were however able to obtain more conclusive 
support for trans relative stereochemistry of protons 2 and lIb of the product through a 
positive ID NOE interaction as indicated in Figure 9. 
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H po~tive NOE CH 2 
interaction 
Figure 9 
o 
In the case of the nucleophilic species attacking from the opposite face, one would expect 
to observe the opposite NOE interactions to those mentioned. The stereochemical 
outcome of the conjugate addition could be explained by the preference of the 
nucleophilic species to adopt a pseudo-equatorial position on the lactam ring. 
With target (120) in mind, we decided to attempt l,4-addition with commercially 
available ethyl l,3-dithiolane-2-carboxylate. Previous work in the group has 
demonstrated successful desulfurisation of the dithioacetal followed by reduction to yield 
the desired alcohol chain.79 Unfortunately, subjection of a,p-unsaturated compound (167) 
to the lithiated dithiolane unit on several occasions failed to yield anything other than 
starting material, perhaps owing to the reversible nature of the addition (Scheme 50). 
J'2Et 
MeO 
SLJS 
MeO 
LDA (2 eq) 
0 ~ • 0 MeO THF MeO 
-78°C to rt, 24 h 
(167) (169) 
Scheme 50 
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In 2004, Vanderwal and J acobsen9o reported a general procedure for the enantioselective 
hydration of a,p-unsaturated imides by aluminium-catalyzed conjugate addition of oxime 
nuc1eophiles (Scheme 51). An a,p-unsaturated imide (170) is treated with an oxime 
nuc1eophile to afford a crude oxime ether (172), which in turn yields catalytic 
hydrogenolysis product (173) in high yields without erosion of optical purity. 
R~Ntph 
H 
HQ,"H 
~N;~Nh ~u~_~ y y_~ tBu 
(170) 
tBu tBu 
x = O-AI (salen) 
(171) 
Scheme 51 
We envisaged that application of this methodology would allow introduction of the 
alcohol moiety at the C-3 position, concurrent with the functionality of tetrabenazine 
targets (128) and (129). Enantioselectivity was not considered important as the alcohol 
moiety would be oxidised to the corresponding ketone in the case of tetrabenazine (128) 
and could possibly be selectively reduced to produce a or P-dihydrotetrabenazine (129). 
Chlorinated, aromatic and ethereal solvents were all described as poor media for the 
oxime addition and therefore removed from our screening (Scheme 52). Unfortunately, 
all attempts to access oxime ether (174) failed to yield anything other than starting 
material. 
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OH N .... OH 
~ MeO 
(salicyladoxime, 1.2 eq) 
0 X • 0 MeO (salen)catalyst (5 mol %) 
1. cyclohexane 
2.hexane o_~ 3. acetonitrile 
rt to reflux, 48 h I~ 
(167) (174) ~ 
Scheme 52 
After these disappointing results, we decided to investigate the viability of epoxidation in 
order to introduce oxygen at the 2 position. We first attempted to form epoxide (175) 
using standard electrophilic peracid conditions, but only starting material was recovered, 
presumably due to the electron deficiency of the conjugated alkene (167). However, 
epoxidation with a standard nucleophilic epoxidising species. hydrogen peroxide (2 eq) 
with sodium hydroxide (2 eq) in water, also failed to yield target (175) (Scheme 53). 
MeO m-CPBA MeO 
X • 
MeO 
0 CHCI3 , reflux, 18 h 0 MeO 
H20 2, NaOH 
X • 
(167) H20, rt (175) 
Scheme 53 
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2.4.4 Protection of the Hydroxymethyl Substituent 
In view of the fact that the opposite stereochemistry at the 2 position of (168) is required 
to proceed toward our initial target (-)-protemetinol (120), a new strategy was devised for 
the l,4-addition. It was thought possible that facial selectivity could be reversed by 
leaving the hydroxymethyl substituent intact and protecting with a group of extreme 
steric bulk. Protection of the hydroxymethyl was carried out with imidazole (3 eq) 
followed by DMAP (0.1 eq) and TBDPSCI (1.5 eq) to give (176) in almost quantitative 
yield (Scheme 54).91 
MeO 
MeO 
MeO 
MeO 
MeO 
MeO 
OH 
o 
imidazole (3 eq) 
DMAP (0.1 eq) 
.. 
TBDPSCI (1.5 eq) 
DCM,O °C to rt, 16 h 
(126) 
(178) 
OTBDPS 
o 
VinylMgBr (15 eq) 
CuCN (7.5 eq) 
TMSCI (7.5 eq) 
THF, -78°C to 0 °C 
then -78°C, 24 h 
(179) 
OTBDPS 
o 
MeOH, H20 
rt, 24 h 
Scheme 54 
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MeO 
MeO 
MeO 
MeO 
(176) 
LDA THF 
PhSeBr -78°C to rt 
18 h 
(177) 
NOT ISOLATED 
OTBDPS 
o 
SePh 
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To TBDPS protected compound (176) was added LDA (3 eq) and then PhSeBr (1.5 eq) at 
-78 QC to furnish selenide (177). The limited solubility of (177) hindered selenoxide 
elimination, and as a result, the corresponding a,~-unsaturated compound (178) was only 
isolable in 42 % yield. It was possible however to recover virtually all of the unreacted 
selenide and repeat the process. 
The conjugate addition product (179) was accessed using conditions similar to those 
previously described in the synthesis of the analogous compound (168), Scheme 49. 
Analysis of the crude IH-NMR spectrum of the product indicated the formation of a 
single diastereoisomer which was purified via column chromatography to give (179) 
exclusively in 70 % yield. The attempt to block the ~-face from nucleophilic attack was 
confirmed to have failed by undertaking a ID NOE study. As previously observed, no 
positive NOE interaction was seen for the protons at positions 2 and 11b. The positive 
NOE interaction between proton 11 b and the vinyl proton (Figure 9) was evidence 
enough to assign the relative stereochemistry as cis. 
In contrast to the axial attack of the vinyl cuprate under stereoelectronic control to give 
the kinetic product (179) (Scheme 54), the conjugate addition of the enolate of ethyl 1,3-
dithiolane-2-carboxylate to unsaturated lactam (178) affords a 1:1 mixture of isomers 
(Scheme 55). It is reasoned that the conjugate addition may be reversible in this case and 
thus both isomers (180a) (2,11b, trans, kinetic) and (180b) (2,11b, cis, thermodynamic) 
are formed under the reaction conditions (-78 QC to rt, 24 h). 
C02Et 
sAS 
MeO OTBOPS LJ 
0 LOA (2 eq) 
MeO THF 
-78°C to rt, 24 h 
(178) 
Scheme 55 
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MeO 
MeO 
OTBOPS 
0 
S 
Et02C sJ 
(180a):(180b) = 1 :1 
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2.5 Amino Alcohol Scale Up Attempt 
In order to produce amino alcohol (159) on a multi-gram scale for the preparation of the 
dimethoxytetrahydro-1H-pyrido[2,1-a]isoquinoline template, the steps detailed in 
Scheme 56 were undertaken. 
o 
HO~OH N ~H2 HO 
(181) 
Et3N (1.2 eq) 
BOC20 (1.05 eq) 
Dioxane, H20 
o °C to rt, 24 h 
HOn° I '-'::: OH 
.0 NH 
HO A 
o O~ 
(182) I "' 
• 
KOH (1.1 then 2.2 eq) DMF 
Mel (1.1 then 2.2 eq) 0 °C to rt, 18 h 
I NaBH4 (4 eq) MeO)()):OH .0 NH .... ---E....!.tO....:...H----'~-
M eO A 0 °C to rt, 18 h 
o 0'-.C' 
(184) I "' 
TFA (20 eq) DCM 
rt 
MeO~OH 
~ NH2 MeO 
(159) 
Scheme 56 
o 
MeO~OMe )l) ~H 
MeO A 
o O~ 
(183) I "' 
Initial Boc protection of the amine of L-DOPA (181) with Et3N (1.2 eq) followed by 
BOC20 gave (182) in quantitative yield. Protection of the amine was necessary to 
facilitate regio-selective methylation in the subsequent step towards (183). The protected 
species was exposed to KOH (1.1 eq) followed by MeI (1.1 eq) to initially yield the ester. 
Secondly, the methoxy groups that are required in the target amino alcohol (159) were 
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introduced by simple repetition of addition of KOH (2.2 eq) followed by MeI (2.2 eq) to 
furnish (183) in a 76 % yield. 
Elaboration of compound (183) to the target amino alcohol (159) was achieved via 
reduction of the ester group with NaB~ (4 eq) giving (184) in excellent 89 % yield. This 
was followed by Boc-deprotection with TF A (20 eq) to produce target compound (159) in 
84 % yield. IH-NMR analysis indicated the formation of an enantiomerically pure 
product, with no epimerization noted. 
Although we have successfully demonstrated the synthesis of the target amino alcohol 
(159) from cheap, commercially available L-3-(3,4-dihydroxyphenyl)alanine, scaling up 
to 20g of starting material resulted in significant yield loss and therefore the route was 
deemed impractical. 
2.6 Literature Approaches Towards Benzo[a]quinolizidine Systems 
In a very similar approach to our group, Garcia et al.92 developed methodology for the 
construction of the benzo[a]quinolizidine skeleton involving either a Parham or N-
acyliminium ion cyclisation. a,p-Unsaturation was introduced by an oxidative elimination 
of a selenoxide in order to facilitate screening of sulfur-stabilised anions (Scheme 57). 
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Meo~ 
Meo~O~O 
(185) 
a), b) 
• 
MeO 
0 
MeO 
(165) R1 = H (83 %) 
(186) R1 = Me (84 %) 
I c), d) 
MeO 
0 
MeO 
(167) R1 = H (56 %) 
(187) R1 = Me (61 %) 
Reagents: a) NaB~, EtOHlH20, HCl, 0 °C (for 165); MeLi, -78°C (for 186). b) TFA, DCM, rt. c) LDA, -
78 cC, PhSeBr. d) PIDA, TFA, MeCNIH20, rt (for 167); H20 2, pyridine, 0 °C to rt (for 187). 
Scheme 57 
For the conjugate additions, 2-lithio-l,3-dithiane and bis-(phenylthio )methyllitihium were 
chosen as the group had previously shown their differing behaviour in l,4-additions.93 
The latter anion would be more stable whereas its acyclic structure allows rotation, 
optimising orbital overlap with the conjugate acceptor.94 It was ob~erved that no reaction 
took place when conjugate acceptors (167) and (187) were added to the lithiated anions at 
-78°C. Optimisation revealed that l,4-addition occurred when the anion was allowed to 
reach room temperature with subsequent quenching with (167) or (187) (Table 4). This 
could possibly account for the failure of lithiated ethyl l,3-dithiolane-2-carboxylate to 
undergo addition to (167) as illustrated in Scheme 50. 
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a) (167), (187) -----=---. 
(Table 4) 
MeO 
MeO 
Reagents: a) (R2S2hCm..i, - 78 cC, 1 h. 
RLi RI 
MeO 
MeO 
(2RS, 11bRS)-(188) (2SR, 11 bRS)-(189) 
(2RS, 11 bRS)-(190) (2SR, 11bRS)-(191) 
(188a), (189a) R1 = H, R2 = Ph 
(188b), (189b) R1 = H, R2 = -(CH2h-
(190a), (191a) R1 = Me, R2 = Ph 
(190b), (191 b) R1 = Me, R2 = -(CH2b-
Scheme 58 
R2 Yield t(h) Product 
dr 
Entry 
(%) translcis 
1 Ph>-Li H Ph 16 189a 5a <5:>95 
PhS 
2 Ph>-Li H Ph 5 189a 70 <5:>95 
PhS 
3 C>-Li H -(CH2h- 5 189b 85 <5:>95 
S 
4 
PhS)-
Li Me Ph 16 190a:191a 93 80:20 
PhS 
5 CS)-Li Me -(CH2h- 16 190b:191b 84 85:15 
S 
6 CS)-Li Me -(CH2)3- 5 190b:191b 75 88:12 
S 
a Cyclopropane denvatlve obtamed m 68 %. 
Table 4 
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Thus, benzo[a]quinolizinones (167) and (187) undergo conjugate addition of suI fur-
stabilised anions with opposite facial selectivity. These results are in agreement with 
those published by Amat and Bosch95 , who have examined the factors controlling facial 
selectivity in the l,4-addition of several nucleophiles to phenylglycinol-derived 
unsaturated bicyclic lactams. Similar effects have been observed by Allin96 for conjugate 
addition reactions on various indolo[2,3-a]quinolizine templates. 
In the case where R = H (167), nucleophilic attack proceeds under stereoelectronic 
control, parallel with respect to the axial hydrogen lIb (exo attack). This gives rise to a 
1,3-syn diaxial interaction between the substituents in the resulting intermediate A 
(Figure 10). However for (187) (R = Me), also a conformationally rigid lactam, anti-
parallel attack to yield the more stable trans diastereoisomer through an intermediate 
such as B is observed. This is promoted by the unfavourable 1,3-syn diaxial interaction in 
the intermediate or the transition state leading to it. 
MeO ~ 
MeO 
1,3-syn 
n 
~lN-ibU 
Meo~----
MeO A 
I 
(2SR, 11 bRS)-(189), (191) 
parallel attack 
(R = H) 
t anti-parallel attack 
(R'=Me) J 
R =Me 
~y-; Meo~ ~NU 
MeO B 
I 
(2RS, 11 bRS)-(188), (190) 
Figure 10 
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Of great importance in this area is the enantioselective two-step route to 
polyfunctionalised benzo[a]quinolizidines developed by Amat and Bosch.97 The 
approach involves the stereoselective condensation of a racemic or prochiral ()-
oxo(di)ester (192a-c) with (3,4-dimethoxyphenyl)alaninol (159). The resulting masked 
N-acyliminium ion present in the bicyclic lactams (193a-c) generated facilitates 
stereocontrolled cyclisation on the aromatic ring (Scheme 59). The amino alcohol used 
not only serves as the chiral inductor for the cyclocondensation; it is also used to 
assemble the final target polycyclic products. 
MeO Meo~ 
OyN"O 
Vn~~ (193a) 8""1 
Me02'L JHO MeO 
(192b) J Meo~ MeO~OH Me02C ~ h ~ NH2 67% 0y8~ MeO 
(159) (193b) 2 
Meo2~o 
Me02C 
(192c) 
Me02C 
Scheme 59 
70% MeO 
OH 
o 
TiCI4 • Me°n-;r~H 
35% Meo'.~ 17 
(194b) :: 
........ C02Me 
OH 
o 
Cyclocondensation of amino alcohol (159) with racemic y-alkyl ()-oxoester (192a), which 
contains a stereocentre capable of epimerization, gave (193a) as the major product out of 
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the four possible enantiopure stereoisomeric lactams. The process involved a dynamic 
kinetic resolution (DKR) of the racemic substrate with minor amounts of the 
diastereoisomer at the S and Sa positions formed. Oxodiester (192b) was similarly 
condensed to furnish enantiopure lactam (193b) in 67 % yield with minor amounts of the 
diastereoisomer at the 7 and Sa positions. The process involved the desymmetrisation of 
the two enantiotopic ester chains. More interestingly, treatment of racemic o-oxoester 
(192c) with amino alcohol (159) constructed three stereogenic centres in a single 
stereoselective step to give 60 % of (193c). Of the other seven possible stereoisomeric 
lactams, only the diastereoisomer at the 2, 8 and Sa positions was isolated in a minor 
amount. 
The stereoselective cyclisation of lactams (193a-c) was promoted with either BF3·Et20 or 
TiCl4 to give enantiopure benzo[a]quinolizidines (194a-c) (detectable by NMR 
spectroscopy). N-acyliminium ion cyclisations upon the 3,4-dimethoxybenzene ring are 
known to occur under kinetic conditions3! without stereochemical equilibration. This 
gives rise to the rationale that the 6,llb-trans relationship seen for (194a-c) is of a result 
of stereoelectronically controlled axial attack of the aromatic ring as shown in conformer 
A (Figure 11). 
A B 
Figure 11 
The alternative cyclisation via the chair-like conformation B is disfavoured due to the 
allylic 1,3-strain between the pseudoequatorial hydroxymethyl substituent (Lewis acid 
complexed) and the lactam carbonyl. The hydroxymethyl auxiliary plays a decisive role 
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as a stereocontrol element in determining the relative stereochemistry of chiral centre 11 b 
generated through cyclisation.98 Such models are analogous to those proposed by our own 
research group. 
Scheme 60 depicts the removal of the hydroxymethyl appendage from (194b) to give the 
enantiopure cis-benzo[a]quinolizidine-2-acetate (195) that matches the relative cis 
stereochemistry of important targets such as protoemetinol (120) at centres 2 and 11 b. 
This is complementary to the trans relative stereochemistry set up at the 2 and 11 b 
positions by our group, which covers trans-type targets such as alangine (124).99 
MeO 
MeO 
(194b) 
OH 
o 
1. Dess-Martin 
2. NaCI02 
3. (PhSe2h, n-Bu3P 
4. AIBN, BU3SnH 
Scheme 60 
MeO 
o 
MeO 
(195) 
The synthetic steps employed to oxidise to the carboxylic acid which is in turn converted 
into a seleno ester and radically decarbonylated, are those recently developed by Allin30 
and also applied to the unfunctionalised piperidine derivative of (194b), (126) (Scheme 
47). 
2.7 Conclusion 
In summary we have developed a facile and highly stereoselective approach to the 
important dimethoxytetrahydro-lH-pyrido[2,I-a]isoquinoline ring system from readily 
available non-racemic substrates. The formation of an N-acyliminium intermediate allows 
for the key cyclisation via attack of a pendant aromatic substituent nucleophile. 
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We have also demonstrated the removal of the hydroxymethyl appendage from the 
system, highlighting the potential of our novel template for manipulation towards 
synthetic targets. Furthermore we have functionalised the C-3 position of our polycyclic 
template (126) through the application of Michael addition chemistry, which may 
constitute a key step in our future progression towards our targets. 
Schemes 61 to 63 provide a rounded overview of the key transformations described 
throughout this chapter. 
• Stereoselective synthesis of a dimethoxytetrahydro-1H-pyrido[2,1-a]isoquinoline 
derivative through cyclisation of an N-acyliminium intermediate (Scheme 61). 
OMe 
TiCI4 (3 eq) 
.. 
DCM, -7SoC 
Scheme 61 
MeO 
MeO 
(126) 
OH 
o 
• Removal of the pendant hydroxymethyl substituent from (126) via radical 
decarbonylation of an acyl selenide (Scheme 62). 
MeO Toluene MeO 
SO°C, 24 h 
.. 
MeO 0 n-Bu3SnH MeO 
0 
AIBN 
(164) (165) 
Scheme 62 
• Functionalisation of a,p-unsaturated compound (167) via diastereoselective 1,4-
addition of a vinyl group (Scheme 63). 
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MeO 
MeO 
(167) R = H 
(178) R = CH20TBDPS 
VinylMgBr (15 eq) 
CuCN (7.5 eq) • 
TMSCI (7.5 eq) 
THF, -78°C to 0 °C 
then -78°C, 24 h 
Scheme 63 
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2.8 Asymmetric Construction of the Dodecahydrobenz[a]indolo[3,2-
h]quinolizine Ring System 
2.8.1 Introduction 
o 
(196) 
Access to the pentacyclic dodecahydrobenz[a]indolo[3,2-h]quinolizine ring system (196) 
is of great interest as this heterocyclic template is a common sub-structure of several 
bioactive indole alkaloids (Figure 12). Manadomanzamine A and B (1301131) exhibit 
strong activity against Mycobacterium tuberculosis and HIV -1 and Aids opportunistic 
infections.68 
'-
tJ":;.N.HCI H" ~ 
(130/131 ) (197) (132) 
Figure 12 
Manzamine A (197) and related structures are highly potent, orally bioavailable 
antimalarial agents that are more effective than most currently available therapeutics, i.e. 
chloroquine and artemisinin. lOo Manzamine B (132) was isolated by Higa and co-
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workers 101 in 1987 from the marine sponge Haliclona sp., collected from Okinawa. Its 
quite unique and complex structure contains a ~-carboline and tetracydic ring system as 
well as 11- and 13-membered aza-cydes with (Z)-olefins. Initial screening revealed 
cytotoxicity against P388 mouse leukaemia cells (IC50 6 ~glml), but more material is 
required for a complete survey. 
2.8.2 Synthetic Strategy 
Our research group, and others, have reported a substantial body of work in recent years 
on the development of asymmetric routes towards important heterocydic templates 
centred upon novel, highly diastereoselective N-acyliminium cydisations.27,3o,62 Allin et 
a1.30,79 have recently applied this methodology in the successful construction of several 
indole alkaloid targets. Identical retrosynthetic principles were applied to the 
manadomanzamine core and consequently Scheme 64 was devised. 
\ I \ H > 
~OH ~~ ~H" N 2 °cnr
H 
OH 
o 
, I, I 
+ 
H 
(196) (198) (138) 
Scheme 64 
Pentacydic target (196), with three contiguous stereocentres at ring positions 1, 10 and 
24 was deconstructed to furnish (S)-tryptophanol (198) as both the source of indole 
moiety and chiral auxiliary. Also revealed is bi-functional aldehydo-acid (138), required 
to facilitate initiallactamisation and eventually become the octahydroisoquinolin-3(4H)-
one component of the template. 
Bi-functional substrate (138) was prepared using a procedure previously employed by 
Cook and co-workers 102 whereby ketones are homologated via Wittig functionalisation 
and subsequent hydrolysis to yield the corresponding aldehyde (Scheme 65). 
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OMe o H 
0 CH3OCH2PPh3CI cYroEt O""yH mOEt 2M HCI KOtBu 55°C .. .. Toluene, rt THF:H2O (3:1) 
(199) (200) rac-(138) 
Scheme 65 
Commercially available ketone (199) was converted to the corresponding enol ether (200) 
in 64 % yield using methyltriphenylphosphonium chloride (2 eq) and potassium tert-
butoxide (3 eq). Subsequent treatment with 2M HCI served the dual purpose of ester and 
vinyl ether hydrolysis to furnish (138) as a mixture of cis and trans isomers (1:3) in 
quantitative yield. The preparation of (S)-tryptophanol on a multi-gram scale is routine 
within the group and this was prepared cleanly in 82 % yield (Scheme 66). 
o 
~OH V ~ ~H? N 2 
H 
(201) 
LiBH4' Me3SiCI .. 
Anhydrous THF 
rt, 24 h 
Scheme 66 
~OH \:::::Z)\ N H? N 2 
H 
(198) 
2.8.3 Stereochemical Outcome of the Cyclocondensation Reactions 
Bosch and Amat have investigated the use of racemic multi-functional aldehyde 
substrates in stereoselective condensation reactions in some detai1.56 In a similar fashion, 
aldehyde (138), a racemate, and (S)-tryptophanol were subjected to the standard Dean-
Stark conditions in toluene for 24 h to give a 1:1 mixture of two readily separable 
diastereoisomers (202a1b) in 69 % yield (Scheme 67). 
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-.;: -....;: 
~#I '? ~#I ~ 
Or ~"'Yo OH ---.:..:To=lue.::..:..;n=-e -- >t§-U 24 h • 2 H ",H 
\\ 10 
H' H 
~OH 
"'=Z ~ NH? + N 2 
H 
(198) rac-(138) (202a) (202b) 
Scheme 67 
The relative stereochemistry of (202a) was determined by NOE studies as summarised in 
Figure 13. The protons at ring positions 1 and 24 give a positive NOE to each other 
while neither gives an NOE to the proton at ring position 10. Further confirmation of the 
relative trans stereochemistry across the ring junction C-lO to C-24 is provided via the 
positive NOE interaction between the proton at C-l and the proton of fixed 
stereochemistry from the chiral auxiliary. 
positive NOE 
interaction 
(202a) 
Figure 13 
positive NOE 
interaction 
Crucially, diastereoisomer (202a) has both the relative and absolute stereochemistry that 
matches that of the manadomanzamine natural products at the C-IO and C-24 positions. 
At this point, the stereochemistry revealed at the C-l position bore no significance as it is 
this hemiaminal centre that is lost during formation of a planar iminium species in the key 
N-acylimium-mediated cyclisation step. The relative stereochemistry of the second 
diastereoisomer (202b) was elucidated by X-ray crystallographic analysis and may prove 
useful in future analogue generation studies (Figure 14). 
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Figure 14. Crystal structure of (202b) 
In order to rationalise the stereochemical outcome of each cyciocondensation, the 
formation of hemiaminal intermediates (203a) and (203b) from each enantiomer of 
aldehyde (138) was studied (Scheme 68). 
~5' H I ",':'(OH 
HO (5)-198 
H 
H02C~ 
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H 
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.. 
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~ HN 0 N ~ 0 
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.. H 
H' 
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H()<:r= OH 
IIIH 
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(203b) (202b) 
Scheme 68 
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In each case a trans-decalin like conformation is adopted in the reactive intermediate, 
with an all equatorial substitution pattern. These favoured arrangements serve to 
minimise diaxial interactions, with the H-atom at the hemiaminal centre for both (203a) 
and (203b) assuming an axial orientation prior to irreversible lactamisation. 
2.8.4 Stereochemical Outcome of the Cyclisation Reactions 
With bicyclic lactam (202a) in hand, we turned our attention to the key N-acyliminium 
cyclisation step in order to construct the pentacyclic manadomanzamine natural product 
framework. Subjection of masked N-acyliminium ion (202a) to 2M HCI in ethanol for 18 
h at room temperature induced acid-catalysed cyclisation to give (204a) as a single 
diastereoisomer in 73 % yield (Scheme 69). 
2MHCI 
EtOH 
rt, 18 h 
• 
(202a) (204a) 
Scheme 69 
positive NOE 
interaction 
positive NOE 
interaction 
(204a) 
NOE experiments were again undertaken to reveal that the relative and absolute 
stereochemistries at ring positions 1, 10, and 24 of (204a) matched that of the natural 
product. The hydroxymethyl (CH2) group gives a positive NOE to the proton at ring 
position 1 which in turn gives a positive NOE to the proton at position 24. Neither of 
protons 1 or 24 gives a positive NOE to the proton at ring position 10. 
We proposed that the stereocontrol observed arises from conformation (205a) (Figure 
15), which would allow for minimal A(1·3) strain between the lactam carbonyl group and 
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the H-atom at the stereo genic centre of the tryptophanol moiety. The indolyl nucleus 
subsequently attacks from a pro-equatorial orientation leading to a seemingly preferred 
axial positioning of all three H-atoms at the three contiguous chiral centres C-l, 10 and 
24. 
A(1,3) 
~O H Y-N~ 
.?=:,!!J, ; = CH,OH 
Ar 
(20Sa) 
Figure 15 
Identical conditions to those described for the cyclisation of (202a) (Scheme 69) were 
applied to lactam substrate (202b) which bares the desired relative trans stereochemistry 
across the ring junction C-lO to C-24 but not the correct absolute stereochemistry. 
Cyclisation proceeded cleanly to give a comparable 75 % yield of a single 
diastereoisomer as illustrated in Scheme 70. 
~ HN 0 N HO 
(202b) 
2M Hel 
EtOH .. 
rt, 18 h 
(204b) 
Scheme 70 
positive NOE 
interaction 
(204b) 
In this instance NOE studies led to the stereochemical assignment above (204b) as 
protons at the 1 and 10 positions of the ring give a positive NOE to each other. The 
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hydroxymethyl CH2 also gives a positive NOE to the proton at the 1 position but no 
signal enhancement of either H-l or H-I0 was observed when irradiating the H- 24 signal 
and vice versa. 
In order to explain the stereochemical outcome observed, the transition state must lead to 
a pro-axial attack onto the N-acyliminium ion (Figure 16). Despite this requirement, the 
preferred conformation (205b) is adopted in order to minimize the A(i,3) strain between 
the H-atom at the stereogenic centre of the trytophan moiety and lactam carbonyl 
group.ID3 
A(1,3) 
O~ 
~H/ 
H HO 
(205b) 
Figure 16 
2.9 Development of a Functionalised Dodecahydrobenz[a]indolo[3,2-h] 
quinolizine Ring System 
With successful construction of test template (204a) in hand, we needed to modify the 
aldehydo-acid substrate to incorporate a masked ketone functionality for subsequent 
enolate functionalisations of the A ring. Also, the ketone is required to introduce one of 
the two terminally-unsaturated alkylamine substituents that are put in place via reductive 
amination. Our full retrosynthetic analysis details the importance of such a handle in 
order to introduce RCM precursors (Scheme 71). 
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2.9.1 Modification of Wittig/Hydrolysis Homologation Route 
It was initially envisaged that the starting material employed in the adapted Cook 
procedurel02 (Scheme 65) to yield aldehydo-acid (138) could be simply fine-tuned to 
prepare our revised bifunctional target (211) with analogous chemistries. Commercially 
available l,4-cydohexanedione monoethylene acetal (208) was converted to the 
corresponding methyl ester (209a) by simple enolate formation with KHMDS (1.15 eq) 
and subsequent trapping with methyl bromoacetate (1.15 eq). Having obtained (209a) in 
72 % yield following flash column chromatography, repetition of the Wittig chemistry 
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used to prepare vinyl ether (200) failed to deliver the analogous acetal-protected 
compound (210) (Scheme 72). 
Q ° 6r KHMDS I OMe Methyl- (!roM. CH3OCH2PPh 3CI bromoacetate KOtBu .. X .. THF Toluene, rt 0 
-78°C to rt 
°LJO V LJ 
(208) (209a) (210) 
H30· t 
Q ",,'!OH 
0 
rao-(211) 
Scheme 72 
It was revealed by IH-NMR and HMQC studies that the acetal protecting group was 
sensitive to the Wittig reagent and as a direct result; an intractable mixture of mono and 
bis-enol ethers was obtained. This in turn prevented our global hydrolysis strategy to 
reveal aldehydo-acid (211) with the desired A-ring ketone in place. 
2.9.2 Adaptation of Darzens Procedure 
The next step taken was to examine the Morrison 70 procedure for the preparation of 2-
formylcyclohexaneacetic acid (138) in the previously discussed synthesis of inside 
yohimbanes (Chapter 1, Scheme 39). In similar fashion to our Wittiglhydrolysis 
protocol, ethyl 2-(2-oxocyclohexyl)acetate (199) is the chosen starting material but the 
homologation is achieved via Darzen's condensation to furnish glycidic ester (212). Base 
catalysed hydrolysis and decarboxylation gave a mixture of the corresponding lactone 
(213) and aldehyde (138). The mixture was refluxed with dilute acid to promote the 
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establishment of an equilibrium mixture of the cis and trans isomers of (138) with the 
trans isomer predominating ca. 1:3 respectively (Scheme 73). 
KOtBu C02Et o~ 0 0 Ethyl- &roEI Na I AcOH (YroEI brom oacetate EtCH/H2O H2O ",''!OH .. QoCtort" t-Butanol reflux Q °C to rt 
(199) (212) (213) rac-(138) 
Scheme 73 
(209b) was prepared through a suitable enolate alkylation using the previously 
established conditions (Scheme 72). Slight fine-tuning of the Darzen conditions was 
required, with crude epoxide (214) being formed in 74 % yield using potassium tert-
butoxide (1.5 eq) and ethyl chloroacetate (1.6 eq) in ether at low temperature. Rather 
unfortunately, (214) proved to be sensitive to chromatography and all attempts to 
promote the hydrolysis/decarboxylation sequence on crude (214) failed with either 
starting material recovered or an intractable mixture formed in each case (Scheme 74). 
KOtBu ~OEI 0!6 o H 0 Q"",!OH MOEl Elhyl- Na I AcOH bromoacetate .. EtOH/H2O H2O X .. 
o Et20 Q °c to rt reflux 
o 0 -10 °C to rt o 0 
°Ll LJ LJ 0 
(20gb) (214) (215) rac-(216) 
Scheme 74 
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2.9.3 Development of a HydroborationJOxidation Protocol 
With our initial strategies failing to deliver either an acetal protected or deprotected 
derivative of our initial substrate ethyl 2-(2-oxocyclohexyl)acetate (199), our attention 
I 
was turned to attempting an in situ hydroboration/oxidation sequence. Application of 
standard Wittig conditions to keto-ester (209a) delivered the required alkene substrate 
(217) in quantitative yield. The first approach employed standard hydroboration 
conditions104, but we were not able to effect oxidation of the boronated intermediate to 
produce (218) using hydrogen peroxide in sodium hydroxide. However, simple exchange 
of oxidising reagent from hydrogen peroxide to pyridinium chlorochromate, mirroring an 
in situ procedure applied to l,4-cyclohexanedione monoethylene acetal (208) by 
Bonjoch,105 afforded key aldehyde (219) directly in 70 % over 2 steps (Scheme 75). 
° ~OMe _C_H3_:_:_~_3B_r_. y 0 THF,rt 
°LJo 
(209a) 
cYr0Me H3S·SMe2 NaOH, H20 2 ° X· THF, rt 
°LJo 
(217) 
crrOMe 
U 
(218) 
oxidation j 
1. H3S·SMe2, THF 
2. PCC, DCM ~ y ~ OMe 
U 
rac-(219) 
Scheme 75 
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2.9.4 Stereochemical Outcome of the Cyclocondensation Reactions 
With acetal-protected bifunctional substrate (219) in hand, our focus turned to the 
proposed cyc1ocondensation reaction with (S)-tryptophanol in order to generate 
asymmetric building blocks (220a) and (220b). Application of Dean-Stark conditions 
afforded two readily separable diastereoisomers in a modest 45 % yield as illustrated in 
Scheme 76. The ratio of isomers in the crude reaction mixture was confirmed as 1:1 by 
IH-NMR studies, this being identical to the analogous lactams (202a1b) lacking A-ring 
functionalisation. 
~OH ~ ~ ~H? + N 2 
H 
~~ 
Dean-Stark HN 0 N ~ 0 HN O~H 0 
Toluene. 1 H "H 
24 h }4 10 ' 
H' A H 
~ ____ p °LJO 
(198) rac-(219) (220 a} (220b) 
Scheme 76 
The absolute stereochemistry of hexacyc1ic lactam (220a) was confirmed using ID NOE 
studies, as all attempts to produce a crystal large enough to provide a sufficient repeat 
unit for X-ray analysis proved unsuccessful. Signal augmentation was observed for H-24 
when irradiating the H-l signal and vice versa. In addition, irradiation of the H-l signal 
also highlights a positive NOE interaction with the proton of known stereochemistry from 
(S)-tryptophanol. No enhancement of the proton at the C-lO position is observed when 
irradiating either the H-l or H-24 signal (Figure 17). 
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interaction 
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interaction 
o 0 
'L..J 
(220a) 
Figure 17 
The absolute stereochemistry at the three contiguous centres C-l, 10 and 24 of (220a) 
matches that of the manadomanzamine natural product targets as did the test substrate 
(202a). Also in accordance with previous results, NOE studies revealed (220b) to have 
the opposite trans stereochemistry across the ring junction C-1O-24 to (220a). When 
irradiating either H-l or 24, a signal enrichment of the other is observed but unlike 
(220a), no positive NOE exists between the protons at the 1 and aminoalcohol 
stereocentre. Furthermore, no signal augmentation of the proton at the 10 position 
occurred when irradiating neighbouring protons 1 and 24 (Figure 18). 
positive NOE 
interaction 
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Figure 18 
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2.9.5 Stereochemical Outcome of the Cyclisation Reactions 
In continuation of our previously established protocol for the highly diastereoselective 
cyclisation of an indolyl nucleus onto such N-acyliminium intermediates, 2 M HCI in 
ethanol at room temperature were the first conditions applied (Scheme 77). Despite the 
harsh reaction conditions, vigorous stirring for 18 h or above only afforded a 1:1 mixture 
of deacetalised cyclised product and deacetalised lactam for both (220a) and (220b). 
Optimisation of these conditions revealed that for (220a), heating at 50 QC for 3 h would 
promote complete deacetalisation and cyclisation and the same transformation was 
effected in a significantly longer 18 h reaction time for (220b). 
~ HN 0 N ~ 0 
O\.. ..... P 
(220a) 
O,--p 
(220b) 
~ ~ // I ~ 2~~~1 HN 00 
.. 
rt, 18 h H 
H'\\ 
° (221 a) 
~ // I ~ 
2M Hel HN HO 
EtOH 0 N 
.. 
rt, 18 h 
o 
(221b) 
Scheme 77 
+ 
+ 
0 
(222a) 
o 
(222b) 
In the case of lactam (220a), it appears that although the overall cyclisationldeprotection 
yield is comparable with that of (220b) (56 % to 58 %), the pro-equatorial attack and/or 
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the deacetalisation step is favoured as completion time is significantly less 05 h) than for 
(220b). From a synthetic standpoint, although deacetalisation at this early stage does not 
constitute a major challenge as differentiation with the amide carbonyl is facile, we may 
wish to proceed with a masked ketone until the enolate chemistries are met. For this 
reason we decided to screen Lewis acid catalysts to investigate the possibility of acetal 
retention through the cyclisation. The reason for using (220b) as the test lactam was 
twofold, not only is it the least valuable from a synthetic standpoint, it also appears to be 
more resistant to cyclisation and thus is a good standard for (220a). A full summary of 
parameters applied to this synthetic difficulty is given in Table 5. It was found that 
regardless of the level of cyclisation, complete acetal cleavage was observed without 
exception. 
Temp Time 
Entry Lactam AcidlLewis acid Product Yield (%) (QC) (b) 
1 (220a) 2MHCI rt 18 (221a)/(222a) (1:1) 63 
2 (220b) 2MHCI rt 18 (221b)/(222b) 0:1) 67 
3 (220a) 2MHCI 50 3 (222a) 56 
4 (220b) 2MHCI 50 18 (222b) 58 
5 (220b) TiCl4 (3 eq) -10 16 (222b) 65 
6 (220b) BF3·0Et2 (3 eq) rt 16 (221b)/(222b) 0:1) 53 
Table 5 
Structural elucidation was once again achieved via NOE studies to confirm that the three 
contiguous chiral centres present in (222a) matched that of the manadomanzamine 
natural product targets. Irradiation of the proton at ring position 1 gave a positive NOE to 
both the proton at position 24 and one of the hydroxymethyl CH2 protons. These three 
protons therefore must be on the same face of the template, and with the chirality of the 
hydroxymethyl centre fixed, we can assign the stereochemistry as shown in Figure 19. 
Rather tellingly, no signal enhancement was recorded for H-lO whilst irradiating H-l 
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interaction 
positive NOE 
interaction 
o 
(222a) 
Figure 19 
The second diastereoisomer (222b) was again proven to have the opposite trans 
stereochemistry across the ring junction C-1O-24 to the required isomer (222a). 
Irradiation of H-l resulted in a signal enhancement of both H-lO and hydroxymethyl CH2 
i.e. a positive NOE. Furthermore, when irradiating H-IO a signal enrichment of H-l is 
observed but no such relationship is observed between H-lO and H-24. The 
stereochemical outcome of this cyclisation is summarised in Figure 20. 
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2.9.6 Removal of Hydroxymethyl Auxiliary 
There are several well established methods within the group for the removal of the chiral 
auxiliary that is not present in our alkaloidal targets. The most direct route, a one step 
procedure involving high grade Raney nickel, was most recently applied by Allin et al in 
the synthesis of the anti-tumour alkaloid (R)-( + )crispine A 106 Despite effecting 
hydroxymethyl removal in quantitative yield however, chiral shift IH-NMR studies 
revealed that racemisation had taken place. 
In the case of our pentacyclic core (222a), we rationalised that the proton at the fixed 
centre C-lO would provide stereocontrol in the event of scrambling aminal centre C-l 
thus eliminating the previously observed racemisation of simpler templates. Despite 
preparing fresh Raney nickel in the laboratory, as it has been found critical to do so in our 
group, only an intractable mixture was observed when attempting the reaction (Scheme 
78). 
W-2 Raney nickel 
0 Toluene 
X .. 
Dean-Stark 
24 h 
0 0 
(222a) (206) 
Scheme 78 
The possibility of rhodium catalysed decarbonylation of the corresponding aldehyde of 
hydroxymethyl containing alkaloid templates has been studied extensively within our 
group.ID7 Most recently, this two-step procedure was employed by Allin et al106 in the 
successful synthesis of (R)-(+)crispine A with an ee >99%. Initial oxidation of the 
hydroxyl group was achieved via IBX oxidation to give aldehyde (223) in 75 % yield 
following flash column chromatography (Scheme 79). 
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Despite using the previously optimised conditions for decarbonylation, of 5 % 
chlorocarbonylbis(triphenylphosphine)rhodium (I) and 12 % diphenylphosphinopropane 
and refluxing for 4 days, the reaction failed to proceed cleanly. Only a trace amount of 
target compound (206) was observed by IH-NMR analysis of characteristic peaks within 
an irresolvable product mixture. 
Due to time constraints the final and previously successful four-step removal strategy 
(Scheme 47), involving radical decarbonylation of an acyl selenide, was not attempted. 
2.9.7 Conclusion 
In summary, we have developed the first highly asymmetric syntheses of pentacyclic core 
templates of the manadomanzamine alkaloids. Both the initial test synthesis and 
subsequent development of a functionalised A-ring core allow the controlled formation of 
the correct relative and absolute stereochemistries at the C-1, 10 and 24 positions. 
Schemes 80 to 82 outline the key transformations involved in construction of the 
manadomanzamine heterocyclic skeleton and are described in more detail throughout this 
chapter. 
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• An in-situ hydroborationloxidation protocol to liberate key trans-aldehyde rac-
(219) (Scheme 80). 
.. 
2. pec, DCM 
Scheme 80 
• Stereos elective condensation of (S)-tryptophanol (198) and rac-(219) to afford 
key asymmetric building block (220a) (Scheme 81). 
~OH \=Z ~ ~H? + N 2 
H 
(198) rac-(219) 
Scheme 81 
~ 
Dean-Stark H NON ~ 0 
Toluene 
24 h 
.. 
O\......~'O 
(220a) 
• N-acyliminium mediated cyclisation of lactam (220a) to furnish functionalised 
core (222a) with the required stereochemistry at the three contigous centres C-l, 
10 and 24 (Scheme 82). 
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CHAPTER THREE: 
TETRACYCLINE RING SYSTEMS 
INTRODUCTION 
3.0 The Tetracycline Antibiotics 
3.1 Background Information 
The seemingly insurmountable challenge of the total synthesis of elaborate natural 
products which are potent antimicrobial agents has long intrigued synthetic chemists. 
Classically, such complex antibiotics are only accessible via multi-step manipulation of 
isolated natural products (semi-synthesis). The absence of a practical synthetic route 
restricts the quest for analogues that might be studied as new antibiotic candidates. J08 
The tetracycline class of antibiotic is characterized by a common scaffold of four linearly 
fused six membered rings with a high density of polar functionality, labelled A to D. The 
A-ring is typically highly functionalized and eis-fused to the B-ring, the C-ring contains a 
tetrasubstituted stereo genic centre and the D-ring is aromatic. This combination is 
exemplified by (-)-tetracycline (Figure 21).109 
HO 0 o 
Figure 21 
The tetracyclines are broad spectrum antibiotics and as a result have been extensively 
clinically employed in human and veterinary medicine over the past 50 years. IIO This has 
inevitably led to the emergence of resistant strains of pathogenic bacteria, heightening 
resurgent interest in studying the mechanisms of resistance and in developing new 
antibiotics. 1 1 1 
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Aureomycin (224) (chlortetracycline) was the first member of the tetracyclines to be 
discovered, isolated from a culture of Streptomyces aureofaciens by Duggar in 1948Y2 
Just two years later, Finlay et al. described methods for the isolation and purification of a 
new broad spectrum antibiotic terramycin (225) (oxytetracycline) yielded from 
Streptomyces rimosus. I13 The third known natural antibiotic in the series is 
demeclocyc1ine (226) (demethylchlortetracycline). 114 
HO 0 HO ~ 0 0 HO 0 o 
(224) (225) 
HO 0 o 
(226) 
Figure 22 
Second generation tetracyclines (those not available by purely microbiological techniques 
and synthetically manipulated) now play a major role in chemotherapy. Of these, the 
glycy1cyclines are currently the only derivatives that exhibit antibacterial activity 
comparable to that of the early tetracyclines when they were first introduced. These 
compounds show potent activity against a broad spectrum of Gram-positive and Gram-
negative bacteria, including tetracycline resistant strains. Two of the glycylcycline 
derivatives DMG-MINO (227) (9-aminominocycline) and DMG-DMDOT (228) (9-
amino-6-demethyl-6-deoxytetracycline) (Figure 23), have been studied by several 
groups. 1 IS 
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(227) (228) 
Figure 23 
Several other unnatural, semi-synthetic tetracyclines are frequently utilized in a clinical 
sense, these include rolitetracycline (229) (pyrrolidinomethyltetracycline), 116 
methacycline (230) (6-methyleneoxytetracycline),117 doxycycline (231) (6-
deoxyoxytetracycline)118 and minocycline (232) (7-dimethylamino-6-demethyl-6-
deoxytetracycline)119 (Figure 24). 
H 
Ni 
HO 0 0 0 HO 0 
(229) (230) 
Me QH NMe2 
= H = H = 
- :: - :: - OH 
NH2 
HO 0 0 HO 0 
(231) (232) 
Figure 24 
Among the derivatives highlighted in Figure 24, those with the hydroxyl group removed 
from carbon 6 of the C-ring have shown particular clinical promise. These 6-
deoxytetracyclines (231) and (232) exhibit greater stability and equal or greater potencies 
. 'b . I . . h' 6 h d 110b 118 H III antI actena assays III companson to t elr - y roxy counterparts.' owever, 
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elaboration of natural tetracyclines is significantly limited in terms of scope and general 
synthetic routes to diverse tetracyclines prove elusive. 
3.2 Synthetic Approaches to the Tetracyclines 
Over the last 50 years there has been little variation in synthetic approaches toward the 
tetracycline antibiotics with the predominant area of research being limited to semi-
synthesis. 120 There is now, however, extensive literature built up around the subject 
stimulated by the arduous challenge that the number of proximate asymmetric centres 
presents. Bearing this in mind, it is deemed no small feat that all of the major 
tetracyclines have fallen to synthesis. The majority of approaches towards the total 
synthesis of tetracyclines have proceeded with a stepwise assembly of the ABCD ring 
system, commencing with either a D or CD-ring precursor, and are typically low 
yielding. 
The first total synthesis of a tetracycline antibiotic was reported by Woodward and co-
workers in 1968 starting with m-methoxybenzoate (233) as the A-ring synthetic unit in 
the synthesis of (±)-6-demethyl-6-deoxytetracycline (234).121 Despite the length of 
synthesis and poor overall yield (25 steps, -0.002 % yield), there is great historical 
significance in such a breakthrough (Scheme 83). 
Chapter 3 Introduction 100 
I .0 3 steps .. q co2Me C02Me 8 steps .. 
MeO MeO MeO 0 
(233) 
Jal 
C02Me 
0 9 steps 
• OH 
MeO 0 HN' t Bu MeO 0 HO 
(NOT ISOLATED) 
Jbl 
NMe2 
0 
3 steps 
• NH2 CONHtBu 
MeO HO HO HO HO 0 0 
(234) 
Reagents: a) NaH, dimethyl oxalate, MeOH, DMF, 20-80 °C b) NaH, MeOH, DMF, 120°C 
Scheme 83 
The Muxfeldt group achieved the total synthesis of (±)-terramycin (225) in 1979, 
adopting a novel approach with juglone (235) chosen as the starting material, a suitable 
CD ring precursor. i22 The synthesis centered upon a key aldehyde (236) that could be 
either condensed with the corresponding oxazolone or thiazolone. The thiazolone 
derivative (237) was selected for simplicity and condensed with glutamate derivative 
(238) to construct the tetracycline core (239), and notably the A and B rings in the one 
step. This low-yielding but most elegant condensation created 3 new C-C bonds in a 
single step with the appropriate substitution as the highly crystalline desired 
diastereoisomer was obtained (Scheme 84). 
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Ph X Ph 
QQ H N~S - 0 0 N===\ W~s 40 ~ """-::; 12 steps 1,,-::; 0 .. .. 
OH 0 MOMO 0 MOMO 0 
(235) (236) (237) 
Jl,U 
MeO (238) NH2 
X'Q H~lph 
H = H = 
: : OH 
« 
6 steps 
NH2 NH2 
HO 0 0 MOMO 0 0 
(225) (239) 
Scheme 84 
In 1996 the most efficient construction of the tetracycline ring system thus far was the 
synthesis of (±)-12a-deoxytetracycline (243) by the Stork laboratory (16 steps, 18 to 25 
% yield).123 Siloxyketal (241) was generated from the C ring ketone (240) with the 
desired simultaneous protection of the keto, tertiary hydroxyl and phenolic groups in ring 
C. Subsequent deprotonation initiates the cascade Dieckmann cyclisation to generate 
(242) in a respectable 59 % yield considering the dual construction of the C and D rings. 
However, the absence of a hydroxyl group at the fusion point between the A and Brings 
is associated with greatly reduced antimicrobial activity. 
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OBn a) ~ OBn 
OH 0 TMSO OTMS OMe 
(240) (241) 
j b) 
1:1 ~Me2 
c) : 0, 
• j,N 
CONH2 
OH 0 OH OH OH 0 OH OH 
(243) (242) 
Reagents: a) TMSCN, KCN, 18-crown-6, DCM b) KH, THF, -78 to 0 cC, then rt to 50°C c) H2IPd (1 atm), 
THFMeOH 
Scheme 85 
3.2.1 Myers' Asymmetric Total Syntheses of the Tetracyclines 
In 2005 Myers reported a groundbreaking short and convergent enantioselective synthetic 
route to a diverse range of 6-deoxytetracyc1ine antibiotics. 1osb The route was initiated by 
whole-cell microbial dihydroxylation of benzoic acid (which would become the B ring of 
the targeted 6-deoxytetracyc1ine (231) using a mutant strain of Alcaligenes eutrophus. 
The stereo genic centre produced at the future ring junction position would elaborate all 
others in the target molecule. Diol (244) was obtained in a promising 79 % yield and with 
>95 % enantiomeric excess. 
Innovatively, Myers' group opted for initial construction of an AB-ring precursor enone 
(245) which could in turn be stereospecifically coupled to a D-ring precursor (246) via 
the Michael-Dieckmann reaction. This step simultaneously constructs the C ring thus 
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completing the four linearly fused ring scaffold of target (231). This approach allows for 
rapid and facile access to analogues via structural manipulation of the D-ring and also 
linear extensions to novel E-ring derivatives. Most significantly, of the four possible 
tetracycline diastereoisomers that in theory may have been yielded from this reaction, the 
analogues are formed as largely one diastereoisomer with stereochemistry that matches 
that of the natural product (Scheme 86). 
a) 
(244) 
b) 
(246) 
CbZ? H ~Me2 
14steps. W{ 
o § 0 OSn 
OTSS 
(245) 
SaeO 0 HO ~ 0 
OTSS 
HO 0 
e) 
d) 
(231) 
o 
Reagents: a) A. eutrophus B9 b) LDA, TMEDA, THF, then (245), -78°C to 0 °C c) HP, MeCN d) H2IPd, 
THF,MeOH 
Scheme 86 
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Although the convergent approach is primarily designed to facilitate access to new, 
possibly more potent derivatives, Myers demonstrated the immense versatility of the 
strategy in the synthesis of (-)-tetracycline (Figure 21).124 It was devised to proceed from 
an AB-ring cursor (247) (10 steps from benzoic acid, 11 % yield, >95 % ee), previously 
employed in the synthesis of 6-deoxytetracycline analogues. The introduction of a 
phenylthio substituent in the a-position of the enone served to activate the molecule 
towards Diels-Alder cycloaddition. Heating a neat mixture of activated enone (248) with 
diene precursor (249) furnished the required endo-cycloadduct. Only four steps from the 
advanced position of having the tetracycline framework in place (250) were required in 
order to synthesise (-)-tetracycline (Figure 21) (Scheme 87). 
H ~Me2 WiN 
o H 0 OBn 
H ~Me2 
__ a_),_b_) _. ('flr~'N 
PhS~ 
o H 0 OBn 
(247) (248) 
eccMe ~ , c) I ~ 
OTES (249) 
4 steps 
.. 
-
HO 0 o 
o 
BnO 0 H 0 
TESO SPh 
(250) 
Reagents: a) HPy·Br3, DeM, b) PhSH, DBU, DMF c) (249), neat, 85 QC) 
Scheme 87 
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The distinct advantages of Myers' synthesis over all other previous attempts are indeed 
the simplicity of the starting materials and also the facile access it provides to a vast array 
of both natural and synthetically modified tetracyclines. 
3.3 Structurally Related Linear Systems 
3.3.1 The Angucycline Antibiotics 
The angucyclines with a unique benz[a]anthraquinone as a common structure (Figure 
25) are a rapidly growing new class of antibiotics. Urdamycinone B (251),125 urdamycin 
B (252),126 C104 (253)127 and aquamycin (254)128 exhibit a variety of biological activities 
including anti-tumour activity and enzyme inhibition. 129 
OH 0 
(251) R = H 
(253)R-pj Me 0 Me HO~O 0 HO~ 
Figure 25 
OH 0 0 
~(252) R = n-C5Hl1 
OH 0 
(254) 
Me 
In 1999 Matsuo and co-workers achieved the total synthesis of urdamycinone B, a 
prototypical member of the C- glycosylangucycline antibiotics via a novel and effective 
strategy without any protecting group in the sugar moiety.126 The synthetic approach 
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began with juglone (235) as a suitable CD-ring precursor, elaborated over 4 steps to yield 
glycosyl acceptor (255). The aryl C-glycosidation of (255) and the unprotected D-olivose 
(256) was realised by previously established methods, generating the desired P-C-
glycoside (257). The A-ring was introduced as a constituent of the diene B-ring precursor 
(259) that underwent regioselective Diels-Alder cydoaddition with the unprotected 
dieneophile (258) to assemble the tetracydic framework. Urdamycinone B (251) was 
synthesised in a further 3 steps from key intermediate (260) (Scheme 88). 
y) 
OH 0 
(235) 
Me QQ HO~ I: I HO OH 4 steps (256) .. .. a) 
OH OBn 
(255) 
. Me 
SiMe2Ph 
°lSiMe'Ph 
~ (259) 
OH 0 
(260) j 3 steps 
OH 0 
(251 ) 
SPh 
.. 
c), d) 
"'OH 
OH 0 
(257) 
b) j 
OH OBn 
(258) 
Reagents: a) (256), TMSOT, MeCN, rt, 1 h b) H2, 10 % PdlC, MeOH, rt, 1 he) (259), B(OAch, DCM, rt, 2 
h d) DBU, DCM, rt, 0.5 h 
Scheme 88 
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CHAPTER FOUR: 
TETRACYCLINE RING SYSTEMS 
RESULTS AND DISCUSSION 
4.0 A Novel Iterative Route towards the Tetracycline Antibiotics 
In the ongoing quest to develop new tetracycline antibiotics in order to combat the 
inevitable emergence of bacterial resistance, it is most evident that recent synthetic 
advances in this area have been critical. 
Our group has recently proposed a novel and versatile route towards linear-fused ring 
frameworks that could facilitate entry to the tetracycline and related natural product 
systems. The proposed route centres upon an innovative iterative protocol of aromatic 
Claisen rearrangement/ring closing metathesis (ReM) chemistries (Scheme 89). 
OH 
RX> I~ al!llate • 1 ~ R 
OH 
(261) 
• 
Repeat 
sequence 
1 __________ _ 
OR2 OR3 OR4 OH 
(266) 
O~ 
RX> aromatic I~ Claisen .. 
R1 ~ 
O~ 
(262) 
iii oxidise 
iv rearomatise 
.. 
(265) 
Scheme 89 
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(263) 
I 
i protect 0 H 
ii RGM 
R1~ 
R1~ 
OR2 
(264) 
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It was proposed that bis-allylation of diol (261), suitably protected at the 2 and 3 position 
would furnish diallyl ether (262) which would undergo Claisen rearrangement to yield 
hydro quinone (263). Alcohol protection and subsequent ring closing metathesis is 
expected to yield bicyclic linear fused adduct (264) which provides access to 1,4-
napthalenediol (265) via sequential oxidation and rearomatisation. With (265) in hand, 
we believe it possible to construct further rings in a left-to-right fashion by recycling into 
the iterative process outlined, and ultimately obtain polycyclic templates such as (266). 
In order to allow for functional group manipulation of the linear core at an advanced 
stage, alcohol protection is carried out following each Claisen rearrangement utilising 
complementary groups that would, at a later stage, enable selective deprotection of any 
pair of hydroxyl groups. 
4.1 Preparation of a Bicyclic Linear-Fused Adduct 
Scheme 90 depicts the successful elaboration of (267) towards the bicyclic linear-fused 
adduct (271) as recently demonstrated within the group.130 With the proposed 
ClaisenIRCM strategies established as a viable synthetic protocol, the extended linear 
cores would be pursued. 
:Q CH2CHCH2Br i?~ K2C03 Acetone Mesitylene .. .. reflux, 24 h reflux, 24 h 
OH O~ OH 
(267) (268) (269) 
DMAP 0 °C to rt A~O j 
TEA 20 h 
:QC I: I Grubbs 2 .. THF rt, 24 h 
OAc OAc 
(271) (270) 
Scheme 90 
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Diallylation of 2,3-dimethylhydroquinone (267) using conventional conditions furnished 
the Claisen-precursor (268) in an excellent 92 % yield following flash column 
chromatography. Double aromatic Claisen rearrangement was achieved by employing 
methodology previously reported by Widenhoefer, whereby a bis-allyl ether such as 
(268) is refluxed in mesitylene for 24 hourS.131 The resulting hydro quinone was obtained 
in a respectable 70 % yield, however it was shown to be unstable above 0 °C and 
consequently carried forward to the protection step without further purification. 
Contrary to our preliminary results, Kotha et al. 132 reported the thermal Claisen 
rearrangement of substrate (268) with quinone (272) as the product obtained (Scheme 
91). However, this would appear to require an oxidation to occur in addition to 
rearrangement and subsequent analysis of our Claisen product (269) has confirmed the 
sole product of the reaction to be the required hydro quinone (269). 
:Q~ 
O~ 
(268) 
Mesitylene 
reflux, 24 h 
[3,3] • 
Scheme 91 
o 
(272) 
We initially chose to protect the alcohol moieties as the corresponding acetates using 
standard conditions to produce diacetate (270) in 90 % yield. In order to complete the 
first left-to-right elaboration of the linear ring system, a ring closing metathesis was 
performed using Grubbs 2nd generation catalyst. 133 The bicyclic target (271) was isolated 
in an efficient 93 % yield following flash column chromatography. 
Having accomplished the synthesis of key adduct (271), attention was turned to the 
subsequent oxidation and rearomatisation steps necessary to furnish l,4-naphthalenediol 
(274). This would allow second entry into the cumulative process and hence construction 
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of the third ring, a feat currently unreported in the literature to our knowledge (Scheme 
92). 
OAc W ~ ~ [0] .. I ~ I rearomatise .. I ~ ~ h- h- h-
OAc OAc 0 OAc OH 
(271) (273) (274) 
Scheme 92 
4.2 Oxidation of the Bicyclic Linear-Fused Adduct 
Numerous methods for the oxidation of unfunctionalised hydrocarbons have been 
developed over the years.134 The dual benzylic and allylic properties of the site at which 
we required the introduction of oxygen functionality were predicted to induce rapid 
oxidation. Due to a benzylic carbon being analogous to an allylic carbon in its reactivity, 
this offers the distinct advantage of increased scope as oxidative methods are applicable 
to both systems and many general procedures are frequently utilised. 135 
Successful oxidation of diacetate adduct (271) to the diacetate of napthazarin (273) was 
reported as early as 1986 by Rodriguez and co-workers. 136 However, when the method of 
adding substrate (271) to a solution of chromium trioxide in acetic acid at 0-5 cc was 
replicated, adduct (271) and elimination product (275) were recovered as a mixture 
(Scheme 93). 
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OAc 
(271) 
CrG,. AcOH. ~ /yV 
OAc 
(275) 
CrG":C
0H
• W 
Scheme 93 
OAc 0 
(273) 
The preparation of naphthalenedione (273) Via oxidation of the corresponding 
naphthalene diacetate derivative (271) has previously proved unsuccessful within the 
group (Table 6). Several methods, including those reported by Wiberg137 and Rathore, 138 
allylic oxidation through selenium dioxide in ethanol and benzylic oxidation via 
pyridinium chlorochromate respectively, have failed. 
Entry Conditions Product 
1 Cr03/AcOH136 (275) 
2 SeOzlt-BuOOH
JJY 
(275) (catal ytic and stoichiometric) 
3 SeOz/EtOH (275) 
4 PCC (275) 
5 Cr03It-BuOOHI40 (275) 
6 ~O~Alz03141 (275) 
Table 6 
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Andreu et al. 142 recently reported a novel procedure for selective benzylic oxidation 
involving 10 % palladium on carbon and aqueous ammonium hydroxide solution in 
. acetonitrile. Rather unfortunately, when this technique was applied to substrate (271) 
mainly starting material was recovered with a trace of naphthalene elimination product 
(275). 
A final attempt to access the diacetate of napthazarin (273) was undertaken employing 
conditions previously described by Durham and Millerl43 . Treatment of diacetate adduct 
(271) with chromium trioxide in a solution of pyridine and dichloromethane again failed 
to yield napthazarin (273) and furnished elimination product (275) (Scheme 93). 
4.3 Benzylic Oxidation Review 
The decision was taken to return to the originally proposed route and alternative 
methodologies to the allylic/benzylic oxidation were considered. It was most apparent 
that elimination was occurring via the C=C of the second ring to yield the undesired 
naphthalene (275). Removal of the double bond and therefore allylic property of the 
reaction site would be offset by the high benzylic reactivity so it was decided to attempt 
oxidation of saturated substrate (276) (Scheme 94). 
OAG OAG OAG 0 
~ H2, PdlC :Go [0] W EtOH • • rt, 24 h 
OAG OAG OAG 0 
(271) (276) (277) 
Scheme 94 
Catalytic hydrogenation of the ring closed substrate (271) was achieved using PdlC under 
an atmosphere of hydrogen, delivering the desired saturated substrate (276) in 
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quantitative yield. The subsequent oxidation was attempted using chromium (VI) oxide, 
believed to be the most harsh and effective method with excess oxidant over a range of 
temperatures (Table 7). 
Entry Oxidant Equivalents Temperature Mono(277) : Bis (277) Yield (%) 
1 Cr03 5 0-2°C 8: 1 62 
2 Cr03 5 rt 6: 1 60 
3 Cr03 10 50°C 1 : 6 52 
4 Cr03 10 60°C 0: 1 91 
5 KMn0 4144 12 rt SM 82 
Table 7 
Having effected bis-oxidation of substrate (276) by employing optimum conditions (entry 
3) deduced from simple modification of those reported previously 1 36, two major flaws 
were encountered. Firstly, the capricious nature of the reaction with yields varying 
between 52 and 91 % significantly limited reproducibility and secondly, all attempts at a 
scale greater than 800 mg resulted in little or no retrievable compound «5%). 
With di-ketone (277) now in hand, we were able to directly attempt the second iterative 
process as tautomerisation occurred readily to furnish 1,4-napthalenediol (274) (Scheme 
95). 
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WCO I~ .0 ---------~ 
OAc 0 OAc OH 
(277) (274) 
Scheme 95 
CH2CHCH2Br 
K2C03 
Acetone 
X .. 
reflux, 24 h 
OAcO~ 
(278) 
y:A )lyy 
OH OH 
(279) 
It was postulated that simple repetition of the conventional allylation conditions 
previously employed would allow access to the second cycle. However, only the 
corresponding deprotected tetraol (279) was isolable in 78 % yield. Hasegawa et al. 145 
previously reported an analogous allylation in the presence of acetate protecting groups 
by heating to 60°C in DMF but when these conditions were applied to 1,4-
naphthalenediol (274) only starting material was recovered. Subsequent attempts to 
produce the allylated target (278) under various conditions are summarised in Table 8. 
Entry Solvent Base Product Yield (%) 
1 Acetone K 2C03 (279) 78 
2 DMF K2C03 SM 84 
3 DMF CsC03 (279) 82 
4 THF K2C0 2 SM 84 
5 THF NaH - -
6 DCM Ag20 SM 76 
Table 8 
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4.4 Screening of Protecting Groups 
Central to the success of the proposed synthetic pathway is the ability to employ 
complementary protecting groups that would allow for selective deprotection in the latter 
stages. It was reasoned that the initial acetate protection had to be replaced by protection 
with a non-enolisable, base and moisture sensitive protecting group. Considering the 
iterative protocol, the protecting group would also have to exhibit inertness towards 
catalytic hydrogenation and moderate heating (50-60 QC) in acetic acid. 
With these criteria in mind, it was decided to protect the alcohol moieties as their silyl-
ether derivatives using standard conditions. This was undertaken with the addition of 
imidazole (2.4 eq) and DMAP (0.2 eq) to hydroquinone (269) followed by TBDMSCI 
(2.2 eq) to give a mixture of mono (280) and bis protected target (281) in 71 % yield 
(Scheme 96). Surprisingly, attempts to separate the mixture via flash column 
chromatography failed and therefore the strategy had to be abandoned as reacting the 
crude mixture would result in complexation of the phenolic -OH group to the metal 
catalyst. 
OH 
(269) 
imidazole (2.4 eq) 
DMAP (0.2 eq) 
.. 
TBDMSCI (2.2 eq) 
DCM, 0 °C to rt, 8 h 
Scheme 96 
+ 
OH OTBDMS 
(280) (281) 
It was envisaged that bis-methylation of hydro quinone (269) would allow for the second 
iteration and ultimately the key third ring in validating the process. This was effected via 
addition of KOH (2.5 eq) and then the electrophile methyl iodide (2.5 eq) to furnish 
product (282) in a 98 % yield. The subsequent step involved ring closing metathesis of 
dimethoxy derivative (282) using conditions previously described. The bicyclic target 
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(283) was obtained in disappointing 54 % yield as it immediately begins to aromatise to 
give the unwanted naphthalene derivate (284) (Scheme 97). 
KOH (2.5 eq) 
Mel (2.5 eq) 
• 
DMF 
o °C to rt, 4 h 
OH OMe 
(269) (282) 
Scheme 97 
Grubbs 2 
Toluene 
• 
rt, 18 h 
OMe 
X(o 
OMe 
(283) 
I 
• 
~ ArV 
OMe 
(284) 
It was next decided to investigate the possibility of successfully completing a second 
cycle with benzoyl protecting groups in place. The benzoyl groups are analogous to the 
initially employed acetates, and offered the prospect of handling crystalline solids formed 
via 1t-stacking, which would be beneficial for handling and purification purposes. 
Initial bis-benzoyl protection under standard conditions proved facile and bis-protected 
target (285) was isolated in 96 % yield following recrystallisation. Ring closure was 
achieved with Grubbs 2nd generation catalyst in toluene for 24 hours to furnish bicyclic 
target (286) as a white crystalline solid that could be simply filtered and recrystallised in 
an encouraging 82 % yield. Catalytic hydrogenation of the ring closed substrate (286) 
was effected using PdlC under hydrogen, with stirring at room temperature for 18 hours. 
The saturated adduct (287) was obtained in 93 % yield and carried forward to a benzylic 
oxidation attempt using the only previously successful method of chromium (VI) oxide in 
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acetic acid. Unfortunately, an intractable mixture was highlighted by crude IH-NMR 
spectral analysis but with evidence of mono (288) and bis (289) oxidised, neither of 
which were isolable via flash column chromatography (Scheme 98). 
OH OCOPh ~ PhCOCI (2.2 eq) Grubbs 2 ~ Et3N (3 eq) Toluene 1.0 .. .. DCM ~ rt, 24 h ~ o cC to rt, 5h 
OH OCOPh OCOPh 
(269) (285) (286) 
H2• Pdlcj ~ 
EtOAc 24 h 
PhOCO 0 PhOCO 0 
x;o w + ~. Cr03 (10 eq) I~ AcOH, rt, 20 h .0 
PhOCO 0 PhOCO OCOPh 
(289) (288) (287) 
Scheme 98 
Further attempts to promote the oxidation were carried out under different methods and 
the results are summarised in Table 9. 
Entry Conditions Product 
1 Se02/t-BuOOH139 mono-deprotected 
2 Se0 2IEtOH137 SM 
3 PCC138 mono-deprotected 
4 KMnO,JCH3CNI44 SM + mono-deprotected 
Table 9 
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In a final attempt to validate the proposed linear route to the tetracycline core it was 
decided to proceed with protection of the alcohol moieties as methoxyethoxymethyl 
(MEM) ethers. This was achieved with the addition of sodium hydride (2.1 eq) followed 
by MEMCI (2.1 eq) to produce bis-protected (290) in excellent 92 % yield. Routine ring 
closing metathesis afforded bicyclic adduct (291) in disappointing 41 % yield following 
flash column chromatography. 
It was noticed that the metathesis product was aromatising in a similar fashion to that of 
the methyl derivative and in future was subjected to catalytic hydrogenation without 
further purification. The saturated product was isolated in typically high yield for this 
conversion (97 %) and subjected to chromium (VI) trioxide (10 eq) in an attempt to 
furnish the corresponding diketone. However, IH-NMR spectral analysis revealed fully 
deprotected diol (293) to be the sole product of the reaction (Scheme 99). 
:QO NaH (2.1 eq) Grubbs 2 MEMCI (2.1 eq) Toluene I ~ I • .. THF rt,24 h 0 o °C to rt, 2h 
OH OM EM OMEM 
(269) (290) (291) 
H2• Pdlcj rt 
EtOAc 19 h 
~ OMEM cr03 (10 eq) :Qo • AcOH, 50°C, 18 h 
OH OMEM 
(293) (292) 
Scheme 99 
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4.5 Synthesis of Structurally Related Linear Systems 
In order to demonstrate the versatility of the proposed left-to-right ring construction 
pathway, it was decided to apply the established chemistries to a suitable glycosyl 
acceptor precursor (juglone (235». Following methodology previously reported by 
Masquelin et al.,146 juglone was first O-methylated with methyl iodide (2 eq) using silver 
(I) oxide (1.5 eq) to yield (294) quantitatively. This was subsequently reduced with 
aqueous sodium dithionite, affording the corresponding hydroquinone intermediate (295) 
as an air sensitive solid in 87 % yield. 
Unfortunately, all attempts to synthesise diallyl ether (297) directly from hydro quinone 
(295) using standard conditions produced the mono-allylated species (296), with a trace 
amount of target (297) identifiable via 1H-NMR spectral analysis. To this crude product 
was added sodium hydride (1.1 eq) followed by allyl bromide (1.1 eq) to furnish 
rearrangement precursor (297) in 67 % yield after recrystallisation from diethyl ether 
(Scheme 100). Unfortunately, time constraints did not allow for application of our 
CalisenIRCM strategy to this system. 
~ A920 (1.5 eq) 9:? Na2S204 (8.5 eq) Y? Mel (2 eq) EtOAc, H2O .. DCM, rt, 22 h rt,1.5h .0 .0 
OH 0 OMeO OMeOH 
(235) (294) (295) 
(CH),CH,Br (6 eq)j Acetone 
K2C03 (5 eq) relfux, 24 h 
~~ NaH (1.1 eq) ~~ (CHhCH2Br (1.1 eq) 
.. 
.0 .0 THF .0 .0 
o °C to rt, 18 h 
OMeO~ OMe OH 
(297) (296) 
NOT ISOLATED 
Scheme 100 
Chapter 4 Results and Discussion 122 
4.6 Fries Rearrangement Route 
The Fries rearrangement of phenyl esters is the most efficient process for the preparation 
of hydroxyaryl ketones from corresponding phenols reported to date. 147 The direct 2-
acylation reaction usually requires stoichiometric amounts of strQng Lewis acids such as 
aluminium (Ill) chloride. 148 There are examples however, of milder catalysts like titanium 
(IV) chloride and lanthanide triflates being employed successfully to promote 
rearrangement. The process can also be driven photochemically with uy light, and this is 
simply termed the photo-Fries rearrangement. 149 
It was initially postulated within our group that a double Fries rearrangement of phenyl 
ester (298) could yield metathesis precursor (300) after suitable bis-protection of (299) 
(Scheme 101). This would negate the need to pursue the problematic benzylic oxidation 
as earlier described in Section 4.3. The initial acrylate (298) was prepared in straight-
forward fashion from 2,3-dimethylhydroquinone (267) and acryloyl chloride in high yield 
following flash column chromatography. 130 
o 
N ~ 
o~ 
o 
(298) 
Fries 
rearrangement 
.. 
OH 0 OAc 0 
(299) (300) 
Scheme 101 
There were several hurdles to overcome in achieving Fries rearrangement with a 
stoichiometric amount of AICl) , regioselectivity is known to be poor, and the harsh 
conditions required (neat, high temperature) for AICiJ-mediated acylation can result in 
deacylation and side reactions. 147 With these obstacles in mind, the conditions described 
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by Vuki6evi615o whereby doubling the quantity of AICh in dilute solutions at room 
temperature still allows the reaction to proceed were applied to substrate (298).136 Despite 
stirring bis-acrylate (298) with AICh in DCM for 24 hours at room temperature, IH-NMR 
analysis of the product revealed starting material exclusively remained. An attempt using 
boron trifluoride diethyl etherate as the Lewis acid, this time in benzene also failed to 
yield any of the desired Fries product (299). 
This initial failure prompted the use of TiCl4 as catalyst at 140 QC for 2 hours in spite of 
the aforementioned complications (Scheme 102). 
o 
oN 
:Q 
o~ 
o 
(265) 
.. 
140°C 
Scheme 102 
OH 0 
(266) 
OH 
(301) 
Unfortunately, the desired Claisen-precursor (299) was not formed, rather the harsh 
conditions resulted in mono-deacylation to give cleavage product (301). Our reservation 
that the first Fries rearrangement would render the second subsequent rearrangement 
unfavourable because of the inevitable ring deactivation may be correct. This would be in 
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agreement with the literature which discloses that bis-Fries rearrangement is not usually 
observed in similar cases. lSl 
4.7 A Mixed Claisen/Fries Strategy 
An alternative rearrangement/metathesis strategy of combining a Claisen and ortho-Fries 
rearrangement was devised as both the double Fries and double Claisen protocols had 
failed to elaborate a third ring in left-to-right fashion (B ring). Although not truly iterative 
in nature, we envisaged proceeding with selective mono-allylation of juglone-like 
substrate (302). We have already deduced that stepwise derivatisation of (302) allows 
allylation to occur preferentially in the required position. Acylation using a suitable 
carbamoyl chloride liberates (303), ready to undergo a mixed ClaisenlFries procedure 
(Scheme 103). 
Qc? 9?~ iii) Claisen i) allylate iv) artha-Fries • .0 .0 ii) acylate .0 .0 v) protect OH 
OBn OH OBn 0I(NMe2 OBn OR1 0 
(302) (303) 0 (304) 
vinyl j 
a rg ana metallic 
OR 1 
• 
steps RCM 
NH2 • 
HO 0 0 OBn OR1 0 OBn OR1 0 
Figure 21 (306) (305) 
Scheme 103 
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Displacement of alkylamine with a vinyl organometallic would yield enone (305) which 
in turn should metathesise to give (306), such transformations are well known. 152 Many of 
the synthetic steps required to convert advanced intermediate (306), which already 
incorporates rings D, C and B, into (-)-tetracycline (Figure 21) are analogous to previous 
syntheses (Schemes 83-87). 
Commencing with juglone (235) as a suitable CD ring core, O-benzylation was achieved 
in 72 % using silver (I) oxide (4 eq) and benzyl bromide (3 eq) in chloroform as 
previously described by Brimble. 153 Subsequent reduction of (307) with an excess (8.5 
eq) of aqueous sodium dithionite in EtOAc!H20 (1:1) was simply performed in a 
separating funnel with vigorous shaking. Benzylated hydro quinone (302) was isolated in 
89 % yield and required no further purification. Mono-allylated species (308) was 
produced cleanly in 83 % yield under standard conditions. A stronger base (NaH, 2eq) 
was again required to access the more hindered hydroxyl, with subsequent addition of 
dimethylcarbamoyl chloride (2 eq) giving key intermediate dimethyl carbamate (303) in 
quantitative yield (Scheme 104). 
Q:) 
OH 0 
(235) 
A920 (4 eq) 
BnBr (3 eg) .. 
CHCI3, rt 
72 h 
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Q:) 
OBn 0 
(307) 
Na2S204 (8.5 eq) 
EtOAc, H20 
.. 
rt, 1.5 h 
OBn OH 
(302) 
(CH)2CH2Br (1.1 eq)j Acetone 
K2C03 (1.1 eq) relfux, 24 h 
NaH (2.0 eq) w~ 
.. (CH3)2NCOCI (2.0 eq) I ~ ~ 
THF, rt .0 .0 
OBn OH 
(308) 
Scheme 104 
126 
With (270) in hand, ready for the mixed ClaisenlFries procedure, it was reasoned that the 
Claisen should be attempted first as from previous endeavours we were aware of the ring 
deactivation caused by the first Fries rearrangement. Scheme 105 outlines our initial 
attempt at a combined rearrangement strategy. 
~ ~ Mesitylene. yy reflux,24h 
OBn 0I(NMe2 
o 
(303) 
Scheme 105 
KOH (1.1 eq) 
Mel (1.1 eq) 
DMF 
o °C to rt 
4h 
• 
OBn 0I(NMe2 
o 
(310) 
s-BuLi (1.1 eq) 1 THF 
TMEDA (1.1 eq) r -78°C 
OBn OH 0 
(311) 
Successful [3,3]-sigmatropic rearrangement of allyl phenyl ether (303) was achieved 
thermally to give the required ortho-substituted phenol derivative (309) in 79 % yield. 
Before attempting the Fries component of the strategy, the free hydroxyl group of (311) 
was protected as its methyl derivative for simplicity in 90 % yield. Carbamate O-to-C 
1,3-migration was attempted under the standard conditions of sec-BuLiffMEDA (1.1 eq) 
metalation followed by slow warming to room temperature as reported by Snieckus. 154 
Rather disappointingly, only the starting material was recovered from the reaction 
mixture following flash column chromatography with no trace of Fries product (311). 
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Returning to key intermediate (303), the order of rearrangement was reversed with the 
ortho-anionic Fries being attempted first, again using the metalation conditions employed 
in Scheme 105. In this case we were able to trigger 1,3-carbamoyl rearrangement 
resulting in (312) in 51 % yield following flash column chromatography (Scheme 106). 
QQO~ s-BuLi(1.1 eq) I ~ ~ TMEDA (1.1 eq). .0.0 THF, -78°C ~~ ~NMe2 
OBn OH 0 
(312) 
Scheme 106 
Mesitylene 
X • 
reflux, 24 h 
OBn OH 0 
(315) 
However, as seen with previous attempts to initiate 1,3-rearrangement with the migrated 
amide already on the ring, the Claisen failed. Without time constraints, the next attempt 
to introduce the allyl group would have been via an ortho-metalationlalkylation strategy 
similar to that utilized by Snieckus in the synthesis of ochratoxin precursors (Scheme 
107).155 
ochratoxin 
precursor 
i) s-BuLi (2 eq) 
TMEDA (2eq) 
ii) MgBr2·Et20 (3 eq) 
Hi) (CH)2CH2Br 
(2.7 eq) 
THF, -78°C 
~ 6NHCI H02C~O • reflux 
MeO 0 
Scheme 107 
~2 H02C~NEt 
MeO 0 
(317) 
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(314) was metalated (2 eq of sec-BuLiffMEDA) and subsequently transmetalated 
(MgBr2·Et20), with the presumed Grignard intermediate treated with allyl bromide to 
afford (315) in 14 % yield. Although mimicking this procedure would detract from the 
rearrangement element of our proposal, it would allow us to investigate diethylamine 
displacement, presumably with a vinyl organometallic. This would facilitate entry to an 
RCM precursor, allowing us to investigate the validity of our protocol with regards to B-
ring construction. 
4.8 Conclusion 
In Summary, a new iterative strategy for the construction of linear fused carbon ring 
templates has been advanced significantly from its inception. The first double 
Claisenlmetathesis sequence has been proven and numerous examples of metathesis on 
related compounds have been provided. The benzylic/allylic oxidation process required to 
access a second cycle has been problematic but a low-yielding benzylic oxidation to 
liberate key diketone (277) has been achieved. Several protecting groups have been 
screened which will allow the operator to deprotect, at will, any chosen individual ring 
for derivatisation. 
A mixed Claisenlanionic artha-Fries route has been investigated with both a single 
Claisen and single artha-Fries rearrangement being developed for this semi-iterative 
route. Schemes 108 to 112 depict the key transformations examined throughout the 
chapter. 
• Double aromatic Claisen rearrangement of bis allyl ether (268). 
+~ __ M_e_si.....;ty_le_n_e_ .... 
~ reflux, 24 h 
O~ 
(268) 
Scheme 108 
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OH 
(269) 
129 
• Ring closing metathesis of Claisen products using Grubbs 2nd generation catalyst. 
OAc 
Grubbs 2 ~ THF .. rt, 24 h 
OAc OAc 
(270) (271) 
Scheme 109 
• Bis-benzylic oxidation of bicyclic diacetate (276) to give diketone (277). 
~ ~ I~ Cr03 (excess) I~ .. .0 AcOH, 60 QC .0 
OAc OAc 0 
(276) (2n) 
Scheme 110 
• Single aromatic Claisen rearrangement of juglone derivative (303) for B-ring 
construction. 
~~ Meshylene. yy reflux, 24 h 
Scheme 111 
OH 
• Anionic ortho-Fries rearrangement of dimethyl carbamate (303) towards B-ring 
construction. 
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~ ~~ s-BuLi(1.1 eq) I TMEDA (1.1 eq) • .0.0 THF, -78°C 
OBn 0I(NMe2 OBn OH 0 
(303) 0 (312) 
Scheme 112 
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CHAPTER FIVE: 
EXPERIMENT AL 
5.0 General Information 
All reactions described were carried out using commercial dry solvents with the 
exceptions of light petroleum, ethyl acetate (distilled over CaCh) and dichloromethane 
(distilled over phosphorus pentoxide). Light petroleum in all cases refers to the bp 40-60 
QC fractions. Sodium hydride was obtained as 60 % dispersion in mineral oil and 
subsequently isolated by washing with hexane in all cases. Melting points were 
determined using a Stuart Scientific SMP3 melting point apparatus and are uncorrected. 
All infrared spectra were obtained from a Perkin-Elmer Paragon 1000 Ff-IR 
spectrophotometer on NaCI plates. All IH (400 MHz) and 13C (100 MHz) NMR spectra 
were collected on a Bruker DPX-400 spectrometer. Unless otherwise stated, all NMR 
samples were prepared as solutions in CDCh with tetramethylsilane as the internal 
standard for IH-NMR spectra and CDCh the standard for 13C-NMR spectra. Chemical 
shifts are quoted in parts per million (ppm) and the J values in hertz (Hz). Mass spectra 
were either recorded on a Jeol JMS-SX102 quadrupole high-resolution mass spectrometer 
or by the EPSRC National Mass Spectrometry Service Centre at the University of 
Swansea. Merck Kieselgel 60 H silica was used for purification via column 
chromatography in all cases. 
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5.1 Stereoselective Synthesis of the Dimethoxy-tetrahydro-1H-pyrido[2,1-
a]isoquinoline Ring System 
Methyl-5-hydroxypentanoate (161).82 
&e 
OH 
To a stirred solution of D-valerolactone (160) (20.0 g, 200 mmol) in methanol (100 ml) 
was added 20 drops of concentrated sulphuric acid. The resulting solution was refluxed 
for 5 hours and then cooled in an ice bath. Sodium hydrogen carbonate (5 g) was added 
and the resulting suspension allowed to stir for 10 minutes and then filtered. Solvent was 
removed under reduced pressure to yield the target compound as a colourless oil which 
was carried forward without additional purification (25.01 g, 95%), Vrnax (thin film, 
neat)/cm- l 3446 (OH), 1732 (C(O)OCH3), 1168 (CO(O)CH3); DH (250 MHz; CDCh) 
1.52-1.59 (2H, m, CH2CH20H), 1.61-1.73 (2H, m, CH2CH2CH20H), 2.05 (lH, br, s, 
2.31 (2H, t, J 7.2, CH2COOCH3), 3.62 (2H, t, J 7.2, CH20H), 3.68 (3H, s, CH3); Dc (lOO 
MHz; CDCh) 21.1 (CH2), 32.0 (CH2), 33.7 (CH2), 51.6 (CH3), 62.1 (CH2), 173.9 (C); 
MS (El) m/z 132 [MH+, 7.5 %] (MH+, 133.0862. C6H1203 requires 133.0865). 
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Methyl-5-oxopentanoate (155).82 
)loMe ~o 
Methyl-5-hydroxypentanoate (161) (11.8 g, 90.0 mmol) was slowly added to a 
suspension of pyridinium chlorochromate (29.0 g, 134.5 mmol) and Celite (29.0 g) in dry 
dichloromethane (185 ml). The resulting mixture was allowed to stir at room temperature 
for a further 3.5 hours. After this time the solution was decanted and the solids washed 
with diethyl ether (3 x 100 ml). The combined organic fractions were filtered through an 
alumina column and the solvent removed on the rotary evaporator to afford the target 
compound as a pale green oil (5.95 g, 52 %), Vrnax (thin film, neat)/cm-1 1733 
(C(O)OCH3), 1166 (CO(O)CH3); OH (400 MHz; CDCh) 1.92-1.97 (2H, m, CH2CH20H), 
2.35 (2H, t, J 6.8, CH2COOMe), 2.52 (2H, t, J 7.2, CH2CHO), 3.68 (3H, s, CH3), 9.78 
(lH, s, CHO); Oc (100 MHz; CDCh) 17.3 (CH2), 32.9 (CH2), 42.9 (CH2), 51.6 (CH3), 
173.3 (c), 201.6 (CH); MS (El) mlz 130 [MH-, 33.1 %] (MH-, 129.0552. C6H IO0 3 
requires 129.0553). 
Chapter 5 Experimental 136 
(S)-2-Amino-3-(3,4-dimethoxyphenyl)propan-l-01 (159).80 
MeO~OH 
~ NH2 MeO 
A solution of chlorotrimethylsilane (5.78 ml, 53.20 mmol) was added under nitrogen to a 
solution of lithium borohydride (13.30 ml of a 2.0 M solution in tetrahydrofuran, 26.60 
mmol) in tetrahydrofuran (20 ml) over the course of 5 minutes. 3-(3,4-dimethoxyphenyl)-
L-alanine (158) (3.00g, 13.30 mmol) was added portion-wise to the mixture over 15 
minutes and left to stir at room temperature for 24 hours. After this time methanol (30 
ml) was added slowly to the resulting pale yellow solution and the solvents were removed 
under reduced pressure. The residue was treated with 20% aqueous potassium hydroxide 
solution and extracted with dichloromethane (3 x 50 ml). The combined organic fractions 
were dried over anhydrous magnesium sui fate and evaporated to dryness to give the 
target compound as a white crystalline solid (2.48g, 88 %) which required no further 
purification. Mp 81-82 cC, Lit: Mp 78-79 cC; [a]D = -20.4 [c = 8.0, EtOH], Lit: [a]D = -
21.5° [c = 8.0, EtOH]; Vrnax (thin film, CH2Ch)/cm-1 3352 (OH); DH (250 MHz; CDCl)) 
1.91 (3H, br. S, OH and NH2), 2.48 (IH, dd, J 13.5, 8.7 CH(H)CHNH2), 2.71 (lH, dd, J 
5.2, 13.6, CH(H)CHNH2), 3.06-3.16 (lH, m, NH2CH), 3.40 (IH, dd, J 7.2, 10.6, 
CH(H)OH), 3.64 (IH, dd, J 3.9, 13.1, CH(H)OH), 3.87 (3H, S, OCH3), 3.88 (3H, s, 
OCH3), 6.72-6.75 (2H, m, ArH), 6.80-6.83 (IH, m ArH); Dc (100 MHz; CDCl)) 42.2 
(CH2), 54.2 (CH), 55.9 (2 x CH3), 66.3 (CH2), 111.3 (CH), 112.2 (CH), 121.1 (CH), 
+ + 131.1 (C), 147.6 (C), 148.9 (C); MS (El) mlz 211 [M , 8.9 %] (M , 211.1205. 
CIIH17N03 requires 211.1208). 
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(3S)-3-(3,4-Dimetboxybenzyl)bexabydrooxazolo[3,2-a ]pyridin -5-one (125a).81 
OMe 
Methyl-5-hydroxypentanoate (155) (1.53 g, 11.74 mmol) was slowly added to a solution 
of (S)-2-amino-3-(3,4-dimethoxyphenyl)propan-1-ol (159) (2.48 g, 11.74 mmol) in 
toluene (150 ml) and the resulting mixture was refluxed under Dean-Stark conditions for 
48 hours. The reaction was allowed to cool to room temperature and the solvent removed 
on the rotary evaporator to yield a brown oil. 250 MHz IH-NMR analysis of the crude 
product mixture revealed the formation of a 6: 1 diastereomeric mixture of the desired 
bicyclic lactam. No further purification was necessary and the brown oil was taken 
directly onto the next step (3.01 g, 90 %), Vrnax (thin film, CH2C}z)/cm-1 1623 (NCO), 
1261 (CHOCH2); Major isomer: bH (400 MHz; CDCb) 1.40-1.49 (1H, m, (CH(H»3CO), 
1.64-1.74 (1H, m, (CH(H»3CO), 1.94-2.02 (1H, m, (CH(H»3CO), 2.20-2.27 (1H, m, 
(CH(H»3CO), 2.32-2.43 (2H, m, (CH(H»3CO), 2.52 (1H, dd, J 10, 13.2, CH(H)Ph), 3.53 
(1H, dd, J 3.2, 13.6, CH(H)Ph), 3.74 (1H, ddd, J 1.6, 6.4, 9.6, OCH(H», 3.86 (3H, s, 
OCH3), 3.88 (3H, s, OCH3), 4.03 (1H, dd J 1.2, 9.6, OCH(H» , 4.20 (1H, m, 
OCH2CHCH2Ph), 4.69 (1H, dd, J 3.2, 9.6, (CH2)3CHOCH2), 6.71-6.82 (3H, m, ArH); 
Major isomer: be (100 MHz; CDCh) 17.5 (CH2), 28.4 (CH2), 31.1 (CH2), 36.6 (CH2), 
55.9 (2 x CH3), 56.9 (CH), 69.2 (CH2), 89.0 (CH), 111.1 (CH), 112.6 (CH), 121.6 (CH), 
+ + 130.7 (C), 147.7 (C), 148.9 (C), 168.0 (NCO); MS (El) mlz 291 [M , 50.8 %] (M , 
291.1474. CI6H21N04 requires 291.1471). 
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(6S ,llbR)-6-(Hydroxymethyl)-9,10-dimethoxy-2,3,6, 7 -tetrahydro-1H-pyrido[2,1-
a ]isoquinolin-4(llbH)-one (126).81 
MeO 
MeO 
OH 
o 
Titanium tetrachloride (9.20 ml, 66.01 mmol) was added drop-wise under nitrogen to a 
stirred solution of (3S)-3-(3,4-dimethoxybenzyl)-hexahydrooxazolo[3,2-a]pyridin-5-one 
(125a!b) (2.75 g, 9.44 mmol) in anhydrous dichloromethane (100 ml) at -78°C via 
syringe. The resulting blood-red suspension was allowed to warm to room temperature 
over 48 hours and then quenched by the addition of saturated aqueous ammonium 
chloride solution (30 ml) and extracted with dichloromethane (3 x 50 ml). The combined 
organic fractions were dried over anhydrous magnesium sulfate and the solvent removed 
under reduced pressure. The resulting crude brown oil was adsorbed onto silica and 
purified by column chromatography using 3:1 ethyl acetate: light petroleum as eluent. 
The product was isolated as a white foam (2.20 g, 79 %), Mp 106-108 QC; [a]D = 94.0 [c 
= 1.0, CHCb]; Vrnax (thin film, CH2Ch)/cm-1 3364 (OH) 1615 (NC=O); DH (400 MHz; 
CDCb) 1.71-1.81 (lH, m, CH(H)CH2CH2CO), 1.88-1.97 (2H, m, CH2CH(H)CO and 
CH(H)CO), 2.39-2.47 (2H, m, CH(H)CH2CH2CO and CH2CH(H)CO), 2.61 (lH, dt, J 
5.3, 17.5, CH(H)CO), 2.67 (lH, dd, J 2.8, 16.0, CH(H)Ph), 3.02 (lH, dd, J 6.0, 16.0, 
CH(H)Ph), 3.53-3.63 (3H, m, CH20H and OH) 3.86 (3H, s, OCH3), 3.87 (3H, s, OCH3), 
4.58 (lH, dd, J 4.4,10, CH2CHNCO), 5.17-5.23 (lH, m, CHCH20H), 6.62 (lH, s, ArH), 
6.66 (lH, s, ArH); Dc (100 MHz; CDCb) 19.2 (CH2), 29.1 (CH2), 30.6 (CH2), 32.2 (CH2), 
49.0 (CH), 53.2 (CH), 55.9 (2 x CH3), 62.5 (CH2), 108.1 (CH), 111.8 (CH), 124.7 (C), 
+ + 127.8 (C), 147.7 (C), 148.0 (C) 171.5 (NCO); MS (El) m/z 291 [M , 19.3 %] (M , 
291.1469. C16H21N04 requires 291.1471). 
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5.2 Functionalisation of the Dimethoxytetrahydro-1H-pyrido[2,I-a] isoquinoline 
Ring System 
(6S,llbR)-9,10-Dimethoxy-4-oxo-2,3,4,6,7,llb-hexahydro-lH-pyrido[2,1-
a ]isoquinoline-6-carbaldehyde (162). 
MeO 
MeO 
H 
o 
A solution of (6S,11bR)-6-(hydroxymethyl)-9,1O-dimethoxy-2,3,6,7-tetrahydro-lH-
pyrido[2, la] isoquinolin-4(llbH)-one (126) (2.00g, 6.86 mmol) in anhydrous 
dichloromethane (50 ml) was added via cannula to a stirred solution of Dess-Martin 
period inane (3.20 g, 7.55 mmol) in anhydrous dichloromethane (50 ml). The resulting 
mixture was allowed to stir at room temperature overnight. After this time the volatiles 
were removed by rotary evaporation and the resulting residue was re-dissolved in ethyl 
acetate (100 ml) and washed with saturated aqueous sodium bicarbonate (2 x 100 ml). 
The organic layer was dried over anhydrous magnesium sulfate and evaporated to 
dryness on the rotary evaporator to yield the crude product that was adsorbed onto silca 
and purified by column chromatography using ethyl acetate as eluent. The target 
compound was isolated as a yellow crystalline solid (1.39 g, 70 %), Mp 112-115 QC; [a]D 
= 64.4 [c = 1.0, CH2Ch]; Vrnax (thin film, CH2Ch)/cm-1 1731 (CHO) 1644 (NCO), 1257 
(CHOCH2); 8H (400 MHz; CDCh) 1.64-1.71 (3H, m, CCHCH(H) and CH2CH2CO), 
2.45-2.52 (2H, m, CH(H)CH) and CCHCH(H», 2.60-2.71 (IH, m, CH(H)CO), 3.03 (lH, 
dd, J 6.2, 16.0, CCH(H)CH), 3.16 (lH, dd, J 3.4, 15.8, CCH(H)CH), 3.85 (3H, s, OCH3), 
3.87 (3H, s, OCH3), 4.71-4.74 (lH, dd, J 3.8, 11.2, CCH), 5.50-5.58 (IH, m, CHCHO), 
6.60 (lH, s, ArH), 6.66 (lH, s, ArH), 9.54 (IH, s, CHO); 8c (100 MHz; CDCb) 19.6 
(CH2) 27.3 (CH2), 31.2 (CH2), 31.8 (CH2), 55.0 (CH), 55.9 (CH3), 56.0 (CH3), 57.0 (CH), 
108.1 (CH), 111.1 (CH), 123.8 (C), 127.8 (C), 148.1 (C), 148.2 (C), 170.6 (NCO), 199.4 
(CHO); MS (El) mlz 289 [M+, 19.3 %] (M+, 289.1310. Cl6Hl9N04 requires 289.1314). 
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(6S,llbR)-9,10-Dimethoxy-4-oxo-2,3,4,6,7,llb-hexahydro-lH-pyrido[2,1-
a]isoquinoline-6-carboxylic acid (163). 
MeO 
MeO 
OH 
o 
A solution of (6S, 11 bR)-9, 1O-dimethoxy-4-oxo-2,3,4,6, 7,11 b-hexahydro-1H-pyrido[2, 1-
a]isoquinoline-6-carbaldehyde (162) (4.25 g, 14.69 mmol) in acetonitrile (42 ml), tert-
butyl alcohol (155.0 ml) and 1-methyl-1-cyclohexene (75.0 ml) was stirred rapidly as it 
was cooled to 0 cc. A solution of sodium chlorite (80 % grade) (12.78 g, 113.11 mmol) 
and sodium dihydrogen phosphate (12.34 g, 102.83 mmol) in water (155.0 ml) was added 
drop-wise over a period of 20 minutes at 0 cC. The solution was then allowed to stir at 
room temperature for a further 18 hours. After this time the reaction mixture was added 
to brine (200 ml) and the solution acidified to pH 2 by addition of 1M hydrochloric acid. 
The resulting mixture was extracted with ethyl acetate (2 x 100 ml) and then washed with 
1M aqueous sodium dithionite solution (150 ml). The combined organic fractions were 
dried over anhydrous magnesium sulfate and the solvent removed on the rotary 
evaporator to give the crude product which was purified by flash column chromatography 
over silica eluting with ethyl acetate affording a white solid (3.86 g, 86 %), Mp 95-97 cC; 
[a]D = 68.0 [c = 1.0, CHCI3]; Vmax (thin film, CH2Cb)/cm-1 3432 (OH) 1634 (NC=O); bH 
(400 MHz; CD Ch) 1.58-1.59 (1H, m, CCHCH(H» , 1.84-1.88 (2H, m, CH2CH2CO), 
2.32-2.37 (2H, m, CH2CO), 2.52-2.56 (1H, m, CCHCH(H» 2.95 (1H, dd, J 5.9, 15.8, 
CCH(H)CH), 3.08 (1H, dd, J 3.4, 15.8, CC(H)HCH), 3.86 (3H, s, OCH3), 3.87 (3H, s, 
OCH3), 4.71 (1H, dd, J 3.9, 11.1 CCH), 5.60-5.62 (lH, m, CHC02H), 6.63 (1H, s, ArH), 
6.64 (lH, s, ArH); bc (100 MHz; CDCh) 19.2 (ClIz), 29.9 (CH2) 31.1 (CH2), 31.5 (CH2), 
50.6 (CH), 54.7 (CH), 55.9 (CH3), 56.0 (CH3), 108.4 (CH), 111.4 (CH), 124.1 (C), 127.7 
(C), 148.0 (C), 148.1 (C), 171.5 (NCO), 174.4 (C02H). MS (El) m/z 305 [MH , 95.1 %] 
(MH ,305.1260. Cl6Hl9NOS requires 305.1263). 
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Se-Phenyl (6S, 11 bR)-9,10-Dirnethoxy -4-oxo-2,3,4,6, 7 ,llb-hexahydro-1H -pyrido[2,1-
a ]isoquinoline-6-carboselenoate (164). 
MeO 
MeO 
SePh 
o 
To a solution of (6S,l1bR)-9,1O-dimethoxy-4-oxo-2,3,4,6,7,l1b-hexahydro-1H-
pyrido[2,1-a]isoquinoline-6-carboxylic acid (163) (2.57 g, 8.42 mmol) in anhydrous 
dichloromethane (80.0 ml) under nitrogen was added diphenyldiselenide (3.94 g, 12.63 
mmol). The resulting mixture was cooled to 0 cc and tributylphosphine (90 % grade) 
(4.15 ml, 16.83 mmol) was added drop-wise. The mixture was heated under reflux for a 
further 20 hours with stirring. After this time dichloromethane (lOO ml) and water were 
added and the aqueous layer was extracted with a further portion of dichloromethane 
(lOO ml). The combined organic fractions were washed with brine (200 ml), dried over 
anhydrous magnesium sulfate and volatiles removed under reduced pressure. The 
resulting crude oil was adsorbed onto silica and purified by flash column chromatography 
eluting with 1:1 ethyl acetate:light petroleum to give the target compound as a white 
foam (2.85 g, 76 %), Mp 120-123 cC; [a]D = -34.8 [e = 1.0, CHCb]; Vrnax (thin film, 
CH2Ch)/cm-1 1716 (COSePh), 1646 (NCO); OH (400 MHz; CDCb) 1.76-1.79 (lH, m, 
CCHCH(H», 2.00-2.06 (2H, m, CH2CH2CO), 2.47-2.58 (2H, m, CCHCH(H) and 
CH(H)CO), 2.74 (lH, dt, J 6.0, 17.0 CH(H)CO), 3.04 (lH, dd, J 6.0, 16.0, CCH(H)CH), 
3.23 (lH, dd, J 4.0, 16.0, CCH(H)CH), 3.86 (3H, s, OCH3), 3.87 (3H, s, OCH3), 4.91 
OH, dd, J 4.0,11.0, CCR), 5.82-5.84 (lH, m, CHCOSePh), 6.63 (2H, s, ArR), 7.30-7.42 
(5H, m, ArR); Oc (100 MHz; CDCI3) 19.1 (CH2), 29.7 (CH2), 31.3 (CH2), 32.0 (CH2), 
55.0 (CH), 55.9 (CH3), 56.1 (CH3), 60.5 (CH), 108.1 (CH), 111.3 (CH), 123.9 (C), 125.3 
(C), 127.5 (C), 128.9 (CH), 129.3, (2 x CH), 136.0 (2 x CH), 148.1, (2 x C), 171.1 
+ + (NCO), 200.7 (COSePh). MS (El) mlz 445 [MH, 11.5 %] (MH, 445.0865. 
C22H23N04Se requires 445.0865). 
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(R)-9,10-Dimethoxy-2,3,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-4(11bH)-one 
(165). 
MeO 
MeO o 
A three-necked flask was fitted with a condenser, glass stopper and a suba seal and was 
flushed with nitrogen. A solution of Se-phenyl-(6S, 11bR)-9,l0-dimethoxy-4-oxo-
2,3,4,6,7,11 b-hexahydro-lH-pyrido[2, I-a ]isoquinoline-6-carboselenoate (164) (0.45 g, 
1.02 mmol) in anhydrous toluene (20 ml) was added via cannula. The solution was then 
degassed with nitrogen for 15 minutes before adding tri-n-butyltin hydride (1.07 ml, 4.05 
mmol) via syringe. The resulting mixture was heated to 80 QC in an oil bath and 
azobisisobutyronitrile (0.03 g, 0.20 mrnol) was added portion-wise over a 2 hour period 
at 80 QC. After a further 2 hours stirring at 80 QC the mixture was allowed to cool to room 
temperature and evaporated to dryness. The resulting crude oil was adsorbed onto silica 
and purified by flash column chromatography over silica eluting with light petroleum 
followed by 3:1 ethyl acetate:light petroleum. The target compound was isolated as a 
white solid (0.25 g, 94 %), Mp 108-110 QC; [a]o = 249.2 [e = 1.0, CHCh]; Vrnax (thin film, 
CH2Ch)/cm-1 1636 (NCO); OH (400 MHz; CDCl3) 1.65-1.72 (lH, m, CCHCH(H», 1.83-
1.96 (2H, m, CH2CH2CO), 2.33-2.41 (IH, rn, CH(H)CO), 2.50-2.59 (2H, m, CCHCH(H) 
and CH(H)CO), 2.60-2.66 (lH, m, CCH(H», 2.77-2.84 (IH, m, CH(H)N), 2.87-2.91 
(lH, m, CCH(H», 3.87 (6H, s, 2 x OCH3), 4.62 (IH, dd, J 4.0, 10.0, CCH), 4.86-4.91 
(lH, m, CH(H)N), 6.62 (lH, s, ArH), 6.68 (lH, s, ArH); Oc (lOO MHz; CDCh) 19.6 
(CH2), 28.5 (CH2) 31.0 (CH2), 32.2 (CH2), 39.6 (CH2), 55.9 (CH3), 56.0 (CH3), 56.7 
(CH), 108.1 (CH), 111.5 (CH), 127.2 (C), 129.1 (C), 147.6 (C), 147.7 (C), 169.3 (NCO). 
MS (El) m/z 261 [M+, 75.0 %] (M+, 261.1365. ClsH19N03 requires 261.1365). 
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(R)-9,10-Dimethoxy -6,7 -dihydro-1H-pyrido[2,1-a ]isoquinolin-4(l1bH)-one (167). 
MeO 
MeO 
To a stirred solution of diisopropylamine (1.17 g, 1.62 ml, 11.60 mmol) in anhydrous 
tetrahydrofuran (20 ml) was added n-butyllithium (2.5 M solution in hexanes) (4.64 ml, 
11.60 mmol) drop-wise under nitrogen at 0 QC. The reaction mixture was stirred for 15 
minutes at 0 QC and then cooled to -78 QC whereupon a solution of (R)-9,10-dimethoxy-
2,3,6,7-tetrahydro-lH-pyrido[2,l-a]isoquinolin-4(llbH)-one (165) (1.01 g, 3.83 mmol) 
in anhydrous tetrahydrofuran (20 ml) was added via cannula. To the resulting mixture 
was added phenylselenylbromide (1.36 g, 5.80 mmol) in anhydrous tetrahydrofuran (20 
ml) drop-wise via syringe. The reaction was allowed to warm slowly from -78 QC to 
room temperature with stirring. After 24 hours the reaction was quenched by the addition 
of saturated aqueous ammonium chloride solution (50 ml) and extracted with diethyl 
ether (3 x 50 ml). The combined ether extracts were washed with saturated aqueous 
ammonium chloride solution (100 ml) and dried with anhydrous magnesium sulfate. The 
solvent was removed by rotary evaporation to yield the crude selenide (1.23 g), which 
was used without further purification. 
The crude selenide was dissolved in methanol (100 ml) and water (50 ml). To the 
resulting solution was added sodium metaperiodate (1.88 g, 8.90 mmol) and sodium 
hydrogen carbonate (0.39 g, 4.60 mmol) and the solution was stirred vigorously at room 
temperature for 20 hours. After this time the reaction was added to a mixture of saturated 
aqueous sodium bicarbonate solution (150 ml) and diethyl ether (200 ml). The ether layer 
was washed with water (150 ml), then brine (150 ml) and dried over anhydrous 
magnesium sulphate. Volatiles were removed under reduced pressure and the crude 
product adsorbed onto silica and purified by flash column chromatography over silica 
eluting with 1:1 ethyl acetate:light petroleum to afford the target compound as a white 
foam (0.61 g, 61 %), Mp 108-109 QC; [u]o = 272.0 [c = 1.0, CHCh]; Vmax (thin film, 
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CH2Ch)/crn-1 1663 (NCO), 1610. (C=C); 8H (400 MHz; CDCh) 2.26-2.35 (1H, rn, 
CCHCH(H», 2.69-2.77 (2H, rn, CCHCH(H) and CCH(H», 2.80-2.91 (2H, rn, CCH(H) 
and CCH(H», 3.87 (3H, s, OCH3), 3.88 (3H, s, OCH3), 4.71-4.80 (2H, rn, CCH and 
CH(H)N), 6.06 (1H, dd, J 3.0, 10.0, CHCO), 6.66 (lH, s, ArH), 6.66 (1H, s, ArH), 6.67-
6.70 (lH, rn, CHCHCO); 8c (100 MHz; CDCh) 29.0 (CH2), 33.7 (CH2) 38.0 (CH2), 54.4 
(CH), 55.9 (CH3), 56.1 (CH3), 108.6 (CH), 111.5 (CH), 125.6 (CH), 127.1 (C), 127.6 (C), 
+ + 138.8 (CH), 147.9 (C), 148.0 (C), 164.8 (NC=O). MS (El) mlz 259 [MH , 100 %] (MH , 
259.1287. ClsH17N03 requires 259.1288). 
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(2R,11bR)-9,10-Dimethoxy-2-vinyl-2,3,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-
4(llbH)-one (168). 
MeO 
MeO 
A 1.0 M solution of vinylmagnesium bromide in tetrahydrofuran (8.88 ml, 8.88 mmol) 
was added to a suspension of copper cyanide (0.60 g, 6.65 mmol) in anhydrous 
tetrahydrofuran (10.0 ml) at -78 cC with stirring. The reaction mixture was warmed to 0 
cc for 15 minutes and then re-cooled to -78 QC. A solution of (R)-9,1O-dimethoxy-6,7-
dihydro-lH-pyrido[2,l-a]isoquinolin-4(llbH)-one (167) (0.23 g, 0.89 mmol) in 
anhydrous tetrahydrofuran (10.0 ml) was added via cannula at -78 cc. After a further 5 
minutes chlorotrimethylsilane (0.84 ml, 6.65 mmol) was added and the resulting 
suspension was warmed slowly (overnight) to room temperature. After this time a 
mixture of saturated aqueous ammonium chloride solution (15.0 ml) and water (15.0 ml) 
was added and stirring continued for 15 minutes. A 1.0 M solution of 
tetrabutylammonium fluoride in tetrahydrofuran (2.0 ml) was added and stirring 
continued for 15 minutes. The organic phase was separated and the aqueous phase 
extracted with ethyl acetate (3 x 40 ml). The combined organic fractions were dried over 
anhydrous magnesium sulfate and the solvent removed on the rotary evaporator. Crude 
400 MHz IH-NMR revealed the formation of the product as a single diastereoisomer. The 
crude product was adsorbed onto silica and purified by flash column chromatography 
eluting with 2: 1 light petroleum:ethyl acetate to give the target compound as a pale 
yellow oil (0.17 g, 67 %), [a]D = 43.0 [c = 1.0, CHCh]; Vrnax (thin film, CH2Clz)/cm-1 
2921 (Vinyl CH), 1645 (Vinyl CH2=CH), 1615 (NC=O); OH (400 MHz; CDCh) 2.02-
2.08 (lH, m, CCHCH(H)), 2.30-2.37 (IH, m, CCHCH(H)), 2.54 (2H, t, J 4.0, CH2CO), 
2.63 (lH, dt, J 2.8, 15.2, CCH(H)), 2.67-2.73 (lH, m, CHCH2CO), 2.78-2.85 (1H, m, 
CCH2CH(H), 2.91-2.90 (IH, m, CCH(H)), 3.86 (3H, s, OCH3), 3.87 (3H, s, OCH3), 4.63-
4.66 (IH, dd, J 5.2, 8.8, CCH), 4.85 (lH, ddd, J 2.4, 5.2, 12.4, CCH2CH(H)), 5.12-5.18 
(2H, m, CH=CH2), 5.91-6.00 (IH, m, CH=CH2), 6.62 (lH, s, ArH), 6.64 (IH, s, ArH); Oc 
(100 MHz; CD Ch) 28.5 (CH2), 33.1 (CH), 34.8 (CH2), 36.3 (CH2), 40.1 (CH) 53.5 (CH), 
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55.9 (CH3), 56.1 (CH3), 107.8 (CH), 11.7 (CH), 115.4 (CH2), 127.6 (C), 129.0 (C), 139.4 
+ + (CH), 146.8 (C), 146.9 (C) 169.0 (NCO); MS (El) m/z 287 [MH , 7.5 %] (MH , 
288.1594. C17H21N03 requires 288.1594). 
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(6S,llbR)-6-«tert-Butyldiphenylsilyloxy)methyl)-9,10-dimethoxy-2,3,6,7-
tetrahydro-1H-pyrido[2,I-a ]isoquinolin-4(llbH)-one (176) 
MeO 
MeO 
OTBDPS 
o 
To a stirred solution of (6S,11bR)-6-(hydroxymethyl)-9,1O-dimethoxy-2,3,6,7-tetrahydro-
1H-pyrido[2,1-a]isoquinolin-4(l1bH)-one (126) (1.02 g, 3.51 mmol) in dichloromethane 
(50.0 ml) at 0 QC was added imidazole (0.72 g, 10.53 mmol). To this mixture was added 
4-dimethylaminopyridine (0.04 g, 0.35 mmol) followed by drop-wise addition of tert-
butyldiphenylsilyl chloride (1.45 g, 1.37 ml, 5.27 mmol). The resulting mixture was 
allowed to warm to room temperature over 16 hours. After this time water (50 ml) was 
added and the organic phase separated. The aqueous phase was extracted with 
dichloromethane (3 x 50 ml) and the combined organic fractions dried over anhydrous 
magnesium sulfate, filtered and the solvent removed by rotary evaporation. The crude 
product was adsorbed onto silica and purified by flash column chromatography over 
silica eluting with 1: 1 ethyl acetate:light petroleum. The target compound was isolated as 
a white foam (1.80 g, 97 %), Mp 66-69 QC; [a]D = 65.0 [e = 1.0, CHCh]; Vrnax (thin film, 
CH2Clz)/cm-1 1634 (NCO) 1111 (COSi); bH (400 MHz; CDCI3) 1.01 (9H, s, C(CH3)3), 
1.59-1.69 (lH, m, CCHCH(H», 1.74-1.84 OH, m, CH(H)CH2CO), 1.88-1.95 (lH, m, 
CH(H)CH2CO), 2.34-2.40 (lH, m, CCHCH(H», 2.44 (lH, dd, J 7.2, 10.8, CH(H)CO), 
2.52-2.58 (lH, m, CH(H)CO), 2.78 (1H, dd, J 2.0, 16.0, CCH(H)CH), 2.97 (lH, dd, J 
6.0, 16.0, CCH(H)CH), 3.61 (2H, d, 7.6, CH20Si), 3.85 (6H, s, 2 x OCH3), 4.34 (lH, dd, 
J 4.0, lOA, CCH), 5.34-5.40 (lH, m, CHCH20Si), 6.54 (1H, s, ArH), 6.58 (1H, s, ArH), 
7.26-7.61 (lOH, m, (C(CH3)3); be (lOO MHz; CDCh) 19.2 (C(CH3h), 19.5 (CH2), 26.7 
«CH3)3), 28.7 (CH2), 31.2 (CH2), 32.3 (CH2), 47.6 (CH), 53.6 (CH), 55.9 (CH3), 56.1 
(CH3), 62.0 (CH2), 108.1 (CH), 111.9 (CH), 124.8 (C), 127.6 (2 x CH), 127.7 (2 x CH), 
128.2 (C), 129.6 (CH), 129.7 (CH), 133.2 (C), 13304 (C), 135.6 (4 x CH), 147.5 (C), 
147.9 (C), 170.0 (NCO); MS (El) m/z 529 [MH+, 14.5 %] (MH+, 530.2720. C32H39N04Si 
requires 530.2721). 
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(6S ,llbR)-6-( (tert-ButyldiphenylsiIyloxy )methyl)-9,10-dimethoxy-6, 7 -dihydro-1H-
pyrido[2,1-a ]isoquinolin-4(llbH)-one (178). 
MeO 
MeO 
OTBDPS 
o 
To a stirred solution of diisopropyl amine (1.03 g, 1.44 ml, 10.19 mmol) in anhydrous 
tetrahydrofuran (30 ml) was added n-butyllithium (2.5 M solution in hexanes) (4.08 ml, 
10.19 mmol) drop-wise under nitrogen at 0 cC. The reaction mixture was stirred for 15 
minutes at 0 °C and then cooled to -78°C whereupon a solution of (6S,llbR)-6-( 
(tert-butyldiphenylsilyloxy)methyl)-9,10-dimethoxy-2,3,6,7-tetrahydro-lH-pyrido[2,I-a] 
isoquinolin-4(llbH)-one (176) (1.80 g, 3.40 mmol) in anhydrous tetrahydrofuran (30 ml) 
was added via cannula. To the resulting mixture was added phenylselenyl bromide (1.20 
g, 5.10 mmol) in anhydrous tetrahydrofuran (20 ml) dropwise via syringe. The reaction 
was allowed to warm slowly from -78°C to room temperature with stirring. After 24 
hours the reaction was quenched by the addition of saturated aqueous ammonium 
chloride solution (50 ml) and extracted with diethyl ether (3 x 50 ml). The combined 
ether extracts were washed with saturated aqueous ammonium chloride solution (100 ml) 
and dried with anhydrous magnesium sulfate. The solvent was removed by rotary 
evaporation to yield the crude selenide (2.30 g), which was used without further 
purification. 
The crude selenide was dissolved in methanol (100 ml) and water (50 ml). To the 
resulting solution was added sodium metaperiodate (1.67 g, 7.82 mmol) and sodium 
hydrogen carbonate (0.34 g, 4.08 mmol) and the solution was stirred vigorously at room 
temperature for 20 hours. After this time the reaction was added to a mixture of saturated 
aqueous sodium bicarbonate solution (150 ml) and diethyl ether (200 ml). The ether layer 
was washed with water (150 ml), then brine (150 ml) and dried over anhydrous 
magnesium sulfate. Volatiles were removed under reduced pressure and the crude 
product adsorbed onto silica and purified by flash column chromatography over silica 
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eluting with 1:1 ethyl acetate:light petroleum to afford the target compound as a white 
foam (0.43 g, 42 %), Mp 81-84 cC; [a]o = 238.0 [e = 1.0, CHCI3]; Yrnax (thin film, 
CH2Ch)/cm-1 1661 (NC=O) 1111 (COSi); ()H (400 MHz; CDCh) 1.00 (9H, s, (CH3)3), 
2.21-2.30 (lH, m, CCHCH(H», 2.61 (lH, ddd, J 4.4,6.4, 17.6, CCHCH(H», 3.01 (2H, 
d, J 3.6 CCH(H)CH), 3.46 (lH, t, J 9.2, CH20Si), 3.60 (lH, q, J 7.6, CH20Si), 3.86 (3H, 
s, OCH3), 3.87 (3H, s, OCH3), 4.49 (lH, dd, J 4.4, 14.0, CCH), 5.19-5.22 (lH, m, 
CHCH20Si), 6.05 (lH, dd, J 2.4, 9.6, CHCO), 6.48 (lH, s, ArH), 6.61-6.66 (2H, m, 
CHCHCO and ArH), 7.21-7.58 (lOH, m, C(CH3)3»; ()c (100 MHz; CDCh) 19.1 
(C(CH3))), 26.7 «CH3))), 29.3 (CH2), 33.9 (CH2), 47.2 (CH), 52.7 (CH), 55.9 (CH3), 56.1 
(CH3), 61.2 (CH2), 108.5 (CH), 112.1 (CH), 124.3 (C), 125.9 (CH), 126.9 (C), 127.5 (2 x 
CH), 127.7 (2 xCH), 129.5 (CH), 129.6 (CH), 133.2 (2 x C), 135.5 (2 x CH), 135.6 (2 x 
CH), 138.9 (CH), 147.8 (C), 148.2 (C), 164.7 (NCO); MS (FAB) mlz 527 [MH , 19.9 %] 
(MH ,526.2420. C32H37N04Si requires 526.2414). 
Chapter 5 Experimental 150 
(28 ,6S,11 bR)-6-( (tert-B utyldiphenylsilyloxy )methyl)-9,10-dimethoxy -2-viny 1-2,3,6, 7-
tetrahydro-1H-pyrido[2,1-a]isoquinolin-4(11bH)-one (179). 
MeO 
MeO 
OTBDPS 
o 
A 1.0 M solution of vinylmagnesium bromide in tetrahydrofuran (17.05 ml, 17.05 mmol) 
was added to a suspension of copper cyanide (0.76 g, 8.53 mmol) in anhydrous 
tetrahydrofuran (20 ml) at -78°C with stirring. The reaction mixture was warmed to 0 °C 
for 15 minutes and then re-cooled to -78°C. A solution of (6S,l1bR)-6-((tert-
butyldiphenylsilyloxy)methyl)-9, 1 0-dimethoxy-6, 7 -dihydro-1H-pyrido[2, I-a] isoquinolin 
-4(l1bH)-one (178) (0.60 g, 1.14 mmol) in anhydrous tetrahydrofuran (20 ml) was added 
via cannula at -78 QC. After a further 5 minutes chlorotrimethylsilane (1.08 ml, 8.53 
mmol) was added and the resulting suspension was warmed slowly (overnight) to room 
temperature. After this time a mixture of saturated aqueous ammonium chloride solution 
(25 ml) and water (25 ml) was added and stirring continued for 15 minutes. A 1.0 M 
solution of tetrabutylammonium fluoride in tetrahydrofuran (4.0 ml) was added and 
stirring continued for 15 minutes. The organic phase was separated and the aqueous 
phase extracted with ethyl acetate (3 x 50 ml). The combined organic fractions were 
dried over anhydrous magnesium sulfate and the solvent removed on the rotary 
evaporator. Crude 400 MHz IH-NMR revealed the formation of the product as a single 
diastereoisomer. The crude product was adsorbed onto silica and purified by flash 
column chromatography eluting with 1:1 light petroleum:ethyl acetate to give the target 
compound as a pale yellow oil (0.44 g, 70 %), [a]D = 19.6 [c = 1.0, CHCh]; Vrnax (thin 
film, neat)/cm-1 1661 (NC=O) 1111 (COSi); OH (400 MHz; CDCh) 1.00 (9H, s, (CH3)3), 
2.05-2.17 (2H, m, CCHCH2), 2.48 OH, dd, J 6.8, 17.2, CH(H)CO), 2.55 OH, dd, J 5.6, 
16.8, CH(H)CO), 2.70-2.74 OH, m, CHCH2CO), 2.88-3.00 (2H, m, CH20Si), 3.63-3.71 
(2H, rn, CCH2CH), 3.86 (6H, s, 2 x OCH3), 4.53-4.56 (lH, m, CCH), 5.07-5.15 (3H, 
CH=CH2 and CHCH20Si), 5.89-5.97 OH, m, CH=CH2), 6.57 OH, s, ArH), 6.63 OH, s, 
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ArH), 7.26-7.61 (lOH, rn, C(CH3h)); Qc (100 MHz; CDCh) 19.2 (CCCH3h), 26.8 
((CH3)3), 29.0 (CH2), 33.1 (CH), 34.6 (CH2), 37.1 (CH2), 48.8 (CH), 50.7 (CH), 56.0 
(CH3), 56.2 (CH3), 62.8 (CH2), 107.6 (CH), 112.0 (CH), 115.1 (CH2), 126.1 (C), 127.6 (2 
x CH), 127.7 (2 x CH), 128.7 (C), 129.7 (CH), 129.7 (CH), 133.2 (C), 133.3 (C), 135.6 
(2 x CH), 135.6 (2 x CH), 140.0 (CH), 147.5 (C), 148.1 (C), 169.2 (NCO); MS (El) m/z 
555 [MH+, 15.5 %] (MH+, 555.2874. C34HnN04Si requires 555.2878). 
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Ethyl 2-( (6S,11 bR)-6-( (tert-butyldiphenylsilyloxy )methyl)-9,10-dimethoxy-4-oxo-
2,3,4,6,7 ,11b-hexahydro-lH -pyrido[2,1-a ]isoquinolin -2-yl)-1,3-dithiolane-2-
carboxylate (180) 
MeO 
MeO 
OTBDPS 
o 
To a stirred solution of diisopropyl amine (0.27 ml, 0.95 mmol) in anhydrous 
tetrahydrofuran (5 ml) was added n-butyllithium (2.5 M solution in hexanes) (0.76 ml, 
1.90 mmol) dropwise under nitrogen at 0 QC. The reaction mixture was stirred for 15 
minutes at 0 QC and then cooled to -78°C whereupon ethyl1,3-dithiolane-2-carboxylate 
(0.16 rnl, 1.14 mmol) was added via syringe and stirring was continued for a further 30 
minutes. After this time a solution of (6S,llbR)-6-«tert-butyldiphenylsilyloxy)methyl)-
9, 1O-dimethoxy-6, 7 -dihydro-1H-pyrido[2, I-a ]isoquinolin-4(11 bH)-one (178) (500 mgs, 
0.95 mmol) in anhydrous tetrahydrofuran (10 ml) was added via cannula at -78°C. The 
resulting mixture was allowed to warm slowly (overnight) to room temperature. The 
reaction was quenched by the addition of water (25 ml) and extracted with ethyl acetate 
(3 x 25 ml). The organic extracts were dried over anhydrous magnesium sulfate, filtered 
and the solvent removed on the rotary evaporator. Crude 400 MHz IH-NMR analysis 
revealed the formation of (180alb) as a 1: 1 mixture of diastereoisomers. These 
diastereoisomers were purified but with only one isomer isolable by flash column 
chromatography over silica using 5: 1 light petroleum:ethyl acetate as eluent to yield a 
yellow solid (188 mgs, 28 %), Mp 89-91 QC; [a]o = 182.0 [e = 1.5, CHCI3]; Vrnax (thin 
film, CH2Clz)/cm-1, 1732 (C(O)OCH3), 1667 (NCO), 1112 (CO(O)CH3); OH (400 MHz; 
CDCb) 1.00 (9H, s, (CH3)3), 1.30 (3H, t, J 7.2, OCH2CH3), 1.99-2.22 (2H, m, CCHCH2), 
2.89 (lH, dd, J 6.0, 16.4, CC(H)HCH), 3.00 (lH, dd, J 6.0,16.4, CCH(H)CH), 3.19-3.29 
(4H, rn, SCH2CH2S), 3.33-3.45 (2H, m, CH2CO), 3.54-3.63 (2H, m, CH20Si), 3.67-3.71 
(lH, rn, CHCH2CO), 3.86 (6H, s, 2 x OCH3), 4.24 (2H, q, J 8.4, OCH2CH3), 4.69 (lH, 
dd, J 3.6, 10.4, CCH), 5.06-5.09 (lH, m, CHCH20Si), 6.57 (lH, s, ArH), 6.61 (lH, s, 
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ArH), 7.25-7.59 (lOH, rn, C(CH3)3»; oc(100 MHz; CDCh) 14.0 (CH3), 19.2 (C(CH3)3), 
26.8 «CH3)3), 28.8 (CHz), 35.0 (CHz), 37.1 (CH), 38.3 (CHz), 38.5 (CHz), 39.4 (CHz), 
49.0 (CH), 51.3 (CH), 55.9 (CH3), 56.4 (CH3), 62.3 (CHz), 62.7 (CHz), 75.2 (C) 108.4 
(CH), 112.1 (CH), 124.9 (C), 127.1 (C), 127.6 (2 x CH), 127.7 (2 x CH), 129.6 (CH), 
129.7 (CH), 133.1 (2 x C), 135.5 (2 x CH), 135.6 (2 x CH), 147.8 (C), 148.3 (C), 166.5 
(NCO), 171.2 (CO); MS (FAB) m/z 705 [M+, 21.0 %] (M+, 705.2621. C38RnN06SzSi 
requires 705.2614). 
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(S)-2-(tert-Butoxycarbonyl)-3-(3,4-dihydroxyphenyl)propanoic acid (182). 
A solution of L-3-(3,4-dihydroxyphenyl)alanine (181) (3.0 g, 15.21 mmol) in water (100 
ml) was stirred rapidly as it was cooled to 0 QC. Triethylamine (2.54 ml, 18.25 mmol) and 
di-tert-butyl dicarbonate (3.49 g, 18.25 mmol) as a solution in dioxane (100 ml) were 
added successively and the resulting mixture was allowed to warm to room temperature 
and stir for a further 24 hours. Volatiles were removed under reduced pressure and the 
I 
aqueous portion extracted with ethyl acetate (3 x 50 ml) at an adjusted pH of 2. The 
combined organic fractions were washed successively with saturated aqueous sodium 
bicarbonate (50 ml) and brine (50 ml) and dried over anhydrous magnesium sulfate. 
Solvents were removed on the rotary evaporator to yield a light brown solid (4.48 g, 99 
%) which was suitable for further reactions. Mp 139-141 QC; [a]D = 40.0 [c = 1.0, H20 ]; 
Vrnax (thin film, CH2Ch)/cm-1 3331 (OH), 1682 (C(O)OH); OH (400 MHz; CDCh) 1.33 
(9H, s, OC(CH3)3), 2.63 (lH, dd, J 9.6, 13.8, CH(H)CHNH), 2.81 (lH, dd, J 4.4, 13.7, 
CH(H)CHNH), 3.94-4.01 (lH, m, NHCH), 6.45-6.47 (lH, m, ArH), 6.59-6.61 (2H, m 
ArH); Oc (lOO MHz; CDCh) 28.2 «CH3h), 36.6 (CH2), 57.0 (CH), 78.0 (C), 115.3 (CH), 
116.6 (CH), 119.9 (CH), 128.9 (C), 143.8 (C), 144.9 (C), 155.5 (NC(O)OtBu), 174.0 
(CHC0 2H); MS (El) mlz 297 [M+, 3.2 %] (M+, 297.1217. Cl4Hl9N06 requires 
297.1212). 
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(S)-Methyl 2-(tert-butoxycarbonyl)-3-(3,4-dimethoxyphenyl)propanoate (183). 
MeoX){ I ~ OMe 
MeO .0 .J:' 
° 01< 
Finely ground potassium hydroxide (0.93 g, 16.59 mmol was added portion wise to a 
solution of (S)-2-(tert-butoxycarbonyl)-3-(3,4-dihydroxyphenyl)propanoic acid (182) 
(4.48 g, 15.08 mmol) in dimethylformamide at 0 cC and stirred for 10 minutes. After this 
time methyl iodide (1.08 ml, 16.59 mmol) was added drop-wise and the solution was then 
allowed to stir at room temperature for 0.5 hours. The resulting mixture was cooled to 0 
QC and finely ground potassium hydroxide (1.86 g, 33.18 mmol) was added portion-wise 
and allowed to stir for 15 minutes before drop-wise addition of methyl iodide (2.16 ml, 
33.18 mmol). The reaction was allowed to warm to room temperature overnight and then 
added to ice (lOO g) and extracted with ethyl acetate (3 x 50 ml). The combined organic 
extracts were dried over anhydrous magnesium sulfate and concentrated to yield a light 
brown oil. The crude oil was adsorbed onto silica and purified by column 
chromatography using 3: 1 hexane: ethyl acetate as eluent. The product was isolated as a 
white solid (3.87 g, 76 %), Mp 123-125 cC; [a]D = 43.5 [c = 1.0, CH2Ch]; Vrnax (thin film, 
CH2Clz)/cm-1 1746 (NCO(OlBu), 1713 (C(O)OCH3), 1262, 1160 (2 x C-O) <>H (400 
MHz; DMSO) 1.30 (9H, s, OC(CH3)3), 2.76 (lH, dd, J 9.9, 13.7, CH(H)CHNH), 2.90 
(lH, dd, J 5.1, 13.8, CH(H)CHNH), 3.60 (3H, s, COOCH3), 3.70 (3H, s, COCH3), 3.72 
(3H, s, COCH3) 4.10-4.16 (lH, m, NHCH), 6.70-6.74 (lH, m, ArH), 6.83-6.85 (2H, m 
ArH); <>c (lOO MHz; DMSO) 28.1 «CH3)3), 36.0 (CH2), 51.8 (CH3), 55.3 (CH), 55.4 
(CH3), 55.5 (CH3), 79.2 (CH), 111.6 (CH), 112.9 (CH), 121.1 (CH), 129.8 (C), 147.4 (C), 
148.4 (C), 172.7 (NC(O)OtBu), 174.0 (CHC02CH3); MS (El) m/z 339 [M+, 5.6 %] (M+, 
339.1677. C17H25N06 requires 339.1682). 
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(S)-tert-ButyI3-(3,4-dimethoxyphenyl)-1-hydroxypropan-2-ylcarbamate (184). 
MeO~OH ~ ~H 
MeO A 
o ay 
To a stirred solution of (S)-methyl 2-(tert-butoxycarbonyl)-3-(3,4-
dimethoxyphenyl)propanoate (183) (3.30 g, 9.73 mmol) in absolute ethanol (150 ml) at 0 
QC was added sodium borohydride (1.47 g, 33.58 mmol) portion wise. The solution was 
allowed to warm to room temperature overnight and then cooled back down to 0 QC. The 
reaction was quenched with successive addition of concentrated hydrochloric acid (2 ml) 
and water (15 ml). Ethanol was removed under reduced pressure and the reaction 
partitioned between ethyl acetate (150 ml) and brine (150 ml). The ethyl acetate layer 
was dried over anhydrous magnesium sulfate and evaporated to dryness to afford a crude 
solid. Recrystallisation from ethyl acetate gave white crystals (2.70 g, 89 %), Mp 91-93 
QC; [a]D = 29.2 [e = 1.0, CH2Ch]; Vrnax (thin film, CH2Ch)/cm-1 3366 (OH), 1684 
(NCO(OiBu), 1261, 1158, (2 x C-O); OH (400 MHz; CDCh) 1.42 (9H, s, OC(CH3)3), 
2.67 (1H, dd, J 13.6,8.4 CH(H)CHNH2), 2.78 (lH, dd, J 6.8, 14.0, CH(H)CHNH2), 3.55 
(1H, dd, J 5.1, 11.0, CH(H)OH), 3.64 (lH, dd, J 6.1, 11.3, CH(H)OH) , 3.86 (3H, s, 
CH30), 3.87 (3H, s, CH30), 4.80-4.82 (lH, m, NHCH) 6.73-6.76 (2H, m, ArH), 6.77-
6.81 (lH, m ArH); Dc (100 MHz; CD Ch) 28.4 «CH3)3), 37.0 (CH2), 53.6 (CH), 55.8 
(CH3), 55.9 (CH3), 64.3 (CH2), 77.3 (C), 111.2 (CH), 112.2 (CH), 121.3 (CH), 130.8 (C), 
147.6 (C), 148.9 (C), 156.2 (NC(O)OtBu); MS (El) mlz 311 [M+, 18.7 %] (M+, 311.1737. 
CI6H2SNOS requires 311.1733). 
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5.3 Asymmetric Construction of the Dodecahydrobenz[a]indolo[3,2-h] 
quinolizine Ring System 
Ethyl 2-(2-(methoxymethylene)cyclohexyl)acetate (200). 
(Methoxymethyl)triphenylphosphonium chloride (7.45 g, 21.72 rnrnol) was added to 
potassium tert-butoxide (3.66 g, 32.58 rnrnol) and dissolved in anhydrous toluene (100 
ml). The subsequent orange solution was stirred at room temperature for 1.5 hours to give 
a blood-red solution. To this solution was added ethyl 2-cyclohexanoneacetate (199) 
(1.96 ml, 10.86 mmol) drop-wise over a 10 minute period and the reaction mixture left to 
stir for a further 18 hours. The reaction was quenched with the careful addition of water 
(20 ml) followed by a further 80 ml and then extracted into ethyl acetate (3 x 50 ml). The 
combined organic fractions were washed with brine (2 x 50 ml), dried over anhydrous 
magnesium sulfate and concentrated under reduced pressure to yield a yellow solid. The 
solid was suspended in diethyl ether to crash out triphenylphosphine oxide and the 
collected filtrate was adsorbed directly onto silica. The crude product was purified by 
flash column chromatography over silica eluting with 4: 1 light petroleum:ethyl acetate to 
furnish the target compound as a colourless oil (1.47 g, 64 %), Vrnax (thin film, 
CH2Ch)lcm-1 1734 (C=O), 1232 (C-O); ()H (400 MHz; CDCh) 1.23-1.27 (3H, m, 
OCH2CH3), 1.36-1.39 (IH, m, CHC(H)H), 1.43-1.52 (3H, m, CCH2CH2 and 
CHCH2C(H)H), 1.59-1.69 (2H, rn, CHCH(H) and CHCH2CH(H», 2.12-2.16 (lH, m, 
CC(H)H), 2.22-2.27 (lH, m, CCH(H), 2.30-2.35 (lH, m, CHC(H)HCO), 2.44-2.50 (IH, 
m, CHCH(H)CO), 2.51-2.58 (lH, m, CCHCH2), 3.52 (3H, s, OCH3), 4.09-4.16 (2H, m, 
OCH2CH3), 5.75 (lH, s, CCHOCH3); Oc (lOOMHz; CDCh) 14.2 (CH3), 23.2 (CH2), 23.6 
(CH2), 26.7 (CH2), 33.0 (CH2), 36.0 (CH), 37.8 (CH2), 59.1 (CH3), 60.0 (CH2), 119.3 (C), 
+ + 139.3 (CH), 172.8 (CO); MS (FAB) m/z 212 [M , 77.9 %] (M , 212.1415. Cl2H2003 
requires 212.1413). 
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2-«lS,2R)-2-formylcyclobexyl)acetic acid rac_(138).70 
Ethyl 2-(2-(methoxymethylene)cyclohexyl)acetate (200) (700 mgs, 3.30 mmol) was 
dissolved in a 3:1 mixture of tetrahydrofuran (30 ml) and water (10 ml). To this 
vigorously stirred solution was added 2M hydrochloric acid until a pH of 1 was attained 
and then the reaction was heated at 55 QC for 6 hours. After this time the tetrahydrofuran 
was removed under reduced pressure and the resulting solution diluted with water (20 ml) 
and extracted with ethyl acetate (5 x 30 ml). The combined organics were dried over 
anhydrous magnesium sulfate and concentrated under reduced pressure to afford a crude 
yellow oil. The oil was purified via flash column chromatography over silica, eluting 
with 2: 1 ethyl acetate:light petroleum to yield a colourless oil (553 mgs, 99 %), Vrnax (thin 
film, CH2C}z)/cm-1 3221 (OH), 1720 (C=O); OH (400 MHz; CDCh) 1.05-2.74 (12 H, br, 
m, OHCHCHCH2CH2CH2CH2CHCH2), 5.74 (lH, d, J 1.6, CHOH); Oc (lOOMHz; 
CDCh) 24.9 (CH2), 25.5 (CH2), 29.2 (CH2), 32.7 (CH2), 35.9 (CH), 40.6 (CH2), 49.1 
(CH), 112.4 (CH), 179.1 (CO); MS (FAB) mlz 170 [MH, 14.8 %] (MH, 170.0863. 
C9Hl403 requires 170.0865). 
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(S)-2-Amino-3-(IH-indol-3-yl)propan-l-01 (198) 
OSCOH 
-- N NH2 
H 
Chlorotrimethylsilane (12.4 ml, 97.9 mmol) was added to a solution of lithium 
borohydride (1.07 g, 49.0 mmol) in anhydrous tetrahydrofuran (75 ml) under a nitrogen 
atmosphere over the course of 2 minutes. L-tryptophan (201) (5.0 g, 24.5 mmol) was 
added portion-wise to the mixture over 5 minutes. After 24 hours stirring at room 
temperature the mixture was treated with methanol (30 ml), which was added in a 
cautious manner. All volatiles were removed under reduced pressure on the rotary 
evaporator to yield an oil that was treated with 20 % potassium hydroxide solution (20 
ml). The solution was washed with ethyl acetate (3 x 100 ml) and the combined organic 
phases dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure to yield a light brown foam (3.82 g, 82 %) which required no further 
purification; Vrnax (thin film, CH2Clz)/cm-1 3275 (NH); OH (400 MHz; DMSO) 2.60 (1H, 
dd, 17.2, 14.1, C(H)HCHNH2), 2.74-2.92 (lH, m, C(H)HCHNH2), 2.97-3.09 (1H, m, 
CHNH2), 3.21-3.29 (1H, m, C(H)HOH), 3.40 (1H, dd, 14.6, 10.2, CH(H)OH), 6.99 (1H, 
t, 1 6.7, ArH), 7.08 (1H, t, 17.4 ArH), 7.15 (1H, s, CHNH), 7.37 (1H, d, 17.9, ArH), 7.57 
(1H, d, 17.6 ArH), 10.90 (lH, br, s, NH); Oc (100MHz; DMSO) 29.7 (CH2), 53.9 (CH), 
66.1 (CH2), 111.7 (CH), 111.8 (C), 118.7 (CH), 118.8 (CH), 121.1 (CH), 123.4 (CH), 
+ + 127.3 (C), 136.5 (C); MS (FAB) m/z 190 [MH , 66.1 %] (MH , 190.1182. CllHl4N204 
requires 190.1184). 
Chapter 5 Experimental 160 
3S,6aS,10aR,10bS)-3-((lH-Indol-3-yl)methyl)octahydro-2H-oxazolo[2,3-
a]isoquinolin-5(3H)-one (202a). 
(S)-2-Amino-3-(lH-indol-3-yl)propan-l-ol (198) (564 mgs, 2.76 mmol) and 2-((lS,2R)-
2-formy1cyclohexyl)acetic acid rac-(138) (470 mgs, 2.76 mmol) were added to toluene 
(30 ml) and refluxed under Dean-Stark conditions for 24 hours. The mixture was allowed 
to cool to room temperature and the solvent removed under reduced pressure to yield the 
target compound. Crude 400 MHz lH-NMR analysis revealed the formation of (202) as a 
1: 1 mixture of diastereoisomers. These diastereoisomers were purified and separated by 
flash column chromatography over silica using 4: 1 light petroleum:ethyl acetate as eluent 
(619 mgs, 69 %). 
Natural product isomer (202a) isolated as a white solid; Mp 214-216 QC; [a]o = 13.9 [c 
= 1.0, CH2Ch], Vrnax (thin film, CH2Cl2)/cm-1 1632 (NCO), 1298 (C-O); OH (400 MHz; 
CD Cb) 1.02-1.10 (2H, m, NCHCHC(H)H and COCH2CHC(H)H), 1.22-1.35 (3H, m, 
NCHCH and NCHCHCH2C(H)H and COCH2CHCH2C(H)H), 1.44-1.54 (lH, m, 
COCH2CH), 1.76-1.83 (3H, m, NCHCHCH2CH(H) and COCH2CHCH(H) and 
COCH2CHCH2CH(H), 2.00-2.16 (2H, m, NCHCHCH(H) and COC(H)H), 2.52 (IH, dd, 
J 6.0, 17.6 COCH(H), 2.61 (IH, dd, J 10.4, 14.0 CHCC(H)H), 3.63-3.67 (IH, m 
CHOC(H)H), 3.78 (lH, d, J 13.6, CHCCH(H), 4.01 (IH, d, J 9.2, CHOCH(H), 4.26-
4.30 (lH, m, CHCCH2CH), 4.32 OH, d, J 8.4, NCH), 7.00 (IH, d, J 2.0, NHCH), 7.12 
(lH, t, J 7.2, ArH), 7.18 (lH, t, J 7.6, ArH), 7.34 (IH, d, J 8.0, ArH), 7.82 (IH, d, J 7.6, 
ArH), 8.32 (lH, s, NH); Oc (lOOMHz; CDCh) 24.8 (CH2), 25.6 (CH2), 26.9 (CH2), 27.5 
(CH2), 32.4 (CH2), 34.5 (CH), 39.3 (CH2), 43.6 (CH), 56.3 (CH), 70.2 (CH2), 92.8 (CH), 
111.1 (CH), 112.6 (C), 119.4 (CH), 119.5 (CH), 122.1 (CH), 122.4 (CH), 127.7 (C), 
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+ + 136.3 (C), 167.6 (NCO); MS (FAB) m/z 324 [MH, 100 %] (MH, 324.1920. 
C2oH24N202 requires 324.1916). 
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(3S,6aR,10aS,10bR)-3-«lH-Indol-3-yl)methyl)octahydro-2H-oxazolo[2,3-
a]isoquinolin-5(3H)-one (202b). 
~ ~ # H I -HN 0 N HO T(5 
(S)-2-Amino-3-(lH-ndol-3-yl)propan-1-01 (198) (564 mgs, 2.76 mmol) and 2-«(lS,2R)-2-
formylcyclohexyl)acetic acid rac-(138) (470 mgs, 2.76 mmol) were added to toluene (30 
ml) and refluxed under Dean-Stark conditions for 24 hours. The mixture was allowed to 
cool to room temperature and the solvent removed under reduced pressure to yield the 
target compound. Crude 400 MHz IH-NMR analysis revealed the formation of (202) as a 
1: 1 mixture of diastereoisomers. These diastereoisomers were purified and separated by 
flash column chromatography over silica using 4: 1 light petroleum:ethyl acetate as eluent 
(619 mgs, 69 %). 
Second isomer (202b) isolated as a white solid; Mp 190-192 cC; [a]D = 11.5 [c = 1.0, 
CH2Ch]; Vrnax (thin film, CH2Ch)/cm-1 1631 (NCO), 1244 (C-O); OH (400 MHz; CDCh) 
0.96-1.03 (2H, m, NCHCHC(H)H and COCH2CHC(H)H), 1.14-1.27 (3H, m, NCHCH 
and NCHCHCH2C(H)H and COCH2CHCH2C(H)H), 1.37-1.48 (lH, m, COCH2CH), 
1.70-1.82 (3H, m, NCHCHCH2CH(H) and COCH2CHCH(H) and 
COCH2CHCH2CH(H), 1.98 (lH, d, J 11.6, NCHCHCH(H), 2.03 (lH, d, J 11.6, 
COC(H)H), 2.57 (lH, dd, J 5.6, 18.0, COCH(H), 3.00 (lH, dd, J 8.8, 14.4, CHCC(H)H), 
3.35 (lH, dd, J 3.2, 14.0, CHCCH(H), 3.67 (lH, dd, J 7.2,8.8, CHOC(H)H), 4.04 (lH, 
dd, J 7.6,8.8, CHOCH(H), 4.15 (lH, d, J 8.4, NCH), 4.57-4.63 (lH, m, CHCCH2CH), 
6.99 (lH, d, J 2.0, NHCH), 7.09-7.20 (2H, m, ArH), 7.34 (lH, d, J 8.0, ArB), 7.70 (lH, 
d, J 8.0, ArH), 8.41, (lH, s, NH); Oc (lOOMHz; CDCh) 24.8 (CH2), 25.3 (CH2), 27.5 
(CH2), 28.3 (CH2), 32.3 (CH2), 33.0 (CH), 39.0 (CH2), 43.1 (CH), 54.8 (CH), 70.0 (CH2), 
91.5 (CH), 111.0 (C), 111.2 (CH), 119.1 (CH), 119.5 (CH), 122.1 (CH), 122.6 (CH), 
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+ + 127.7 (C), 136.3 (C), 168.4 (NCO); MS (FAB) m/z 324 [MH , 13.1 %] (MH ,324.1920. 
C2oH24N202 requires 324.1916). 
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7 -Hydroxymethyl-l,3,4,4a' S,5, 7' S ,8,13,13b 'R,13c'R -decahydro-2H -6a,13-diaza-
indeno[1,2-c ]phenanthren-6-one (204a) 
3S,6aS, 1 OaR, 1 ObS)-3 -( (IH-Indol-3-yl )methyl)octahydro-2H-oxazolo[2,3-a] isoquinolin-
5(3H)-one (202a) (200 mgs, 0.62 mmol) was dissolved in a solution of 2M hydrochloric 
acid in absolute ethanol (8 ml) and the mixture stirred for a further 18 h at room 
temperature. After this time the reaction was quenched by addition of saturated aqueous 
sodium bicarbonate (15 ml) and extracted with ethyl acetate (3 x 20 ml). The organic 
fraction was dried over anhydrous magnesium sulfate and the solvent removed by rotary 
evaporation to yield a crude yellow solid. Crude 400 MHz IH-NMR analysis revealed the 
formation of (204a) exclusively and purification via flash column chromatography over 
silica with ethyl acetate as eluent gave the target compound as an off-white solid (145 
mgs,73 %). 
Natural product isomer (204a) isolated as a white solid; Mp 187-189 QC; [alD= 15.1 [c 
= 1.0, CH2Chl; Vrnax (thin film, CH2Ch)/cm-1 3415 (OH), 1653 (NCO); ()H (400 MHz; 
DMSO) 0.95-1.45 (1H, m COCH2CHC(H)H), 1.24-1.42 (3H, m, NCHCHC(H)H and 
NCHCHCH2C(H)H and COCH2CHCH2C(H)H), 1.49-1.63 (2H, m, NCHCH and 
COCH2CH), 1.69-1.77 (2H, br, COCH2CHCH2CH(H) and COCH2CHCH(H», 1.82-1.88 
(1H, br, NCHCHCH2CH(H), 1.95 (IH, dd, J 12.0,17.2, COC(H)H), 2.33 (1H, dd, J 4.4, 
17.2, COCH(H», 2.50-2.51 (1H, m, NCHCHCH(H», 2.66-2.75 (2H, m, NHCCCH2), 
3.30-3.44 (2H, m, CHCH20H), 4.37 (IH, d, J 9.2, NCHCH), 4.78 (IH, t, J 5.6 OH), 
5.16-5.21 (1H, m, CHCH20H), 6.95-6.99 (1H, m, ArH) , 7.05-7.09 (1H, m, ArH), 7.38 
(1H, d, J 8.0), 7.40 (1H, d, J 8.0, ArH), 10.46 (1H, s, NH); ()c (100MHz; CDCh) 21.0 
(CH2), 24.9 (CH2), 25.4 (CH2), 31.1 (CH2), 32.2 (CH2), 34.5 (CH), 39.1 (CH2), 43.1 
(CH), 48.4 (CH), 55.1 (CH), 59.6 (CH2), 106.5 (C), 111.6 (CH), 117.5 (CH), 118.6 (CH), 
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+ 
121.0 (CH), 126.5 (C), 133.2 (C), 136.4 (C), 168.8 (NCO); MS (FAB) m/z 324 [MH , 
100 %] (MH+, 324.1912. C2oH24N202 requires 324.1916). 
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7 -Hydroxymethyl-l,3,4,4a' R,5, 7' S ,8,13,13b' R,13c' S -decahydro-2H -6a,13-diaza-
indeno[1,2-c ]phenanthren-6-one (204b). 
(3S,6aR,10aS,10bR)-3-«IH-Indol-3-yl)methyl)octahydro-2H-oxazolo[2,3-a]isoquinolin-
5(3H)-one (202b) (200 mgs, 0.62 mmol) was dissolved in a solution of 2M hydrochloric 
acid in absolute ethanol (8 ml) and the mixture stirred for a further 18 h at room 
temperature. After this time the reaction was quenched by addition of saturated aqueous 
sodium bicarbonate (15 ml) and extracted with ethyl acetate (3 x 20 ml). The organic 
fraction was dried over anhydrous magnesium sulfate and the solvent removed by rotary 
evaporation to yield a crude yellow solid. Crude 400 MHz IH-NMR analysis revealed the 
formation of (204b) exclusively and purification via flash column chromatography over 
silica with ethyl acetate as eluent gave the target compound as an off-white solid (149 
mgs, 75 %). 
Second isomer (204b) isolated as a white solid; Mp 209-211 QC; [a]D = 27.3 [c = 1.0, 
CH2Ch]; Vrnax (thin film, CH2Ch)/cm-1 3426 (OH), 1660 (NCO); DH (400 MHz; CDCh) 
0.90-1.00 (IH, m, COCH2CHC(H)H), 1.23-1.35 (2H, m, NCHCHCH2C(H)H and 
COCH2CHCH2C(H)H), 1.52-1.63 (lH, m, COCH2CH), 1.65-1.83 (3H, m 
NCHCHC(H)H and COCH2CHCH2CH(H) and COCH2CHCH(H), 1.90-1.99 (2H, m, 
NCHCH and NCHCHCH2CH(H), 2.02-2.15 (2H, m, NCHCHCH(H) and COC(H)H), 
2.45-2.51 (2H, m, COCH(H) and NHCCC(H)H), 3.12 (lH, ddd, J 2.4, 6.4, 16.0, 
NHCCCH(H), 3.61-3.65 (2H, m, CHCH20H), 4.83 (lH, d, J 5.2, NCHCH), 5.29-5.35 
(IH, m, CHCH20H), 7.07-7.12 (IH, m, ArH), 7.15-7.19 (IH, m, ArH), 7.35 (IH, dd, J 
0.8, 8.0), 7.44 (lH, d, J 7.6, ArH), 8.29 (lH, s, NH); Dc (lOOMHz; CDCh) 21.6 (Cl-h), 
25.4 (Cl-h), 26.7 (CH2), 29.7 (CH2), 32.3 (CH), 33.6 (CH2), 40.6 (CH2), 43.0 (CH), 50.9 
(CH), 53.4 (CH), 61.2 (CH2), 111.1 (CH), 111.2 (C), 118.0 (CH), 119.7 (CH), 122.3 
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+ (CH), 127.0 (C), 131.4 (c), 136.0 (C), 172.7 (NCO); MS (FAB) m/z 324 [MH ,33.3 %] 
(MH+, 324.1920. CzoHz4NzOz requires 324.1916). 
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5.4 Development of a Functionalised Dodecahydrobenz[a]indolo[3,2-h] 
quinolizine Ring System 
Methyl 2-(8-oxo-l,4-dioxaspiro[ 4.5]decan-7 -yl)acetate (209a). 
1,4-Cyclohexanedione mono ethylene acetal (208) (2.0 g, 12.80 mmol) was dissolved in 
anhydrous tetrahydrofuran (30 ml) under an inert atmosphere and the solution cooled to 
-78 DC. Potassium hexamethyldisilazide (KHMDS) (28.2 ml, 14.80 mmol) was added at 
such a rate that the temperature did not rise above -70 DC and the reaction stirred at this 
temperature for 1 hour. Methyl bromo acetate (1.32 ml, 14.80 mmol) was added drop-
wise to the mixture and after 30 minutes the reaction was allowed to warm to room 
temperature over 4 hours. The reaction was quenched with addition of water (50 ml) and 
extracted into ethyl acetate (3 x 75 ml). The organic fractions were combined, dried over 
anhydrous magnesium sulfate and concentrated under reduced pressure. The crude 
product was adsorbed onto silica and purified by flash column chromatography over 
silica eluting with 1: 1 light petroleum:ethyl acetate to give the target compound as a pale 
yellow oil (2.10 g, 72 %); Vrnax (thin film, neat)/cm-1 1715 (C=O), 1174 (C-O); OH (400 
MHz; CD Ch) 1.82 (IH, t, J 13.2, CHC(H)HC), 2.00 (IH, dd, J 4.8, 13.6 COC(H)HCH2), 
2.03-2.14 (2H, m, CHCH(H)C and COCH(H)CH2), 2.20 (IH, dd, J 6.0, 16.8, 
CHC(H)HCO), 2.40 (lH, ddd, J 2.4, 4.8, 14.4, COCH2C(H)H), 2.68-2.77 (2H, m, 
CHCH(H)CO and COCH2CH(H», 3.19-3.24 (IH, m, COCH), 3.68 (3H, s, OCH3), 4.00-
4.09 (4H, m, OCH2CH20); Oc (100MHz; CDCh) 33.9 (CH2), 34.6 (CH2), 37.8 (CH2), 
40.2 (CH2), 43.1 (CH), 51.7 (CH3), 64.7 (CH2), 64.8 (CH2), 107.1 (C), 172.5 (C0 2Me), 
209.6 (CO); MS (FAB) mlz 228 [MH+, 71.9 %] (MH+, 228.1074. CllH160S requires 
228.1076). 
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Ethyl 2-(8-oxo-l,4-dioxaspiro[ 4.5]decan-7 -yl)acetate (209b). 
1,4-Cyclohexanedione monoethylene acetal (208) (2.0 g, 12.80 mmol) was dissolved in 
anhydrous tetrahydrofuran (30 ml) under an inert atmosphere and the solution cooled to 
-78 cC. Potassium hexamethyldisilazide (KHMDS) (29.4 ml, 14.70 mmol) was added at 
such a rate that the temperature did not rise above -70 QC and the reaction stirred at this 
temperature for 1 hour. Ethyl bromo acetate (1.63 ml, 14.70 mmol) was added drop-wise 
to the mixture and after 30 minutes the reaction was allowed to warm to room 
temperature over 4 hours. The reaction was quenched with addition of water (50 ml) and 
extracted into ethyl acetate (3 x 75 ml). The organic fractions were combined, dried over 
anhydrous magnesium sulfate and concentrated under reduced pressure to yield (209b) as 
a white solid (2.60 g, 84 %) which required no further purification; Mp 65-67 cC; Vmax 
(thin film, CH2Clz)/cm-1 1717 (C=O), 1180 (C-O); bH (400 MHz; CDCh) 1.26 (3H, t, J 
7.2, OCH2CH3) , 1.82 (lH, t, J 13.2, CHC(H)HC), 1.95-2.01 (IH, m, COC(H)HCH2), 
2.03-2.14 (2H, m, CHCH(H)C and COCH(H)CH2), 2.19 (lH, dd, J 6.0, 16.8, 
CHC(H)HCO), 2.40 (IH, ddd, J 2.8, 4.8, 14.4, COCH2C(H)H), 2.66-2.77 (2H, m, 
CHCH(H)CO and COCH2CH(H», 3.16-3.25 (IH, m, COCH), 4.00-4.07 (4H, m, 
OCH2CH20), 4.10-4.16 (2H, m, OCH2CH3); bc (lOOMHz; CDCh) 14.2 (CH3), 34.0 
(CH2), 34.6 (CH2), 37.8 (CH2), 40.0 (CH2), 43.1 (CH), 60.5 (CH2), 64.7 (CH2), 64.8 
+ + (CH2), 107.4 (C), 172.0 (C02Et), 209.6 (CO); MS (FAB) m/z 242 [MH , 100 %] (MH , 
242.1238. Cl2HlSOS requires 242.1233). 
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Methyl 2-(8-methylene-l,4-dioxaspiro[ 4.5]decan-7 -yl)acetate (217). 
To a mixture of methyltriphenylphosphonium bromide (3.52 g, 9.86 mmol) and sodium 
hydride (395 mgs, 9.86 mmol) under nitrogen was added anhydrous tetrahydrofuran (50 
ml) around the sides of the flask. The reaction mixture was stirred vigorously for 45 min 
to give a bright yellow suspension at which time methyl 2-(8-oxo-l,4-
dioxaspiro[4.5]decan-7-yl)acetate (209a) (1.50g, 6.58 mmol) was added drop-wise as a 
solution in anhydrous tetrahydrofuran (15 ml). Upon complete addition a deep red 
colouration was observed and the reaction left to stir vigorously for a further 3 hours. The 
reaction mixture was cooled to 0 QC and quenched via careful addition of water (100 ml), 
followed by extraction into ethyl acetate (3 x 75 ml). The combined organics were dried 
over anhydrous magnesium sulfate, filtered and concentrated under pressure to yield a 
pale yellow oil. The crude oil was suspended in diethyl ether to precipitate 
triphenylphosphine oxide and the resulting filtrate evaporated to dryness on the rotary 
evaporator to furnish the target compound as a colourless oil (1.46 g, 99 %); Vrnax (thin 
film, neat)/cm-l 1738 (CO(O)CH3), 1647 (C=O), 1167 (C-O); OH (400 MHz; CDCh) 
1.40-1.46 (lH, rn, CHC(H)HC), 1.60-1.66 (lH, rn, CH2=CCH2C(H)H), 1.76-1.82 (lH, rn, 
CH2=CCH2CH(H), 1.88 (IH, ddd, J 2.4, 4.4, 12.8, CHCH(H)C), 2.31-2.38 (3H, rn, 
CHC(H)HCO and CH2=CCH2CH2), 2.65 (IH, dd, J 7.2, 15.2, CHCH(H)CO), 2.81-2.89 
(1H, m, CCH), 3.68 (3H, s, OCH3), 3.93-4.00 (4H, m, OCH2CH20), 4.62 (lH, s, 
CC(H)H), 4.77 (lH, s, CCH(H); Oc (lOOMHz; CDCh) 32.3 (CH2), 36.2 (CH2), 36.8 
(CH), 37.5 (CH2), 41.4 (CH2), 51.6 (CH3), 64.3 (CH2), 64.4 (CH2), 106.8 (CH2), 108.4 
+ + (C), 149.1 (C), 173.1 (C02Me); MS (FAB) m/z 226 [MH , 100 %] (MH , 226.1288. 
Cl2HIS04 requires 226.1283). 
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Methyl 2-( (7S,SR)-S-formyl-l,4-dioxaspiro[ 4.5]decan-7 -yl)acetate rac-(219). 
Methyl 2-(8-methylene-l,4-dioxaspiro[4.5]decan-7-yl)acetate (217) (2.00 g, 8.33 mmol) 
in anhydrous tetrahydrofuran (30 ml) under nitrogen was treated with borane-
dimethylsulfide complex (2M) in tetrahydrofuran (2.50 ml, 5.00 mmol). The mixture was 
stirred vigorously for 1 hour and then all volatiles were removed under reduced pressure 
to give a colourless oil. The crude oil was taken up in a minimum amount of 
dichloromethane and added drop-wise to a solution of pyridinium chlorochromate (4.31 
g, 19.99 mmol) in dichloromethane (40 ml). The reaction mixture was then refluxed for 2 
hours before being allowed to cool to room temperature and diluted with diethyl ether (50 
ml). The organic phases were decanted and filtered through a silica pad and the 
remaining black solids washed exhaustively with further portions of diethyl ether (5 x 30 
ml). All volatiles were removed under reduced pressure to yield a crude oil that was 
purified by flash column chromatography over silica using 4: 1 hexane:ethyl acetate as 
eluent to yield the target compound as a colourless oil (1.49 g, 70 %); Vrnax (thin film, 
neat)lcm-l 1732 (CHO), 1176 (C-O); DH (400 MHz; CDCh) 1.51-1.59 OH, rn, 
CHOCHCH2C(H)H), 1.63-1.80 (3H, m, CHCH2C and CHOCHCH2CH(H), 1.84-1.93 
OH, rn, CHOCHC(H)H), 2.03-2.09 OH, rn, CHOCHCH(H), 2.45-2.60 (3H, rn, 
CHOCHCH and CHCH2CO), 2.64 OH, q, J 4.0, CHOCH), 3.67 OH, s, OCH3), 3.91-
3.98 (4H, m, OCH2CH20), 9.76, (CHO); Dc (100MHz; CDCh) 22.1 (CH2), 31.9 (CH2), 
32.4 (CH), 36.4 (CH2), 37.7 (CH2), 49.2 (CH), 51.6 (CH3), 64.2 (CH2), 64.4 (CH2), 108.2 
+ + (C), 173.0 (C02Me), 203.6 (CHO); MS (FAB) m/z 242 [MH ,28.1 %] (MH ,242.1232. 
Cl2HIS05 requires 242.1233). 
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{3'S,6a'S,10a'R,10b'S)-3'-{{IH-Indol-3-yl)methyl)octahydrospiro[[I,3]dioxolane-
2,8' -oxazolo[2,3-a ]isoquinolin ]-5' {6'H)-one (220a) 
(S)-2-Amino-3-(lH-indol-3-yl)propan-1-o1 (198) (1.12 g mgs, 5.47 mmol) and Methyl 2-
{(7 S,SR)-S-formyl-1 ,4-dioxaspiro[ 4.5]decan-7 -yl)acetate rae-(219) (1.40 g, 5.47 mmol) 
were added to toluene (50 ml) and refluxed under Dean-Stark conditions for 24 hours. 
The mixture was allowed to cool to room temperature and the solvent removed under 
reduced pressure to yield the target compound. Crude 400 MHz IH-NMR analysis 
revealed the formation of (220) as a 1: 1 mixture of diastereoisomers. These 
diastereoisomers were purified and separated by flash column chromatography over silica 
using 4: 1 light petroleum:ethyl acetate as eluent (940 mgs, 45 %). 
Natural product isomer (220a) isolated as a white solid; Mp 205-207 cC; [a]D = -27.9 
[e = 1.0, CH2Ch]; Vrnax (thin film, CH2Ch)/cm-1 1631 (NC=O), 1229 (C-O); OH (400 
MHz; CDCh) 1.29-1.47 (3H, m, NCHCH and NCHCHC(H)H and COCH2CHC{H)H), 
1.51-1.61 (lH, m, NCHCHCH2C(H)H), 1.77-1.92 (3H, m, COCH2CH and 
NCHCHCH2CH{H) and COCH2CHCH{H), 2.00-2.21 (2H, m, COC{H)H and 
NCHCHCH(H», 2.54 (lH, dd, J 6.0, lS.0, COCH{H», 2.63 (lH, dd, J 10.4, 13.6, 
CHCC{H)H), 3.67-3.69 (lH, m, CHOC(H)H), 3.72-3.77 (lH, m, CHCCH(H», 3.92-3.98 
(4H, m, OCH2CH20), 4.03 (lH, d, J 9.2, CHOCH{H», 4.27-4.33 (lH, m, CHCCH2CH), 
4.34 (lH, d, J S.8, NCH), 7.02 (lH, d, J 1.6, NHCH), 7.10-7.21 (2H, m, ArH), 7.35 (lH, 
d, J 8.0, ArH), 7.80 (lH, d, J 7.6, ArH), 8.3 (lH, s, NH); Dc (lOOMHz; CDCI3) 24.8 
(CH2), 26.8 (CH2), 32.3 (CH), 33.4 (CH2), 38.7 (CH2), 40.6 (CH2), 42.3 (CH), 56.3 (CH), 
64.5 (CH2), 64.5 (CH2), 70.2 (CH2), 92.3 (CH), 108.0 (C), 111.1 (CH), 112.4 (C), 119.3 
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(CH), 119.5 (CH), 122.1 (CH), 122.4 (CH), 127.6 (C), 136.2 (C), 167.2 (NCO); MS 
(FAB) m/z 382 [MH+, 93.6 %] (MH+, 382.1967. C22H26N204 requires 382.1971). 
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(3' S,6a' R, lOa' S,lOb' R)-3' -( (lH -Indol-3-yl)methyl)octahydrospiro[[I,3]dioxolane-
2,8' -oxazolo[2,3-a ]isoquinolin]-5' (6'H)-one (220b). 
~ ~ /. H // I -HN 0tNto HV 
CV 
(S)-2-Arnino-3-(IH-indol-3-yl)propan-l-01 (198) (1.12 g rngs, 5.47 rnmol) and methyl 2-
((7S,8R)-8-formyl-l,4-dioxaspiro[4.5]decan-7-yl)acetate rac-(219) (l.40 g, 5.47 mmol) 
were added to toluene (50 ml) and refluxed under Dean-Stark conditions for 24 hours. 
The mixture was allowed to cool to room temperature and the solvent removed under 
reduced pressure to yield the target compound. Crude 400 MHz IH-NMR analysis 
revealed the formation of (220) as a 1: 1 mixture of diastereoisomers. These 
diastereoisorners were purified and separated by flash column chromatography over silica 
using 4: 1 light petroleum:ethyl acetate as eluent (940 mgs, 45 %). 
Second isomer (220b) isolated as a white solid; Mp 182-183 QC; [a]D = 19.6 [c = 1.0, 
CH2Ch]; vrnaxCthin film, CH2Ch)/cm-1 1631 (NC=O), 1230 (C-O); OH (400 MHz; CDCh) 
1.17-1.42 (3H, rn, NCHCH and NCHCHC(H)H and COCH2CHC(H)H), 1.49-1.58 (lH, 
m, NCHCHCH2C(H)H), 1.76-1.90 (3H, m, COCH2CH and NCHCHCH2CH(H) and 
COCH2CHCH(H)), 1.97-2.00 (2H, m, COC(H)H and NCHCHCH(H)), 2.60 (lH, dd, J 
5.2, 18.0, COCH(H), 2.99 (IH, dd, J 8.8, 14.0, CHCC(H)H), 3.36 (lH, dd, J 3.6, 14.4, 
CHCCH(H), 3.66 (lH, dd, J 1.6, 7.2, CHOC(H)H), 3.89-3.97 (4H, m, OCH2CH20) , 
4.05 (lH, dd, J 7.6, 8.8, CHOCH(H)), 4.22 (IH, d, J 8.0, NCH), 4.56-4.63 (IH, rn, 
CHCCH2CH), 6.99 (IH, d, J 2.0, NHCH), 7.10-7.21 (2H, m, ArH), 7.35 (IH, d, J 8.0, 
ArH), 7.69 (IH, d, J 8.0, ArH), 8.43 (lH, s, NH); Bc (lOOMHz; CDCh) 25.5 (CH2), 27.3 
(CH2), 31.1 (CH), 33.3 (CH2), 38.5 (CH2), 40.5 (CH2), 41.8 (CH), 54.9 (CH), 64.3 (CH2), 
64.4 (CH2), 70.0 (CH2), 91.0 (CH), 107.9 (C), 110.9 (C), 111.1 (CH), 119.0 (CH), 119.5 
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(CH), 122.1 (CH), 122.5 (CH), 127.7 (C), 136.2 (C), 167.9 (NCO); MS (FAB) m/z 382 
[MH+, 97.1 %] (MH+, 382.1965. C22H26N204 requires 382.1971). 
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7-Hydroxymethyl-l,4a'S,5,7'S,8,13,13b'R,13c'R-octahydro-2H,4H-6a,13-diaza-
indeno[1,2-c ]phenanthrene-3,6-dione (222a). 
o 
(3'S,6a'S,10a'R,10b'S)-3'-((IH-indol-3-yl)methyl)octahydrospiro[[1,3]dioxolane-2,8'-
oxazolo[2,3-a]isoquinolin]-5'(6'H)-one (220a) (500 mgs, 1.31 rnmol) was dissolved in a 
solution of 2M hydrochloric acid in absolute ethanol (15 ml) and the mixture stirred for a 
further 3 h at 50 QC. After this time the reaction was quenched by addition of saturated 
aqueous sodium bicarbonate (30 ml) and extracted with ethyl acetate (3 x 40 ml). The 
organic fraction was dried over anhydrous magnesium sulfate and the solvent removed by 
rotary evaporation to yield a crude yellow solid. Crude 400 MHz IH-NMR analysis 
revealed the formation of (222a) exclusively and purification via flash column 
chromatography over silica with 95:5 ethyl acetate:methanol as eluent gave the target 
compound as an off-white solid (248 mgs, 56 %); 
Natural product isomer (222a); Mp 202-204 QC; [a]D = 52.0 [e = 0.5, CH30H]; Vrnax 
(thin film, CH2Clz)/cm-1 3317 (OH), 1621 (NCO); bH (400 MHz; DMSO) 1.64-1.73 (IH, 
m, NCHCHC(H)H), 1.90-2.06 (3H, m, NCHCH and COCH2CH and COC(H)H), 2.10-
2.31 (4H, rn, NCHCHCH2C(H)H and COCH2CHCH2 and COCH(H), 2.45-2.55 (1H, m, 
NCHCHCH2CH(H), 2.61 (2H, dd, J 2.0, 5.6, NHCCCH2), 2.63-2.67 (1H, m, 
NCHCHCH(H), 3.19-3.33 (2H, m, CHCH20H), 4.34 (1H, d, J 8.4, NCHCH), 4.66 (IH, 
t, J 5.6, OH), 5.04-5.09 (IH, m, CHCH20H), 6.84-6.88 (1H, rn, ArH), 6.94-6.98 (1H, m, 
ArH), 7.26-7.29 (2H, m, ArH); be (100MHz; DMSO) 20.9 (CH2), 30.8 (CH2), 35.5 (CH), 
39.3 (CH2), 39.9 (CH2), 40.9 (CH), 45.9 (CH2), 48.6 (CH), 54.2 (CH) 59.6 (CH2), 106.7 
(C), 111.5 (CH), 117.6 (CH), 118.7 (CH), 121.2 (CH), 126.5 (C), 132.9 (C), 136.5 (C), 
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+ + 
168.0 (NCO), 209.0 (CO); MS (FAB) m/z 338 [MH , 69.8 %] (MH , 338.1715. 
C2oH22N203 requires 338.1709). 
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7-Hydroxymethyl-l,4a'R,S,7'S,8,13,13b'R,13c'S-octahydro-2H,4H-6a,13-diaza-
indeno[1,2-c ]phenanthrene-3,6-dione (222b). 
o 
(3'S,6a'R,10a'S,10b'R)-3'-((IH-indol-3-yl)methyl)octahydrospiro[[1,3]dioxolane-2,8'-
oxazolo[2,3-a]isoquinolin]-5'(6'H)-one (220b) (500 mgs, 1.31 mmol) was dissolved in a 
solution of 2M hydrochloric acid in absolute ethanol (15 ml) and the mixture stirred for a 
further 18 h at 50°C. After this time the reaction was quenched by addition of saturated 
aqueous sodium bicarbonate (30 ml) and extracted with ethyl acetate (3 x 40 ml). The 
organic fraction was dried over anhydrous magnesium sulfate and the solvent removed by 
rotary evaporation to yield a crude yellow solid. Crude 400 MHz IH-NMR analysis 
revealed the formation of (222b) exclusively and purification via flash column 
chromatography over silica with 95:5 ethyl acetate:methanol as eluent gave the target 
compound as an off-white solid (256 mgs, 58 %); 
Second isomer (186b); Mp 212-213 QC; [a)o = 9.9 [e = 0.5, CH30H); Vrnax (thin film, 
CH2Ch)/cm·1 3311 (OH), 1633 (NCO); DH (400 MHz; CDCh) 2.00-2.11 (2H, m, 
COCH2CH and NCHCHC(H)H), 2.30-2.34 OH, m, NCHCH) , 2.39-2.49 (2H, m, 
NCHCHCH(H) and NCHCHCH2C(H)H), 2.51-2.59 (5H, m, NCHCHCH2CH(H) and 
COCH2CHCH2 and COCH2), 2.63-2.69 OH, m, NHCCC(H)H), 3.11 OH, ddd, J 2.0,6.4, 
16.0, NHCCCH(H), 3.62-3.72 (2H, m, CHCH20H), 5.02 OH, d, J 5.2, NCHCH), 5.25-
5.28 OH, m, CHCH20H), 7.08-7.20 (2H, m, ArH), 7.30 OH, d, J 8.0, ArH), 7.45 OH, d, 
J 7.6, ArH), 8.38 OH, s, NH); Dc (lOOMHz; CDCh) 21.5 (CH2), 28.2 (CH2), 34.0 (CH), 
40.3 (CH2), 41.0 (CH2), 41.6 (CH), 46.7 (CH2), 51.1 (CH), 52.3 (CH), 61.6 (CH2), 111.1 
(CH), 111.2 (C), 118.1 (CH), 120.0 (CH), 122.7 (CH), 126.8 (C), 130.0 (C), 136.2 (C), 
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+ + 172.0 (NCO), 208.6 (CO); MS (FAB) mlz 338 [MH, 47.7 %] (MH , 338.1713. 
C2oH22N203 requires 338.1709). 
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7-Formyl-l,4a'S,5,7'S,8,13,13b'R,13c'R-octahydro-2H,4H-6a,13-diaza-indeno[1,2-
c ]phenanthrene-3,6-dione (223). 
o 
o-Iodoxybenzoic acid (492 mgs, 1.77 mmol) was added to a solution of 7-
hydroxymethyl-l,4a'S,5, 7'S,8, 13, 13b'R, 13c'R-octahydro-2H,4H-6a, 13-diaza-indeno[ 1,2-
c]phenanthrene-3,6-dione (222a) (200 mgs, 0.59 mmol) in ethyl acetate (10 ml) and the 
reaction heated under reflux for 4 hours. The resulting mixture was allowed to cool to 
room temperature, filtered through a sinter funnel and evaporated under reduced pressure 
to a crude brown residue. The crude product was adsorbed onto silica and 
chromatographed using silica gel as absorbent and 99: 1 ethyl acetate:methanol as eluent 
to isolate the target compound as a yellow solid (149 mgs, 75 %), Mp 165-168 QC; [a]D= 
53.1 [e = 0.5, CH2Clz]; Vrnax (thin film, CH2Clz)/cm-1 1732 (CHO); ()H (400 MHz; CD Ch) 
1.84 (IH, m, NCHCHC(H)H), 1.94-2.02 (1H, m, NCHCH) , 2.12 (IH, t, J 12.0, 
COCH2CHC(H)H), 2.18-2.30 (2H, m, COCH2CH and COC(H)H), 2.38-2.47 (1H, m, 
NCHCHCH2C(H)H), 2.50-2.56 (2H, m, NCHCHCH2CH(H) and COCH2CHCH(H), 
2.65-2.71 (1H, m, NCHCHCH(H), 2.78 (IH, dd, J 4.4, 16.8, COCH(H), 3.12 (IH, ddd, 
J 2.4, 6.4, 16.0, NHCCC(H)H), 3.44 (IH, d, J 16.0, NHCCCH(H), 4.66 (1H, d, J 9.6, 
NCHCH), 5.97 (IH, dd, J 1.2, 6.0, CHCHO), 7.14-7.24 (2H, m, ArH), 7.33 (1H, d, J 7.6 
ArH), 7.56 (IH, d, J 7.6 ArH), 8.18 (1H, s, NH), 9.36 (IH, s, CHO); ()c (100MHz; 
CDCh) 20.6 (CH2), 29.8 (CH2), 36.9 (CH), 38.9 (CH2), 39.9 (CH2), 42.7 (CH), 46.7 
(CH2), 57.3 (CH), 57.8 (CH), 108.8 (C), 111.2 (CH), 118.4 (CH), 120.3 (CH), 123.1 
(CH), 126.0 (C), 131.5 (C), 136.4 (C), 169.1 (NCO), 119.0 (CHO), 208.1 (CO); MS 
(FAB) m/z 336 [MH+, 16.3 %] (MH+, 336.1558. C20H20N203 requires 336.1552). 
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5.5 Application of a ClaisenIRCM protocol 
1,4-bis(AIIyloxy)-2,3-dimethylbenzene (268).130 
o~ 
A suspension of 2,3-dimethylhydroquinone (267) (2.50 g, 18.09 mmol), allyl bromide 
(3.83 ml, 45.23 mmol) and anhydrous potassium carbonate (6.25 g, 45.23 mmol) in 
acetone (15 ml) was refluxed for 24 hours. The reaction was allowed to cool to room 
temperature before water (50 ml) and diethyl ether (50 ml) were added. The layers were 
separated and the aqueous layer extracted with diethyl ether (4 x 50 ml). The combined 
organic extracts were washed with 1M aqueous sodium hydroxide solution (3 x 100 ml) 
and water (100 ml), dried over anhydrous magnesium sulfate, filtered and concentrated 
under reduced pressure to give the crude product as a brown oil. Flash column 
chromatography on silica, eluting with 10: 1 light petroleum:ethyl acetate, yielded bis-
allyl ether (268) as a white solid (3.63 g, 92 %), Mp 66-68 QC; Vrnax (thin film, 
CH2Ch)/cm-1 1647 (C=C), 1101 (C-O); OH (400MHz; CDCh) 2.18 (6H, s, 2 x ArCH3), 
4044 (4H, dt, J 2.0, 5.2, 2 x OCH2CH=CH2 ), 5.24 (2H, dq, J 1.6, lOA, 2 x 
OCH2CH=CH(H», 5040 (2H, dq, J 1.6, 17.2,2 x OCH2CH=CH(H), 6.01-6.10 (2H, m, 2 
x OCH2CH=CH2), 6.61 (2H, s, ArH); Oc (100 MHz; CDCh) 12.2 (2 x CH3), 69.7 (2 x 
CH2), 109.5 (2 x CH), 116.7 (2 x CH2), 127.2 (2 x (C», 134.1 (2 x CH), 151.0 (2 x (C»; 
MS (FAB) mlz 218 [M+, 52.9 %] (M+, 218.1312. CI4HI802 requires 218.1307). 
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2,3-Dimethyl-5,6-diallylhydroquinone (269).131 
OH 
Bis-allyl ether (268) (3.53 g, 16.18 mmol) was refluxed in mesitylene (20 ml) for 24 
hours. The solvent was removed under reduced pressure to yield a tarry brown solid. 
Hexane (50 ml) was added and removed on the rotary evaporator to azeotrope any 
residual mesitylene. The resulting solid was filter-washed with cold hexane (50 ml) to 
yield the hydroquinone (269) as a brown solid (2.47 g, 70 %), Mp 93-95 cC; Vrnax (thin 
film, CH2Ch)/cm-1 3404 (OH), 1635 (C=C); ()H (400MHz; CDCh): 2.06 (6H, s, 2 x 
ArCH3), 3.31 (4H, dt, J 1.6, 6.0, 2 x CH2CH=CH2), 4.85-4.92 (4H, m, 2 x CH2CH=CH2), 
5.80-5.90 (2H, m, 2 x CH2CH=CH2), 7.40 (2H, s, 2 x ArOlI); ()e (lOOMHz; DMSO): 
13.04 (2 x CH3), 30.49 (2 x CH2), 114.07 (2 x CH2), 122.36 (2 x (C», 123.41 (2 x (C», 
+ + 137.48 (2 x CH), 145.71 (2 x(C»; MS (FAB) m/z 218 [M , 100 %] (M , 218.1304. 
C14H1802 requires 218.1307). 
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2,3-Dimethyl-S,6-diallylhydroquinone diacetate (270).130 
OAc 
Acetic anhydride (5.6 ml, 59.59 mmol) was added slowly to a solution of hydro quinone 
(269) (5.0 g, 22.92 mmol) and DMAP (0.84 g, 6.88 mmol) in triethylamine (8.0 ml) at 0 
QC and the resulting mixture stirred at room temperature for 20 hours. Methanol (20 ml) 
and diethyl ether (150 ml) were added and the solution washed with IM aqueous 
hydrochloric acid solution (100 ml) and saturated aqueous sodium hydrogen carbonate 
solution (lOO ml). The resulting organic phase was dried over anhydrous magnesium 
sulfate, filtered and concentrated under reduced pressure to yield a brown oil. Flash 
column chromatography on silica, eluting with 10: 1 light petroleum:ethyl acetate, 
furnished diacetate (270) as a white solid (6.23 g, 90 %), Mp 97-99 QC; Vrnax (thin film, 
CH2Clz)/cm-1 1758 (C=O), 1637 (C=C), 1191 (C-O); OH (400MHz; CDCh) 2.04 (6H, s, 2 
x ArCH3), 2.30 (6H, s, 2 x OCOCH3), 3.21-3.33 (4H, br, 2 x CH2CH=CH2), 4.92-5.01 
(4H, m, 2 x CH2CH=CH2), 5.75-5.85 (2H, m, 2 x CH2CH=CH2); Oc (100MHz; CDCh): 
13.4 (2 x CH3), 20.7 (2 x CH3), 31.5 (2 x CH2), 115.6 (2 x CH2), 128.7 (2 x (C», 128.8 
+ (2 x (C», 135.6 (2 x CH), 146.0 (2 x (C», 169.1 (2 x (C»; MS (FAB) mlz 302 [MH , 
29.1 %] (MH+, 302.1602. CIsH2204 requires 302.1596). 
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2,3-Dimethyl-5,8-dihydro-l,4-naphthalendiol diacetate (271).130 
OAc 
A catalytic amount of Grubbs 2nd generation catalyst was added to a solution of diacetate 
(270) (3.15 g, 10.41 mmol) in anhydrous tetrahydrofuran under an inert atmosphere of 
nitrogen. The completion of the reaction was monitored by TLC analysis and additional 
catalyst was added if required. After 24 hours stirring the reaction mixture was absorbed 
on to silica following removal of the reaction solvent and loaded on to a chromatographic 
column. Flash column chromatography on silica, eluting with 10: 1 light petroleum:ethyl 
acetate, yielded the ring-closed product (153) as a white solid (0.44 g, 89 %), Mp 186-
189 QC; Vrnax (thin film, CH2Ch)/cm-1 3024, 974 (C-H alkene), 1747 (C=O), 1200 (C-O); 
OH (400MHz; CDCl}) 2.05 (6H, s, 2 x ArCH3) , 2.34 (6H, s, 2 x OCOCH3), 3.07-3.20 
(4H, br, 2 x CH2CH=CH2), 5.81 (2H, t, J 1.2, CH=CH); Oc (100MHz; CDCl}): 13.0 (2 x 
CH3), 20.5 (2 x CH3), 24.4 (2 x CH2), 123.0 (2 x CH), 125.1 (2 x (C)), 127.5 (2 x (C)), 
+ + 145.0 (2 x (C)), 169.1 (2 x (C)); MS (FAB) mlz 274 [MH , 11.0 %] (MH ,274.1279. 
C16H1804 requires 274.1283). 
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2,3-Dimethyl-S,6,7 ,8-tetrahydro-1,4-napthalendiol diacetate (276).130 
OAc 
Pd/C (0.074 g, 10 % w/w) was added to a solution of diacetate adduct (271) (0.74 g, 2.70 
mmol) in absolute ethanol (30 ml). The resulting suspension was stirred at atmospheric 
pressure under hydrogen at room temperature for 24 hours. The solution was filtered 
through Celite and the filtrate washed with ethyl acetate (50 ml). The solvent was 
removed under reduced pressure, to yield the product as a white solid (0.73 g, 99 %), Mp 
194-196 QC; Vrnax (thin film, CH2Clz)/cm-1 1748 (C=O), 1199 (C-O); bH (400MHz; 
CD Ch) 1.54-1.87 (4H, br, CH2CH2CH2CH2), 2.04 (6H, s, 2 x ArCH3), 2.33 (6H, s, 2 x 
OCOCH3), 2.51-2.77 (4H, br, CH2CH2CH2CH2); be (100MHz; CDCh) 12.9 (2 x CH3), 
20.5 (2 x CH3), 22.0 (2 x CH2), 23.5 (2 x CH2), 126.8 (2 x (C», 127.9 (2 x (C», 145.3 (2 
+ + 
x (C», 169.2 (2 x (C»; MS (FAB) m/z 276 [MH ,46.6 %] (MH , 276.1438. CI6H200 4 
requires 276.1440). 
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2,3-Dimethyl-S,8-dioxo-S,6, 7 ,8-tetrahydro-l,4-napthalendiol diacetate (277) 
WC I~ ~ 
OAc 0 
To a saturated solution of chromium (VI) oxide (1.81 g, 18.10 mmol) in 80 % acetic acid 
(10 ml) was added 2,3-dimethyl-5,6,7,8-tetrahydro-1,4-napthalendiol diacetate (276) 
(0.50 g, 1.81 mmol) portionwise. The resulting mixture was heated to 50 QC for a further 
20 hours with stirring. After this time the mixture was added to ice water (20 ml) with 
continuous stirring and a precipitate began to form. The aqueous mixture was maintained 
at 0 QC for a further 18 hours to yield a larger volume of a white precipitate which was 
collected via filtration. The precipitate was dissolved in ethyl acetate, dried over 
anhydrous magnesium sulphate, filtered and concentrated to give the bis-oxidised product 
as a white solid (286 mg, 55 %), Mp 205-207 QC; Vrnax (thin film, CH2Clz)/cm-1 1761 
(C=O(O», 1695 (C=O), 1200 (C-O); OH (400MHz; CDCh) 2.23 (6H, s, 2 x ArCH3), 2.43 
(6H, s, 2 x OCOCH3), 2.99 (4H, br, C=OCH2CH2C=O); Oc (lOOMHz; CDCh) 13.6 (2 x 
CH3), 20.1 (2 x CH3), 39.1 (2 x Clh), 125.3 (2 x (C), 139.4 (2 x (C», 144.9 (2 x (C», 
+ + 
169.2 (2 x (C» 194.2 (2 x C=O); MS (El) mlz 304 [M ,5.1 %] (M ,304.0943. C16H160 6 
requires 304.0947). 
(274); Vrnax (thin film, CH2Clz)/cm-1 3382 (OH), 1260 (C-O); OH (400MHz; CDCh) 2.09 
(6H, s, 2 x ArCH3), 2.45 (6H, s, 2 x OCOCH3), 7.33 (2H, CCHCHC). 
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1,4-Dimethoxy-2,3-dimethyl-5,6-diallylhydroquinone (282). 
OMe 
Finely ground potassium hydroxide (0.64 g, 11.46 mmol) was added portion wise to a 
solution of 2,3-dimethyl-5,6-diallylhydroquinone (269) (1.0 g, 4.58 mmol) in 
dimethylformamide at 0 °C and stirred for 10 minutes. After this time methyl iodide 
(0.71 ml, 11.46 mmol) was added drop wise and the solution was then allowed to stir at 
room temperature for 4 hours. The mixture was then added to ice water (100 ml) and 
extracted with ethyl acetate (3 x 50 ml). The combined organic extracts were dried over 
anhydrous magnesium sulfate and concentrated to yield a dark brown oil. The crude oil 
was adsorbed onto silica and purified by column chromatography using 5:1 light 
petroleum:ethyl acetate as eluent. The product was isolated as a light brown oil (1.10 g, 
98 %), Vrnax (thin film, CH2Ch)/cm-1 1636 (C=C), 1242 (C-O); ()H (400MHz; CDCl) 2.19 
(6H, s, 2 x ArCH3), 3.41 (4H, dt, J 2.0,5.6,2 x CCH2CH=CH2 ), 3.66 (6H, s, 2 x OCH3), 
4.90 (2H, dq, J 1.6, 16.8, 2 x CCH2CH=CH(H», 4.99 (2H, dq, J 1.6, 10.0, 2 x 
CCH2CH=CH(H), 5.92-6.01 (2H, m, 2 x CCH2CH=CH2); Dc (lOOMHz; CDCl) 12.1 (2 
x CH3), 30.8 (2 x CH2), 60.9 (2 x CH3), 114.7 (2 x CH2), 129.1 (2 x (C», 129.5 (2 x 
+ + (C», 137.6 (2 x CH), 153.2 (2 x (C»; MS (FAB) mlz 246 [M , 100 %] (M , 246.1620. 
Cl6H2202 requires 246.1620). 
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1,4-Dimethoxy-2,3-dimethyl-5,8-dihydronaphthalene (283). 
OMe 
~ 
OMe 
A catalytic amount of Grubbs 2nd generation catalyst was added to a solution of 1,4-
dimethoxy-2,3-dimethyl-5,6-diallylhydroquinone (282) (2.0 g, 8.12 mmol) in anhydrous 
toluene under an inert atmosphere of nitrogen. The completion of the reaction was 
monitored by TLC analysis and additional catalyst was added if required. After 18 hours 
stirring the reaction mixture was absorbed onto silica and purified by flash column 
chromatography with 6: 1 light petroleum:ethyl acetate as eluent. The target compound 
was isolated as a light brown oil (957 mg, 54 %), Vrnax (thin film, CH2CI2)/cm-1 1628 
(C=C), 1241 (C-O); OH (400MHz; CDCl)) 2.11 (6H, s, 2 x ArCH3), 3.27 (4H, d, J 1.2 , 2 
x CCH2CH), 3.60 (6H, s, 2 x OCH3), 5.84 (2H, t, J 1.2, 2 x CCH2CH); Oc (lOOMHz; 
CDCl)) 12.5 (2 x CH3), 24.3 (2 x CH2), 60.9 (2 x CH3), 124.0 (2 x CH), 125.7 (2 x (C)), 
+ + 128.0 (2 x (C)), 152.0 (2 x (C)); MS (FAB) mlz 218 [M , 90.0 %] (M , 218.1312. 
Cl4H1S02 requires 218.1307). 
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1,4-Dibenzoyl-2,3-dimethyl-5,6-diallylhydroquinone (285). 
To a stirred solution of 2,3-dimethyl-5,6-diallylhydroquinone (269) (1.0 g, 4.58 mmol) in 
dichloromethane (15 ml) was added triethylamine (1.92 ml, 13.74 mmol) dropwise at 
room temperature. The reaction mixture was stirred for 15 minutes at room temperature 
and then cooled to 0 cc whereupon benzoyl chloride (1.17 ml, 10.08 mmol) was added 
dropwise. The resulting mixture was stirred for a further 5 hours after which time 
triethylamine hydrochloride salt precipitated out. Diethyl ether (50 ml) was added and the 
suspension filtered, dried over anhydrous magnesium sulfate and concentrated to yield a 
crude white solid. Recrystallisation from diethyl ether yielded the purified product as a 
crystalline white solid (1.87 g, 96 %), Mp 169-171 cC; Vrnax (thin film, CH2Clz)/cm-1 1731 
(C=O), 1639 (C=C), 1268 (C-O); bH (400MHz; CDCb) 2.12 (6H, s, 2 x ArCH3), 3.27 
(2H, dd, J 5.2, 15.2, 2 x CCH(H)CH=CH2 ), 3.44 (2H, dd, J 5.6, 15.6, 2 x 
CCH(H)CH=CH2 ), 4.88-4.98 (4H, br, 2 x CCH2CH=CH2), 5.80-5.87 (2H, m, 2 x 
CCH2CH=CH2), 7.53 (4H, t, J 7.6, ArH), 7.66 (2H, t, J 7.6, ArH), 8.24 (4H, dd, J 1.2, 
8.4, ArH); be (100MHz; CDCb); 13.6 (2 x CH3), 31.7 (2 x CH2), 115.8 (2 x CH2), 128.7 
(4 x CH), 129.0 (2 x (C», 129.1 (2 x (C», 129.3 (2 x (C», 130.2 (4 x CH), 133.7 (2 x 
+ CH), 135.6 (2 x CH), 146.2 (2 x (C», 164.8 (2 x (C»; MS (FAB) m/z 426 [MH , 15.7 
%] (MH+, 426.1916. C28H2604 requires 426.1909). 
Chapter 5 Experimental 190 
1,4-Dibenzoyl-2,3-dimethyl-5,8-dihydronaphthalene (286). 
»SO Ph I ~ I ~ 
OCOPh 
A catalytic amount of Grubbs 2nd generation catalyst was added to a solution of 1,4-
dimethoxy-2,3-dibenzoyl-5,6-diallylhydroquinone (285) (1.53 g, 3.59 mmol) in 
anhydrous toluene under an inert atmosphere of nitrogen. The completion of the reaction 
was monitored by TLC analysis and additional catalyst was added if required. After 24 
hours a white precipitate was filtered, dissolved in ethyl acetate and dried over anhydrous 
magnesium sulfate. The solvent was removed on the rotary evaporator to give the crude 
target compound which was recrystallised from diethyl ether to yield a white solid (1.17 
g, 82 %), Mp 226-228 QC; Vrnax (thin film, CH2Clz)lcm-1 1732 (C=O), 1649 (C=C), 1266 
(C-O); OH (400MHz; CDCh) 2.13 (6H, s, 2 x ArCH3), 3.22 (4H, br, 2 x CCH2CH), 5.78 
(2H, s, 2 x CCH2CH), 7.55 (4H, t, J 7.6, ArH), 7.67 (2H, t, J 7.6, ArH), 8.26 (4H, dd, J 
1.6, 8.4, ArH); Oc (lOOMHz; CDCh); 13.0 (2 x CH3), 24.5 (2 x CH2), 123.0 (2 x CH), 
125.4 (2 x (C», 127.8 (2 x (C», 128.7 (4 x CH), 129.2 (2 x(C» 130.2 (4 x CH), 133.7 (2 
+ + 
x CH), 145.1 (2 x (C», 164.7 (2 x (C»; MS (FAB) m/z 398 [MH , 3.3 %] (MH , 
398.1611. C26H2204 requires 398.1596). 
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1,4-Dibenzoyl-2,3-dimethyl-5,6, 7 ,8-tetrahydronapthalene (287) 
:9)0Ph I~ d-
OCOPh 
PdlC (127 mgs, 10 % w/w) was added to a solution of 1,4-dibenzoyl-2,3-dimethyl-5,8-
dihydronaphthalene (286) (1.27 g, 3.17 mmol) in ethyl acetate (30 ml). The resulting 
suspension was stirred at atmospheric pressure under hydrogen at room temperature for 
24 hours. The solution was filtered through Celite and the filtrate washed with ethyl 
acetate (2 x 50 ml). The solvent was removed on the rotary evaporator to furnish the 
product (287) as a white solid (1.19 g, 93 %), Mp 229-231 QC; Vrnax (thin film, 
CHzCh)lcm-1 1731 (C=O), 1260 (C-O); OH (400MHz; CDCh) 1.58-1.83 (4H, br, 
CHzCHzCHzCHz), 2.12 (6H, s, 2 x ArCH3), 2.38-2.79 (4H, br, CHzCHzCHzCHz), 7.53 
(4H, t, 17.6, ArH), 7.65 (2H, t, 17.2, ArH), 8.26 (4H, dd, 11.6,8.4, ArH); Oc (100MHz; 
CDCl); 13.1 (2 x CH3), 22.0 (2 x CHz), 23.7 (2 x CHz), 127.2 (2 x (C», 128.3 (2 x (C», 
128.7 (4 x CH), 129.3 (2 x (C» 130.2 (4 x CH), 133.7 (2 x CH), 145.5 (2 x (C», 164.7 
(2 x (C»; MS (FAB) m/z 400 [MH+, 4.0 %] (MH+, 400.1759. CZ6HZ404 requires 
400.1753). 
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1,4-Dimethoxyethoxymethyl-2,3-dimethyl-5,6-diallylhydroquinone (290). 
OMEM 
Anhydrous tetrahydrofuran (30 ml) was added to sodium hydride (770 mgs, 19.25 mmol) 
under nitrogen and the suspension cooled to 0 cC. 2,3-Dimethyl-5,6-diallylhydroquinone 
(269) (2.00 g, 9.17 mmol) was added portion-wise and the reaction left to stir for 5 
minutes. After this time methoxyethoxymethyl chloride (2.20 ml, 19.25 mmol) was 
added drop-wise and the mixture allowed to warm to room temperature over 2 hours. The 
reaction was quenched with the addition of ice water (30 ml) and ethyl acetate (50 ml) 
added. The aqueous layer was extracted with further portions of ethyl acetate (2 x 50 ml) 
and the combined organic fractions combined, dried over anhydrous magnesium sulfate 
and volatiles removed under reduced pressure. The crude product was purified via flash 
column chromatography eluting with 4: 1 light petroleum:ethyl acetate to give the target 
compound as a light brown oil (3.33 g, 92 %), Vrnax (thin film, CH2Ch)!cm-1 1635 (C=C), 
1116 (C-O); OH (400MHz; CDCh); 2.20 (6H, s, 2 x ArCH3), 3.39 (6H, s, 2 x OCH3), 
3.42-3.46 (4H, br, 2 x CCH2CH=CH2), 3.58-3.61 (4H, m, 2 x OCH20CH2CH20), 3.92-
3.94 (4H, m, 2 x OCH20CH2CH20), 4.82-4.88 (2H, br, 2 x CCH2CH=CH(H», 4.96-4.99 
(2H, br, 2 x CCH2CH=CH(H), 4.98 (4H, s, 2 x OCH20CH2CH20), 5.90-6.00 (2H, m, 2 
x CCH2CH=CH2); Oc (lOOMHz; CDCh): 13.6 (2 x CH3), 31.0 (2 x CH2), 59.0 (2 x CH3), 
69.1 (2 x CH2), 71.7 (2 x CH2), 98.7 (2 x CH3), 114.8 (2 x CH2) 129.3 (2 x (C», 129.7 (2 
+ + 
x (C», 137.3 (2 x CH), 150.9 (2 x (C»; MS (FAB) m/z 394 [M , 100 %] (M ,394.2359. 
C22H3406 requires 394.2355). 
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1,4-Dimethoxyethoxymethyl-2,3-dimethyl-5,8-dihydronaphthalene (291) 
:9)EM I ~ I A 
OMEM 
A catalytic amount of Grubbs 2nd generation catalyst was added to a solution of 1,4-
dimethoxyethoxymethyl-2,3-dimethyl-5,6-diallylhydroquinone (290) (2.60 g, 6.59 mmol) 
in anhydrous toluene under an inert atmosphere of nitrogen. The completion of the 
reaction was monitored by TLC analysis and additional catalyst was added if required. 
After 24 hours stirring the reaction mixture was adsorbed onto silica and purified by flash 
column chromatography with 6: 1 light petroleum:ethyl acetate. The target compound was 
isolated as a white solid (990 mgs, 41 %), Mp 53-55 0 C; Vmax (thin film, CH2Ch)/cm-1 
1595 (C=C), 1111 (C-O); OH (400MHz; CDCh); 2.18 (6H, s, 2 x ArCH3), 3.34-3.36 (4H, 
br, 2 x CCH2CH=CH2), 3.40 (6H, s, 2 x OCH3), 3.59-3.63 (4H, m, 2 x 
OCH20CH2CH20) , 3.94-3.96 (4H, m, 2 x OCH20CH2CH20), 4.98 (4H, s, 2 x 
OCH20CH2CH20), 5.88 (2H, t, J 1.2, CH=CH); Oc (lOOMHz; CDCh): 13.5 (2 x CH3), 
25.1 (2 x CH2), 59.1 (2 x CH3), 69.2 (2 x CH2), 71.8 (2 x CH2), 98.2 (2 x CH3), 124.0 (2 
+ 
x CH), 126.2 (2 x (C», 128.1 (2 x (C», 150.0 (2 x (C»; MS (FAB) mlz 366 [M , 19.2 
%] (M+, 366.2048. C20H3006 requires 366.2042). 
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1,4-Dimethoxyethoxymethyl-2,3-dimethyl-5,6, 7 ,8-tetrahydronapthalene (292). 
~EM I~ A 
OMEM 
PdlC (lOO mgs, 10 % w/w) was added to a solution of 1,4-dimethoxyethoxymethyl-2,3-
dimethyl-5,8-dihydronaphthalene (291) (1.0 g, 2.73 mmol) in ethyl acetate (25 ml). The 
resulting suspension was stirred at atmospheric pressure under hydrogen at room 
temperature for 19 hours. After this time the solution was filtered through Celite and the 
filtrate washed with ethyl acetate (2 x 30 ml). Volatiles were removed under reduced 
pressure to yield the crude target which was adsorbed onto silica and purified by flash 
column chromatography eluting with 10: 1 light petroleum:ethyl acetate. The target 
compound was isolated as a crystalline white solid (975 mgs, 97 %), Mp 56-58 0 C; Vmax 
(thin film, CH2Ch)/cm-1 1113 (C-O); OH (400MHz; CDCh); 1.69-1.75 (4H, br, 
CH2CH2CH2CH2), 2.17 (6H, s, 2 x ArCH3), 2.69-2.75 (4H, br, CH2CH2CH2CH2) 3.40 
(6H, s, 2 x OCH3), 3.60-3.62 (4H, m, 2 x OCH20CH2CH20), 3.94-3.96 (4H, m, 2 x 
OCH20CH2CH20), 4.97 (4H, s, 2 x OCH20CH2CH20); Oc (lOOMHz; CDCh) 13.4 (2 x 
CH3), 22.6 (2 x CH2), 24.4 (2 x CH2), 59.1 (2 x CH3), 69.1 (2 x CH2), 71.8 (2 x CH2), 
98.0 (2 x CH2), 127.6 (2 x (C», 128.9 (2 x (C», 150.3 (2 x (C»; MS (FAB) m/z 368 
[M+, 46.5 %] (M+, 368.2204. C20H3206 requires 366.2199). 
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5-Methoxy-l,4-naphthoquinone (294).146 
o 
9Y 
OMeO 
To a stirred solution of juglone (235) (1.75 g, 10.05 mmol) and silver (I) oxide (3.49 g, 
15.07 mmol) in anhydrous dichloromethane (30 ml) was added methyl iodide (1.25 ml, 
20.10 mmol) under nitrogen. The reaction mixture was stirred for 22 hours and then 
filtered through Celite and the cake washed with dichloromethane (2 x 25 ml). The 
filtrate was evaporated to dryness on the rotary evaporator and then recrystallized from 
ethanol to yield target (294) as a red solid (1.87 g, 99 %), Mp 186-188 °C, Lit: Mp 186-
187°C; Vrnax (thin film, CH2Ch)/cm-1 1650 (C=C), 1018 (C-O); ()H (400MHz; CDCh); 
4.02 (3H, s, OCH3), 6.88 (2H, s, COCHCHCO), 7.33 (lH, dd, J 1.6, 8.4, CH30CCH), 
7.70 (lH, t, J 7.6, CH30CCHCH), 7.74 (lH, dd, J 1.6, 7.6, CH30CCHCHCH ); ()c 
(lOOMHz; CDCh) 56.5 (CH3), 117.9 (CH), 119.2 (CH), 119.7 (C), 134.0 (C), 135.0 
(CH), 136.2 (CH), 140.9 (CH), 159.6 (C), 184.4 (C), 185.2 (C); MS (FAB) m/z 188 
[MH+, 55.2 %] (MH+, 188.0548. CllHg03 requires 188.0552). 
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5-Methoxy-l,4-naphthalenedioI (295).146 
OMe OH 
To a solution of sodium dithionite (13.76 g, 79.06 mmol) in water (75 ml) was added a 
solution of 5-methoxy-l,4-naphthoquinone (294) (1.75 g, 9.30 mmol) in ethyl acetate (50 
ml). The resulting two phase solution was stirred for 1.5 hours, the organic layer 
separated, and the aqueous phase extracted with further portions of ethyl acetate (2 x 75 
ml). The combined organics were washed with water (3 x 100 ml), dried over anhydrous 
magnesium sulfate and reduced under pressure. The product was obtained as a light-
brown solid and required no further purification (1.54 g, 87 %), Mp 207-209 cC, Lit: Mp 
>100 °C (dec.); Vmax (thin film, ) CH2Ch/cm-1 3433 (OH), 1633 (C=C), 1017 (C-O); bH 
(400MHz; MeOD); 3.97 (3H, s, OCH3), 6.62 (IH, d, J 8.0, COCHCHCO), 6.74 (lH, d, J 
8.0, COCHCHCO), 6.83 (lH, d, J 7.6, CH30CCH), 7.26 (lH, t, J 7.6, CH30CCHCH), 
7.76 (lH, dd, J 0.8, 804, CH30CCHCHCH); bc (100MHz; MeOD) 56.6 (CH3), 105.7 
(CH), 11004 (CH), 110.8 (CH), 116.6 (C), 117.0 (CH), 125.8 (CH), 128.5 (C), 146.6 (C), 
148.2 (C), 157.3 (C); MS (FAH) mlz 190 [M+, 100 %] (M+, 190.0633. Cl1HIO03 requires 
190.0630). 
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1,4-Bis(allyloxy)-8-methoxynaphthalene (297). 
OMeO~ 
A solution of 5-methoxy-1,4-naphthalenediol (295) (1.25 g, 6.57 mmol), potassium 
carbonate (4.54 g, 32.85 mmol) and allyl bromide (3.34 ml, 39.44 mmol) in acetone (50 
ml) was heated at reflux for 24 hours. The reaction mixture was filtered and evaporated to 
dryness. The resulting solid was dissolved in ethyl acetate (30 ml), washed with brine (3 
x 30 ml), dried over anhydrous magnesium sulfate and the solvent removed under 
pressure. The crude brown oil was used without further purification. 
Anhydrous tetrahydrofuran (15 ml) was added to sodium hydride (153 mgs, 3.82 mmol) 
under nitrogen and the suspension cooled to 0 QC. The crude 4-Allyloxy-8-methoxy-1-
naphthaleneol (296) (800 mgs, 3.47 mmol) was added via syringe and the reaction left to 
stir for 10 minutes. After this time allyl bromide (0.32 ml, 3.82 mmol) was added drop-
wise and the mixture allowed to warm to room temperature over 18 hours. The reaction 
was quenched with the addition of ice water (20 ml) and ethyl acetate (30 ml) added. The 
aqueous layer was extracted with further portions of ethyl acetate (2 x 30 ml) and the 
combined organic fractions combined, dried over anhydrous magnesium sulfate and 
volatiles removed under reduced pressure. The crude brown solid was recrystallised from 
diethyl ether to yield colourless block-like crystals (643 mgs, 67 %), Mp 201-203 QC; 
Vrnax (thin film, CH2Clz)/cm-1 1633 (C=C), 1017 (C-O); OH (400MHz; CDCh) 3.95 (3H, s, 
2 x OCH3), 4.55 (2H, dt, 1 1.6, 4.8, OCH2CH=CH2 ), 4.63 (2H, dt, 1 1.6, 5.2, 
OCH2CH=CH2), 5.28-5.30 (lH, m, OCH2CH=CH(H)), 5.31-5.32 OH, rn, 
OCH2CH=CH(H), 5.49 (lH, dq, 1 1.6,17.2, OCH2CH=CH(H)), 5.57 OH, dq, 12.0,17.2, 
OCH2CH=CH(H)), 6.10-6.21 (2H, rn, 2 x OCH2CH=CH2) , 6.71 (lH, d, 1 8.4, 
COCHCHCO), 6.78 OH, d, 1 8.4, COCHCHCO), 6.89 (lH, dd, 10.8, 8.0, CH30CCH), 
7.38 (lH, t, 18.4, CH30CCHCH), 7.91 OH, dd, 10.8, 8.4, CH30CCHCHCH); Oc (100 
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MHz; CDCl) 56.2 (CH3), 69.4 (CH2), 71.9 (CH2), 105.8 (CH), 107.0 (CH), 109.8 (CH), 
114.7 (CH), 116.5 (CH2), 117.2 (CH2), 119.1 (C), 125.9 (CH), 129.1 (C), 133.6 (CH), 
+ + 
134.1 (CH), 148.9 (C), 149.8 (C), 156.7 (C); MS (FAB) m/z 270 [M , 100 %] (M , 
270.1256. C17HlS03 requires 270.1256). 
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5.6 Application of a mixed Claisenlortho-Fries strategy 
5-Benzyloxy-l,4-naphthoquinone (307).153 
q) 
OBn 0 
Silver (I) oxide (5.85 g, 25.26 mmol) was added to a stirred solution of juglone (235) (1.1 
g, 6.32 mmol) and benzyl bromide (1.54 ml, 18.96 mmol) in chloroform (20 ml). After 2 
hours the solution was filtered through a Celite pad to remove silver salts and the solvent 
was removed at reduced pressure. The oily residue was purified by flash column 
chromatography over silica using 10: 1 hexane:ethyl acetate as the eluent to afford (307) 
as fine orange needles (1.20 g, 72 %), Mp 111-112 QC, Lit: Mp 113 QC; Vrnax (thin film, 
CH2Ch)/cm-1 1659 (C=O), 1163 (C-O); bH (400MHz; CDCh); 5.27 (2H, s, OCH2Ph), 
6.86 (2H, s, COCHCHCO), 7.30-7.35 (2H, m, CH20CCH and CH2CCHCHCH), 7.40 
(2H, t,J7.6, 2 x CH2CCHCH), 7.57-7.64 (3H, m, 2 x CH2CCHand CH20CCHCH), 7.71 
OH, dd, J 0.8,7.6, CH20CCHCHCH); be (100MHz; CDCh) 70.9 (a-h), 119.5 (CH), 
119.6 (CH), 120.2 (C), 126.7 (2 x CH), 128.0 (CH), 128.7 (2 x CH), 134.1 (C), 134.9 
(CH), 136.0 (C), 136.2 (CH), 140.9 (CH), 158.5 (C), 184.2 (C), 185.2 (C); MS (FAB) m/z 
264 [M+, 44.8 %] (M+, 264.0868. Cl7HI203 requires 264.0865). 
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5-Benzyloxy-l,4-naphthalenediol (302) 
OBn OH 
5-Benzyloxy-l,4-naphthoquinone (2.12 g, 11.27 mmol) (307) was dissolved in ethyl 
acetate (lOO ml) and added to a separating funnel containing an aqueous solution of 
sodium dithionite (16.67g, 95.77 mmol, in 100 ml). After several minutes of vigorous 
shaking, the organic layer was isolated and washed with water (2 x 50 ml). The organic 
layer was then dried over anhydrous magnesium sulfate and concentrated to give the 
target hydro quinone as a light-brown foam, which required no further purification (1.90 
g, 89 %), Mp 157-159 QC; Vmax (thin film, CH2Clz)/cm-1 3386 (OH), 1606 (C=C), 1262 
(C-O); cSH (400MHz; CDCh); 5.27 (2H, s, OCH2Ph), 6.69 (lH, d, J 8.4, COCHCHCO), 
6.76 (lH, d, J 8.4, COCHCHCO), 6.92 (IH, d, J 7.6, CH20CCH), 7.33 (lH, t, J 8.4, 
CH20CCHCH), 7.39-7.45 (5H, m, 2 x CH2CCH and 2 x CH2CCHCH and 
CH2CCHCHCH), 7.79 (IH, dd, J 1.2, 8.8, CH20CCHCHCH); cSc (100MHz; CDCh) 71.6 
(CH2), 106.1 (a-I), 109.4 (CH), 110.8 (a-I), 115.6 (C), 115.9 (CH), 125.2 (a-I), 126.8 
(C), 128 (2 x CH), 128.9 (a-I), 129 (2 x a-I), 135.2 (C), 143.7 (C), 148.2 (C), 155.2 (C); 
MS (FAB) m/z 266 [M+, 100 %] (M+, 264.0941. C17H1403 requires 266.0943). 
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4-(Allyloxy )-8-(benzyloxy )naphthalen -1-01 (308). 
OBn OH 
A solution of 5-benzyloxy-l,4-naphthalenediol (302) (1.0 g, 3.76 mmol), potassium 
carbonate (571 mgs, 4.13 mmol) and allyl bromide (0.35 ml, 4.13 mmol) in acetone (20 
ml) was heated at reflux for 24 hours. The reaction mixture was filtered and evaporated to 
dryness. The resulting solid was dissolved in ethyl acetate (30 ml), washed with brine (3 
x 30 ml), dried over anhydrous magnesium sulfate and the solvent removed under 
pressure. The dark brown solid required no further purification (954 mgs, 83 %), Mp 
116-118 QC; Vrnax (thin film, CH2Clz)/cm-1 3411 (OH), 1630 (C=C), 1292 (C-O); bH 
(400MHz; CDCh); 4.63 (2H, dt, J 1.6, 5.2, OCH2CH=CH2), 5.26 (2H, s, OCH2Ph) 5.30 
(lH, dq, J 1.6, 10.4, OCH2CH=CH(H», 5.48 (lH, dq, J 1.6, 17.2, OCH2CH=C(H)H) 
6.10-6.20 (lH, m, OCH2CH=CH2), 6.76 (2H, q, J 8.8, COCHCHCO), 6.92 (lH, d, J 7.6, 
CH20CCH), 7.32 (lH, t, J 8.2, CH20CCHCH), 7.39-7.49 (5H, m, 2 x CH2CCH and 2 x 
CH2CCHCH and CH2CCHCHCH), 7.92 (lH, dd, J 0.8, 8.4, CH20CCHCHCH), 9.02 
(lH, s, COH); be (lOOMHz; CDCl3) 69.7 (CH2), 71.7 (CH2), 106.2 (CH), 108.1 (CH), 
109.1 (CH), 115.7 (C), 116.3 (CH), 117.2 (CH2), 125.2 (CH), 128.0 (2 x CH), 128.3 (C), 
128.8 (CH), 129.1 (2 x CH), 133.7 (CH), l35.3 (C), 147.0 (C), 148.1 (C), 155.1 (C); MS 
(FAB) mlz 306 [M+, 86.3 %] (M+, 306.1256. C20H1803 requires 306.1256). 
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4-(Allyloxy )-8-(benzy loxy )naphthalen -l-yl dimethylcarbamate (303). 
To a well stirred solution of sodium hydride (993 mgs, 24.83 mmol) in anhydrous 
tetrahydrofuran (20 ml) was added 4-(allyloxy)-8-(benzyloxy)naphthalen-1-ol (3.80g, 
12.41 mmol) (308) in anhydrous tetrahydrofuran (20 ml) drop-wise at room temperature. 
After stirring the reaction mixture for 2 hours, N,N-dimethylcarbamoyl chloride (2.28 ml, 
24.83 mmol) was added and stirring continued for another 8 hours. The reaction was 
quenched via careful addition of water (10 ml) and then a further 50 ml added. The 
resulting carbamate was extracted with ethyl acetate (3 x 75 ml) and the combined 
organic fractions dried over anhydrous sodium sulfate and evaporated under reduced 
pressure. The crude was purified by flash column chromatography over silica eluting 
with hexane:ethyl acetate 3:1 to furnish (303) as a yellow solid (4.62 g, 99 %), Mp 101-
102°C; Vrnax (thin film, CH2Ch)lcm-1 1645 (C=C), 1265 (C-O); bH (400MHz; CDCb); 
2.55 (3H, s, CONCH3), 2.72 (3H, s, CONCH3), 4.67 (2H, dt, J 1.6, 5.2, CCH2CH=CH2) 
5.08 (2H, s, OCH2Ph), 5.32 (lH, dq, J 1.2, 10.4, CCH2CH=CH(H», 5.50 (1H, dq, J 1.6, 
17.2, CCH2CH=C(H)H), 6.10-6.20 (1H, m, CCH2CH=CH2), 6.75 (1H, d, J 8.4, 
COCHCHCO), 6.93 (2H, m, COCHCHCO and CH20CCH), 7.33 (lH, t, J 8.0, 
CH20CCHCH), 7.35-7.48 (5H, m, 2 x CH2CCH and 2 x CH2CCHCH and 
CH2CCHCHCH), 7.93 (lH, dd, J 0.8, 8.4, CH20CCHCHCH); be (100MHz; CDCb) 35.7 
(CH3), 36.4 (CH3), 69.3 (CH2), 70.8 (CH2), 105.4 (CH), 107.7 (CH), 115.1 (CH), 117.4 
(CH2), 119.3 (CH), 120.6 (C), 125.6 (CH), 128.1 (CH), 128.5 (C), 128.6 (2 x CH), 128.7 
(2 x CH), 133.3 (CH), 136.8 (C), 140.8 (C), 151.8 (C), 154.7 (C), 155.8 (NCO); MS 
(FAB) m/z 377 [M+, 45.7 %] (M+, 377.1631. C23H23N04 requires 377.1627). 
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3-AIIyl-8-(benzyloxy )-4-hydroxynaphthalen -1-yl dimethylcarbamate (309) 
4-(Allyloxy)-8-(benzyloxy)naphthalen-l-yl dimethylcarbamate (303) (1.0 g, 2.65 mmol) 
was refluxed in mesitylene (l0 ml) for 24 hours. The solvent was removed under 
reduced pressure to yield a tarry brown solid. Hexane (30 ml) was added and removed 
on the rotary evaporator to azeotrope any residual mesitylene. The resulting solid was 
filter-washed with cold hexane (30 ml) to yield the hydro quinone (309) as a dark brown 
solid (793 mgs, 79 %), Mp 89-91 QC; Vrnax (thin film, CH2Clz)/crn-1 3416 (OH), 1634 
(C=C), 1262 (C-O); OH (400MHz; CDCh); 2.58 (3H, s, CONCH3), 2.75 (3H, s, 
CONCH3), 3.26 (2H, d, J 6.4, CCH2CH=CH2), 5.10 (2H, s, OCH2Ph) 5.11-5.12 (lH, m, 
CCH2CH=CH(H)), 5.15 (IH, q, J 2.0 , CCH2CH=C(H)H), 5.90-5.97 (lH, m, 
CCH2CH=CH2), 6.14 (IH, s, COH), 6.74 (IH, s, COCCHCO), 6.82 (IH, d, J 7.6, 
CH20CCH), 7.20 (IH, t, J 8.4, CH20CCHCH), 7.36-7.49 (5H, rn, 2 x CH2CCH and 2 x 
CH2CCHCH and CH2CCHCHCH), 7.65 (IH, d, J 8.4, CH20CCHCHCH); Oc (lOOMHz; 
CDCh) 34.3 (CH2), 35.7 (CH3), 36.4 (CH3), 70.7 (CH2), 106.5 (CH2), 115.0 (CH), 116.2 
(CH2), 119.1 (CH), 120.1 (C), 121.5 (CH), 125.0 (CH), 126.9 (CH), 128.0 (CH), 128.2 
(C), 128.5 (2 x CH), 129.2 (C), 136.2 (CH), 137.0 (C), 139.6 (C), 147.0 (C), 154.4 (C), 
156.3 (NCO); MS (FAB) mlz 377 [M+, 36.1 %] (M+, 377.1621. C23H23N04 requires 
377.1627). 
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3-Allyl-8-(benzyloxy)-4-methoxynaphthalen-l-yl dimethylcarbamate (310). 
Finely ground potassium hydroxide (65 mgs, 1.17 mmol) was added portion wise to a 
solution of 3-allyl-8-(benzyloxy)-4-hydroxynaphthalen-1-yl dimethy1carbamate (309) 
(400 mgs, 1.06 mmol) in dimethylformamide (10 ml) at 0 °C and stirred for 10 minutes. 
After this time methyl iodide (0.1 ml, 1.17 mmol) was added drop-wise and the solution 
was then allowed to stir at room temperature for 4 hours. The mixture was then added to 
ice water (50 ml) and extracted with ethyl acetate (3 x 50 ml). The combined organic 
extracts were dried over anhydrous magnesium sulfate and concentrated to yield a dark 
brown oil. The crude oil was adsorbed onto silica and purified by column 
chromatography using 1: 1 light petroleum:ethyl acetate as eluent. The product was 
isolated as a dark brown solid (373 mgs, 90 %), Mp 79-81 cC; Vrnax (thin film, 
CH2Clz)/cm-1, 1635 (C=C), 1261 (C-O); DH (400MHz; CDCh); 2.57 (3H, s, CONCH3), 
2.72 (3H, s, CONCH3), 3.55 (2H, dt, J 1.2, 6.0, CCH2CH=CH2), 3.87 (3H, s, COCH3), 
5.10 (2H, s, OCH2Ph), 5.09-5.11 (lH, m, CCH2CH=CH(H», 5.13(lH, q, J 2.0, 
CCH2CH=C(H)H), 5.95-6.05 (lH, m, CCH2CH=CH2), 6.87 (lH, d, J 8.0, CH20CCH), 
6.91 (lH, s, COCCHCO), 7.33-7.48 (6H, m, CH20CCHCH, 2 x CH2CCH, 2 x 
CH2CCHCH and CH2CCHCHCH), 7.69 (lH, d, J 8.4, CH20CCHCHCH); Dc (lOOMHz; 
CDCh) 33.6 (CH2), 35.6 (CH3), 36.3 (CH3), 62.0 (CH3), 70.8 (CH2), 106.7 (CH), 115.0 
(CH), 116.4 (CH2), 119.8 (C), 121.6 (CH), 126.3 (CH), 128.1 (CH), 128.5 (2 x CH), 
128.6 (C), 128.6 (2 x CH), 131.2 (C), 136.6 (C), 136.8 (CH), 143.4 (C), 150.8 (C), 155.2 
(C), 155.5 (NCO); MS (FAB) mlz 391 [M+, 35.7 %] (M+, 391.1789. C24H2sN04 requires 
391.1784). 
Chapter 5 Experimental 205 
4-(Allyloxy )-8-(benzyloxy )-I-hydroxy-N,N -dimethyl-2-naphthamide (311). 
OBn OH 0 
A solution of 4-(allyloxy)-8-(benzyloxy)naphthalen-1-yl dimethylcarbamate (303) (400 
mgs, 1.06 mmol) in anhydrous tetrahydrofuran (10 ml) was added to a stirred solution of 
sec-butyllithium (lA M solution in hexanes) (0.84 ml, 1.17 mmol) and 
tetramethylethylenediamine (0.18 ml, 1.17 mmol) in anhydrous tetrahydrofuran under an 
inert atmosphere at -78 QC. After 2 hours of stirring at -78 QC the reaction was allowed to 
attain room temperature and then quenched with careful addition of saturated aqueous 
ammonium chloride solution (20 ml). The resulting mixture was extracted with ethyl 
acetate (3 x 30 ml) and the combined organics dried over anhydrous magnesium sui fate 
and then volatiles removed on the rotary evaporator. The crude brown oil was purified 
via flash column chromatography over silica using hexane:ethyl acetate 1: 1 as eluent to 
yield the target (187) as a yellow solid (204 mgs, 51 %), Mp 86-88 QC; Vrnax (thin film, 
CH2Ch)/cm-1 3367 (OH), 1633 (C=C); DH (400MHz; CDCl)); 2.88-3.03 (6H, br, 2 x 
CONCH3), 4.56 (2H, dt, J 1.2, 5.2, CCH2CH=CH2), 5.18 (2H, s, OCH2Ph), 5.24 (lH, dd, 
J 1.2, lOA CCH2CH=CH(H)), 5041 (lH, dq, J 1.6, 17.2, CCH2CH=C(H)H), 6.02-6.11 
(lH, rn, CCH2CH=CH2), 6.66 (lH, s, COCCHCO), 6.91 (lH, d, J 7.6, CH20CCH), 7.28-
7042 (6H, rn, CH20CCHCH, 2 x CH2CCH, 2 x CH2CCHCH and CH2CCHCHCH), 7.85 
(lH, dd, J 0.8, 8.8 CH20CCHCHCH), 9.26 (lH, s, COH); Dc (lOOMHz; CDCl)) 34.9 
(CH3), 38.1 (CH3), 69.5 (CH2), 71.8 (CH2), 106.1 (CH), 107.0 (CH), 115.5 (C), 116.3 
(CH), 117.1 (C), 11704 (CH2), 126.1 (CH), 128.2 (2 x CH), 128.7 (C), 128.9 (CH), 129.1 
(2 x CH), 133.3 (CH), 134.9 (C), 144.1 (C), 147.0 (C), 155.6 (C), 169.7 (NCO); MS 
(FAB) m/z 377 [MH+, 74.9 %] (MH+, 377.1698. C23H23N04 requires 377.1705). 
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CHAPTER SIX: 
APPENDIX 
6.0 X-Ray CrystaIlograpby Data 
(3S,6aR,10aS,10bR)-3-«IH-Indol-3-yl)metbyl)octahydro-2H-oxazolo[2,3-a]isoquinolin-S(3H)-
one (202b). 
~ ~ // H I : 
HN o"cto HU 
Table 1. Crystal data and structure refinement for (202b). 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Appendix 
sma57 
C20H24N202 
324.41 
150(2) K 
0.71073 A 
Orthorhombic 
P2(1)2(1)2(1) 
a = 6.9425(6) A 
b = 15.0126(12) A 
c = 15.7895(13) A 
1645.7(2) A3 
207 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 28.33° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data 1 restraints 1 parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
4 
1.309 Mg/m3 
0.085 mm· l 
696 
0.25 x 0.16 x 0.14 mm3 
colourless block 
1.87 to 28.33°. 
-9<=h<=9, -20<=k<=20, -21<=k=20 
17070 
2347 [R(int) = 0.0502] 
100.0 % 
Semi-empirical from equivalents 
0.9882 and 0.9791 
Full-matrix least-squares on F2 
2347/0/220 
1.042 
RI = 0.0369, wR2 = 0.0853 
RI = 0.0462, wR2 = 0.0903 
10(10) 
0.215 and -0.191 e.A:3 
Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2x 
103) 
for (202b). U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
x y z U(eq) 
C(I) 4348(3) 8672(1) -749(1) 23(1) 
C(2) 4993(3) 8351(1) 105(1) 26(1) 
C(3) 5809(3) 9112(1) 642(1) 20(1) 
N(4) 6803(2) 8794(1) 1398(1) 21(1) 
C(5) 8746(3) 8684(1) 1425(1) 22(1) 
0(1) 9737(2) 8759(1) 789(1) 30(1) 
C(6) 9599(3) 8478(1) 2284(1) 23(1) 
C(6A) 8157(3) 8248(1) 2979(1) 22(1) 
C(7) 9118(3) 8254(2) 3850(1) 29(1) 
Appendix 208 
C(8) 7687(4) 8059(2) 4561(1) 35(1) 
C(9) 6016(3) 8719(2) 4542(1) 30(1) 
C(10) 5023(3) 8703(1) 3677(1) 24(1) 
C(IOA) 6451(3) 8899(1) 2961(1) 21(1) 
C(IOB) 5471(3) 8831(1) 2107(1) 20(1) 
0(11) 4349(2) 9605(1) 1933(1) 25(1) 
C(12) 4207(3) 9703(1) 1028(1) 26(1) 
C(13) 2578(3) 8982(1) -978(1) 26(1) 
N(I) 2573(3) 9218(1) -1821(1) 27(1) 
C(14) 4371(3) 9057(1) -2150(1) 22(1) 
C(15) 5047(3) 9154(1) -2979(1) 25(1) 
C(16) 6931(3) 8908(1) -3135(1) 27(1) 
C(17) 8116(3) 8575(1) -2488(1) 27(1) 
C(IS) 7456(3) 8487(1) -1670(1) 24(1) 
C(19) 5539(3) 8722(1) -1492(1) 21(1) 
Table 3. Bond lengths [A] and angles [0] for (202b). 
C(1)-C(13) 1.363(3) C(8)-C(9) 1.526(3) 
C(1)-C(19) 1.437(3) C(9)-C(10) 1.531(3) 
C(1)-C(2) 1.500(3) C(1O)-C(IOA) 1.532(2) 
C(2)-C(3) 1.532(3) C(10A)-C(IOB) 1.513(2) 
C(3)-N(4) 1.459(2) C(IOB)-0(11) 1.426(2) 
C(3)-C(12) 1.547(3) 0(11)-C(12) 1.439(2) 
N(4)-C(5) 1.360(2) C(13)-N(1) 1.378(2) 
N(4)-C(IOB) 1.453(2) N(1)-C(14) 1.373(3) 
C(5)-O(1) 1.222(2) C(14)-C(15) 1.398(3) 
C(5)-C(6) 1.512(3) C(14)-C(19) 1.411(3) 
C(6)-C(6A) 1.525(3) C(15)-C(16) 1.381(3) 
C(6A)-C(7) 1.529(3) C(16)-C(17) 1.403(3) 
C( 6A)-C( lOA) 1.536(3) C(17)-C(18) 1.378(3) 
C(7)-C(8) 1.527(3) C(18)-C(19) 1.405(3) 
C(13)-C(I)-C(19) 106.53(16) C(19)-C(1)-C(2) 125.36(18) 
C(13)-C(l)-C(2) 128.10(19) C(1)-C(2)-C(3) 111.63(16) 
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N(4)-C(3)-C(2) 112.56(16) 
N(4)-C(3)-C(12) 101.87(14) 
C(2)-C(3)-C(12) 112.34(17) 
C(S)-N(4)-C(lOB) 127.75(17) 
C(S)-N(4)-C(3) 122.30(16) 
C(lOB)-N(4)-C(3) 108.47(14) 
O(1)-C(S)-N(4) 121.4S(18) 
O(1)-C(S)-C(6) 122.37(16) 
N(4)-C(S)-C(6) 116.17(17) 
C(S)-C(6)-C(6A) 11S.77(16) 
C(6)-C(6A)-C(7) 111.08(16) 
C(6)-C(6A)-C(lOA) 11O.39( IS) 
C(7)-C(6A)-C(lOA) 110.47(16) 
C(8)-C(7)-C(6A) 112.08(18) 
C(9)-C(8)-C(7) 110.88(17) 
C(8)-C(9)-C( 1 0) 110.41(17) 
C(9)-C( 1O)-C( lOA) 111.39(16) 
C( 1 OB)-C( 1 OA)-C( 1 0) 11O.71(lS) 
C(lOB)-C(lOA)-C(6A) 108.67(1S) 
C(1 O)-C(1 OA)-C(6A) 111.26(1S) 
O(11)-C(lOB)-N(4) 103.28(14) 
O(ll)-C(lOB)-C(lOA) 111.24(1S) 
N(4)-C(lOB)-C(10A) 113.76(lS) 
C(10B)-O(11)-C(12) 108.22(14) 
O(11)-C(12)-C(3) 106.41(lS) 
C(l)-C(13)-N(l) 110.22(18) 
C(14)-N(1)-C(13) 108.S6(17) 
N(1)-C(14)-C(lS) 129.8S(18) 
N(1)-C(14)-C(19) 107.87(17) 
C(lS)-C(14)-C(19) 122.24(18) 
C(16)-C(1S)-C(14 ) 117.20(19) 
C(1S)-C(16)-C(17) 121.39(19) 
C(18)-C(17)-C(16) 121.42(19) 
C(17)-C(18)-C(l9) 118.62(19) 
C(18)-C(19)-C(l4) 119.12(18) 
C(18)-C(19)-C(l) 134.03(18) 
C(14)-C(19)-C(1) 106.81(17) 
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Table 4. Anisotropic displacement parameters (A2x 103) for (202b). The anisotropic 
displacement factor exponent takes the form: -202[ h2 a*2Ull + ... + 2 h k a* b* {j12 ] 
ull {]22 U33 1]23 Ul3 Ul2 
C(1) 31(1) 20(1) 18(1) 0(1) -4(1) 0(1) 
C(2) 37(1) 23(1) 17(1) 1(1) -3(1) -2(1) 
C(3) 20(1) 23(1) 17(1) 1(1) 1(1) -1(1) 
N(4) 20(1) 26(1) 16(1) 0(1) 1(1) 1(1) 
C(5) 18(1) 22(1) 25(1) -4(1) 0(1) 0(1) 
0(1) 22(1) 42(1) 26(1) -1(1) 6(1) 1(1) 
C(6) 20(1) 24(1) 25(1) -3(1) 0(1) 2(1) 
C(6A) 23(1) 23(1) 19(1) -1(1) -2(1) 3(1) 
C(7) 28(1) 35(1) 24(1) 0(1) -5(1) 7(1) 
C(8) 44(1) 41(1) 19(1) 3(1) -5(1) 8(1) 
C(9) 34(1) 36(1) 20(1) -1(1) 1(1) 2(1) 
C(10) 26(1) 27(1) 20(1) 0(1) 3(1) 2(1) 
C(lOA) 22(1) 20(1) 19(1) -1(1) 2(1) 0(1) 
C(10B) 17(1) 22(1) 20(1) 0(1) 2(1) 0(1) 
0(11) 27(1) 30(1) 18(1) -2(1) 0(1) 9(1) 
C(12) 25(1) 34(1) 20(1) -1(1) -2(1) 4(1) 
C(13) 29(1) 29(1) 21(1) -2(1) 1(1) 1(1) 
N(1) 23(1) 32(1) 25(1) 1(1) -5(1) 6(1) 
C(14) 24(1) 19(1) 24(1) -1(1) -4(1) 1(1) 
C(15) 32(1) 25(1) 18(1) 1(1) -5(1) -1(1) 
C(16) 33(1) 26(1) 23(1) -4(1) 4(1) -4(1) 
C(17) 22(1) 22(1) 37(1) -4(1) 1(1) -1(1) 
C(18) 25(1) 20(1) 29(1) 0(1) -6(1) 1(1) 
C(19) 26(1) 16(1) 20(1) -1(1) -6(1) -1(1) 
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3) 
for (202b). 
x y z U(eq) 
H(2A) 5993 7887 32 31 
H(2B) 3888 8078 404 31 
H(3) 6700 9485 293 24 
H(6A) 10359 9001 2471 28 
H(6B) 10503 7973 2221 28 
H(6A1) 7654 7634 2869 26 
H(7A) 10155 7801 3861 35 
H(7B) 9715 8844 3948 35 
H(8A) 7183 7446 4497 42 
H(8B) 8352 8098 5114 42 
H(9A) 6503 9326 4659 36 
H(9B) 5074 8563 4989 36 
H(10A) 3980 9152 3667 29 
H(10B) 4435 8110 3584 29 
H(lOC) 6953 9519 3032 25 
H(10D) 4622 8293 2098 24 
H(12A) 4396 10333 864 32 
H(12B) 2925 9507 827 32 
H(13) 1502 9029 -608 31 
H(15) 4245 9380 -3416 30 
H(16) 7435 8965 -3692 33 
H(17) 9402 8407 -2618 32 
H(18) 8279 8271 -1235 29 
H(lN) 1650(40) 9451(17) -2096(16) 40 
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Table 6. Hydrogen bonds for (202b) [A and 0]. 
D-H. .. A d(D-H) d(H ... A) 
N(1)-H(1N) ... O(1l)#l 0.85(3) 2.20(3) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+ 1I2,-y+2,z-1I2 
Appendix 
d(D ... A) «DHA) 
2.963(2) 149(2) 
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Abstract-We report new and complementary routes for the highly stereoselective construction offunctionalized benzoquinolizidine 
targets from readily available, non-racemic chiral templates. The methods developed aIlow us to predetermine relative product ste-
reochemistries by judicious choice of substrate sub-structure, and provide ready access to alternative stereoisomers. 
© 2006 Elsevier Ltd. All rights reserved. 
The benzo[a]quinolizidine ring system is of considerable 
interest and significance since this heterocycIic template 
is found within a range of pharmacologically interesting 
alkaloids. For example (-)-protoemetinol 1,1 isolated 
by Battersby from Alangium lamarckii, is structurally re-
lated to psychotrine 2 and O-methylpsychotrine 3, and 
indeed 1 has formed the basis of synthetic approaches 
to these more functionalized derivatives.2 Alangine, 4, 
a recently isolated natural product also from A. lama-
rckii differs stereochemically from compounds 1-3 in 
that it has trans relative stereochemistry at positions 2 
and 11 b. 3 Compounds 2 and 3 are known to be potent 
inhibitors of HIV-l reverse transcriptase, and such 
MeO 
MeO 
MeO 
MeO 
OH 
biological significance earmarks the development of 
new asymmetric routes for accessing functionalized 
benzo[a]quinolizidine targets as an important task.4 
Over recent years our research teams have, indepen-
dently, developed a new approach for the stereoselective 
synthesis of heterocycIic ring systems that involves the 
cycIization of a pendent aromatic substituent onto an 
N-acyliminium intermediate as the key ring-forming 
step.5 We now wish to report the development of com-
plementary routes for the highly stereoselective synthesis 
of functionalized benzo[a]quinolizidine targets that 
allow at will, the efficient preparation of targets with a 
2 (R = H) 
3 (R=Me) 
4 
• Corresponding authors. Tel.: +44 1509 222559; fax: +44 1509223925 (S.M.A.); e-mail addresses: S.M.Allin@lboro.ac.uk; joanbosch@ub.edu 
0040-4039/$ - see front matter © 2006 Elsevier Ltd. All rights reserved. 
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range of relative product stereochemistries through 
judicious choice of substrate structure and reaction 
protocol. 
We envisaged one route to the chosen functionalized 
targets through application of conjugate addition chem-
istry to an (J[,~-unsaturated tetrahydroisoquinoline 
substrate, since in related work on an indolo[2,3-a]quin-
olizine skeleton the use of appropriate nucleophilic 
reagents in conjugate addition reactions has proved to 
be very successful, proceeding with good yield and with 
exclusive diastereoselectivity.6.7 
In an attempt to influence the approach of the attacking 
nucleophile we generated template 6 through TBDPS-
protection of the hydroxyl group of5 before introducing 
un saturation (Scheme 1). Substrate 5 was obtained as a 
single diastereoisomer on Lewis acid induced cyclization 
of the corresponding bicyclic lactam precursor, as previ-
ously reported by our group. 8 Our aim here was to 
shield the 'upper' face of the heterocycle to encourage 
attack from below, and hence produce the desired cis 
product stereochemistry (relative to the H-atoms at 
stereo centres 2 and lIb). 
The results of conjugate addition studies on template 6 
are highlighted in Scheme 2, with product 7 isolated in 
70% yield as a single diastereoisomer, and product 8 in 
55% yield but as a 1: 1 mixture of diastereoisomers. 
The relative stereochemistry of 7 was confirmed by 
nOe studies, and found to have trans relative stereo-
chemistry with respect to the H-atoms at the chiral 
centresY 
One possible explanation for the observed stereochemi-
cal outcome of the conjugate addition reactions to 
unsaturated lactam 6 could be, as highlighted in Figure 
1, an axial attack of the vinyl cuprate, under stereoelec-
tronic control, to give the kinetic product 7. However, 
the conjugate addition of the enolate of ethyl 1,3-dithiol-
axial attack 
MeO OMe 
Figure 1. 
ane-2-carboxylate may be reversible, affording the 1: 1 
mixture of isomers 8a (2,11 b trans, kinetic ):8b (2,11 b 
eis, thermodynamic) under the reaction conditions 
(-78°C to 25 QC, 24 h). 
In an attempt to determine the effect, if any, of the 
hydroxymethyl substituent on the stereos electivity of 
the conjugate addition process, we decided to examine 
the reaction of substrate 13, having removed the 
hydroxymethyl substituent by the route highlighted in 
Scheme 3. 
With cx,~-unsaturated amide 13 in hand, we turned our 
attention to the proposed functionalization of the ~­
position of the unsaturated lactam through conjugate 
addition chemistry using the more successful vinyl 
nucleophile (Scheme 4). 
Product 14 was isolated in good yield (67%), and we 
were pleased to observe the formation of a single diaste-
reoisomer by examination of the crude reaction mixture 
by 250 MHz IH NMR spectroscopy. The relative stereo-
chemistry of 14 was confirmed by nOe studies, and 
again found to have the H-atoms at the chiral centres 
showing trans relative stereochemistry.9 We also at-
tempted the addition reaction with the lithiated dithio-
lane nUcleophile, but in this case we only obtained an 
intractable product mixture. 
Meo~1 OH 
MeO:::"" NO 
H 
(i) Meo~1 OTBDPS 
MeO ~ N 0 
H 
MeO%1 OTBDPS 
MeO~ NO 
H 
o 
(ii) 
5 6 
Scheme I. Reagents and conditions: (i) imidazole (3 equiv), DMAP (cat.), TBDPSCI (2 equiv), DCM, rt, 24 h, (97%); (ii) LDA, PhSeBr, THF, 
-78 QC to rt, 24 h; then NaI04, NaHC03, MeOH, H20, rt, 18 h (42%, two steps). 
MeO~OTBDPS I N 0 (i) or (ii) 
MeO ~ -----
H 
o 
6 
MeO~OTBDPS 
MeO ~ ~ N 0 8a:8b = 1:1 
S C02EI 
~S 
Scheme 2. Reagents and conditions: (i) vinylmagnesium bromide (10 equiv), CuCN (7.5 equiv), TMSCI (7.5 equiv), THF, -78 QC 10 rt, 24 h; (ii) 
LDA (2 equiv), ethyl 1,3-dithiolane-2-carboxylate (1.2 equiv), THF, -78 QC to rt, 24 h. 
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(iii) (v) MeO%1 R' 
MeO~ NO 
H 
MeoXQfI R' 
MeO~ NO 
H 
5, R' =CH20H 
9, R'=CHO 
) (i) 
) (ii) 
11, R' = cosePJh 
(iv) 
12, R'= H 
Scheme3. Reagents and conditions: (i) IBX, DMSO, rt, 24 h (70%); (ii) NaCI02, NaH2P04, I-methyl-I-cyclohexene, CH3CN, t-BuOH, H20, 0 °C to 
rt, 18 h (86%); (iii) (PhSeh, PBU3, CH2Ch, 0 °C to rt, 18 h (76%); (iv) n-Bu3SnH, AIBN, toluene, 80°C, 2 h (81%); (v) LDA, Ph Se Br, THF, -78°C to 
rt, 24 h; then NaI04, NaHC03, MeOH, H 20, rt, 18 h (61% for two steps). 
MeOrn~/! 
M,O' "'~VO (i) o 14 
13 
Scheme 4. Reagents and conditions: (i) vinylmagnesium bromide (10 equiv), CuCN (7.5 equiv), TMSCI (7.5 equiv), THF, -78 °C to rt, 24 h. 
Clearly the (protected) hydroxymethyl group of 
substrate 6 plays no major role in determining the 
approach of the nucleophile, with the inherent confor-
mation of the parent heterocyclic template being respon-
sible for the stereochemical induction, with the 
nucleophile approaching from the least hindered (con-
vex) face of the ring system. In summary, products 7 
and 14 are formed as single diastereoisomers and with 
trans relative stereochemistry at positions 2 and llb, 
as required for alkaloids such as alangine, 4. 
An alternative route for the introduction of substituents 
onto the lactam ring would involve the incorporation of 
functionality at an earlier stage in the sequence. The 
development of synthetic routes to prochiral or racemic 
glutarates,lO such as 15, and the subsequent use of these 
oxo diesters in stereoselective cyclocondensation reac-
tions with ehiral amino alcohols has previously been 
demonstrated.5b In this current approach, cycloconden-
sation of the appropriate substrates leads to the forma-
tion of functionalized bicyclic lactams 16a and 16b in a 
process that involves the discrimination of two enantio-
topic acetate chains (Scheme 5). 
Lactams 16a,b were separable, and their relative stereo-
chemistry was established by X-ray crystallography. N-
Acyliminium ion precursor 16a, on treatment with TiCI4 
MeO~OH 
MeoA.) NH2 
+ 
15 
Scheme 5. 
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in DCM at reflux for 3 days, gave 17 in 36% yield as a 
single product diastereoisomer (Scheme 6). X-ray crys-
tallographyll confirmed the relative stereochemistry of 
this product to be as shown in Scheme 6, with the 
H-atoms at the chiral centres now having cis relative 
stereochemistry, as required in benzo[a]quinolizidine 
targets, such as 1-3. 
Removal of the hydroxymethyl moiety from 17 by an 
analogous route to that described in Scheme 3 gave 
the desired functionalized benzo[a]quinolizidine target 
18. 
Meo~ 
MoO < .~ 0 
H" 
:::,.... 
trans 14 
~o 
cis 18 'C02Me 
In conclusion, we have developed new and highly stereo-
selective routes to functionalized benzo[a]quinolizidine 
targets, both in the 2,11 b-cis and -trans series. The rela-
tive stereochemistry of the products can be influenced 
through appropriate selection of synthetic approach, 
allowing complementary routes to diastereoisomerically 
Toluene,~ 
~,,""--Ar f\' 
:>()O 
Me02C/ 
..... ·--Ar 
~ Me02C 24h,80% 
16a (67%) 16b (13%) 
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.. ··-Ar 
1\' 
~ 
Me02C/ 
16a 
DeM,/';.,3days 
36% 
HO
r 
.... I~ OMe 
ON.. ~ OMe 
"H 
·····H 
Me02C 17 
Scheme 6. 
substituted products 14 and 18 as single diastereoiso-
mers.12 The absolute stereochemistry of such products 
can, if required, be tuned by the choice of appropriate 
enantiomer of the ~-aminoa1cohol starting material. 
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data can be obtained free of charge via www.ccdc.cam. 
ac.uk/conts/retrieving.html (or from the CCDC, 12 Union 
Road, Cambridge, CB2 lEZ, UK. Fax +44 1223336033, 
e-mail: deposit@ccdc.cam.ac.uk). 
12. Data for selected compounds: Compound 14: [O(l~ +43.0 
(c 1.0, CHCI3); OH (400 MHz; CDCI3) 2.02-2.08 (lH, m), 
2.30-2.37 (lH, m), 2.54 (2H, t, J=4), 2.63 (lH, dt, 
J = 2.8,15.2),2.67-2.73 (lH, m), 2.78-2.85 (lH, m), 2.91-
2.90 (lH, m), 3.86 (3H, s), 3.87 (3H, s), 4.63--4.66 (lH, m), 
4.83--4.88 (lH, m), 5.12-5.18 (2H, m), 5.91-6.00 (lH, m), 
6.62 (lH, s), 6.64 (1H, s); Oc (100 MHz; CDCh) 28.5, 33.1, 
34.8, 36.3,40.1, 53.5, 55.9, 56.1, 107.8, 11.7, 115.4, 127.6, 
129.0, 139.4, 146.8, 146.9, 169.0 (Found (El): M+ 
288.15935. C17H21N03 requires 288.15940). Compound 
18: [O(l~ +124.9 (c 1.6, CHCh); OH (400 MHz; CDCI3) 
1.34--1.43 (lH, m), 2.07 (lH, dd, J= 17, 12), 2.34-2.36 
(2H, m), 2.43-2.49 (lH, m), 2.55-2.68 (3H, m), 2.74-2.92 
(2H, m), 3.70 (3H, s), 3.83 (3H, s), 3.84 (3H, s), 4.65 (lH, 
dd, J= 11, 4), 4.81--4.85 (lH, m), 6.59 (lH, s), 6.63 (lH, 
s); Oc (100 MHz; CDCI3) 28.4 (2C), 37.0, 38.1, 39.5, 39.9, 
51.7, 55.8, 56.0, 56.1, 108.2, 111.5, 127.1, 128.6, 147.7, 
147.8, 168.1, 172.1 (Found (El): M+, 333.1576. 
CI8H23NOs requires 333.1576). 
13. Sheldrick, G. M. SHELXTL version 6.12, Bruker-AXS, 
Madison WI, 2001. 
217 
Available online at www.sciencedirect.com 
--,,, 
.. 
0
; 11 ScienceDirect Tetrahedron 
Letters 
ELSEVIER Tetrahedron Letters 48 (2007) 4711-4714 
Towards a total synthesis of the manadomanzamine alkaloids: 
the first asymmetric construction of the pentacyclic indole core 
Steven M. Allin,a,. Liam 1. Duffy,a Philip C. Bulman Page,a 
Vickie McKeea and Michael 1. McKenzieb 
aDepartment o/Chemistry, Loughborough University, Loughborough, Leicestershire LEll 3TU, UK 
bCharnwood Molecular Ltd., The Heritage Building, Prince WiIliam Road, Loughborough LEll 5GA, UK 
Received 22 March 2007; accepted 2 May 2007 
Available online 10 May 2007 
Abstract-We report a highly diastereoselective approach for the synthesis of the pentacyC\ic indole core of the manadomanzamine 
alkaloid skeleton, with complete control over the relative and absolute stereochemistries at the three contiguous stereocentres at ring 
positions I, 10, and 24, from a readily available chiral template. 
Crown Copyright © 2007 Published by Elsevier Ltd. All rights reserved. 
In 2003 Hamann and co-workers reported the isolation 
of two novel marine alkaloids, manadomanzamine A 
and B, from the Indonesian sponge Acanthostrongylo-
phora Sp.l These compounds were found to exhibit 
strong activity against mycobacterium tuberculosis 
(Mtb) with MIC values of 1.9 and 1.51lg/mL, respec-
tively. In addition these alkaloids show activities against 
HIV -1 and AIDS opportunistic infections. The recent 
increasing occurrence and threat of tuberculosis has 
renewed interest in the development of anti-tuberculosis 
agents, since the WHO estimates that currently one-
third of the worlds popUlation is infected with TB, with 
3.1 million deaths occurring per annum. Further, such a 
lead compound with activity against both HIV -1 and 
AIDS opportunistic infections is of significant value. A 
plausible biosynthetic pathway to the manadomanz-
Manadomanzamine A, 22 P-H 
Manadomanzamine B, 22 a-H 
• Corresponding author. E-mail: S.M.Allin@lboro.ac.uk 
amines has been proposed from the more common 
manzamine alkaloids. To date no total synthesis of 
the manadomanzamines has been reported, and indeed 
a general and stereoselective approach to simpler core 
analogues, including 1, a dodecahydrobenz[a]indolo-
[3,2-h]quinolizine, is still lacking. This pentacyclic ring 
system, sometimes referred to as an 'inside yohimbane', 
has previously been prepared in racemic fashion by 
Morrison et al.,2 and has been observed as a by-product 
in approaches to racemic yohimbine and reserpine by 
Martin.3 Our research group, and others, have had con-
siderable success in recent years in the development of 
asymmetric routes to several important heterocyclic 
templates, based on the development of highly diaste-
reo selective N-acyliminium cyclization strategies.4 Our 
own recent applications of this methodology in natural 
0040-4039/$ - see front matter Crown Copyright © 2007 Published by Elsevier Ltd. All rights reserved. 
doi: 10.1 016/j. tetlet.2007 .05.030 
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product synthesis have included targets from the 
erythrina group of alkaloids4f,i and several indole alka-
loids.4a ,d,e,g In this Letter we report a highly diastereose-
lective construction of the manadomanzamine core, 1, 
with complete stereo control control over the three con-
tiguous stereocentres at ring positions 1, 10, and 24.s 
Our retrosynthetic analysis of the pentacyc1ic target 1, 
presented in Scheme I, led back to the use of (S)-tryp-
tophanol 3, as both a source of indole and as the chiraI 
auxiliary in the proposed N-acyliminium cyclization. 
The bifunctional substrate 2 was prepared by an homo-
logation reaction through Wittig functionalization of 
commercially available ketone 4, followed by hydrolysis 
of the resulting enol ether (Scheme 2). Compound 2 is 
isolated as a mixture of the cis and trans isomers (ca. 
1:3, respectively), with the trans isomer predominating.2 
:> 
Scheme 1. Our retrosynthetic analysis of the manadomanzamine core. 
Aldehyde 2, a racemate, was subjected to the standard 
cyclocondensation reaction with (S)_tryptophano1.4a•d.g,e 
The use of racemic multi-functional aldehyde substrates 
in stereose1ective condensation reactions has been much 
explored by Bosch and Amat.6 In our hands, the con-
densation of racemic cisltrans-2 with (S)-tryptophanol 
under Dean-Stark conditions in toluene for 24 h gave 
a 1: 1 mixture of two readily separable diastereoisomers 
Sa,b in 69% overall yield (Scheme 3). Presumably the 
dynamic kinetic resolution that is well known for such 
substrates under cyclocondensation conditions occurs 
here to give the preferred trans orientation in 2.6 
The relative stereochemistry of Sa was determined by 
NOE studies on the isolated compound7 and that of 
isomer Sb by X-ray crystallographic analysis. Whereas 
diastereoisomer Sa has the correct relative and absolute 
O~HJ:C U 
HO/""'uY 
+ NH2 N 
H 
3 
2 
0'C6 0l(5"' °10H (i) (ii) .... cS 
4 rac-2 
Scheme 2. Reagents and conditions: (i) CH30CH2PPh3C1 (2.0 equiv), KOBu' (3.0 equiv), toluene, rt (64% yield); (ii) 2 N HCI, 55 °C, THF/H20 
(3:1), (99% yield). 
H 
H02C~ __ 5_-3 __ _ 
OHC~ 
2a H 
o OH 
""( CHO 
~(5 H ~C02H __ 5-_3 __ _ ~CHO 
2b H 
Scheme 3. Cyclocondensation/resolution of rac-aldehyde 2. 
Appendix 
H 
H02C_I~ H:~ R~O H 
6a 
lactamization 
5a 
H ~: ~ ~1/~,02H /, 
" R lactamization HN -~b 01tfH ------" o~ 
5b 
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stereochemistry required for the C-1O and C-24 
positions of the manadomanzamine natural products, 
isomers such as Sb may prove useful in future analogue 
generation studies. The stereochemistry at the noted Col 
position is of no significance at this stage, as this 
corresponding aminal centre will form a planar iminium 
carbon atom in subsequent reaction steps. The stereo-
chemical outcome of the cyclocondensation reaction 
shown in Scheme 3 can be rationalized by considering 
the formation of the aminal intermediates from each 
enantiomer of the aldehyde substrate 2, formed en 
route to the lactam products Sa,b, as highlighted in 
Scheme 3. 
The preferred aminal conformations 6a,b allow a 
favoured trans-decalin-like arrangement of the reactive 
intermediate, with an all-equatorial substituent pattern,6 
prior to irreversible lactamization, with the H-atom at 
the aminal carbon centre preferred in an axial arrange-
ment, leading only to minimal diaxial interactions in 
these conformations. 
With individual asymmetric building blocks Sa and Sb in 
hand, we turned our attention to the proposed N-acyl-
iminium cyclization step. These asymmetric building 
blocks were separately subjected to acid-induced cycliza-
tion reactions promoted by 2 M HCI in EtOH at room 
temperature for 18 h. Under these conditions, substrate 
Sa underwent clean cyclization in 73% yield to a single 
diastereoisomer of the desired product Sa (Scheme 4). 
NOE experiments subsequently established that the pen-
tacyclic product Sa was generated with the correct rela-
tive and absolute stereochemistries at ring positions 1, 
10 and 24 as required for the manadomanzamine natu-
ral product skeleton.8 
Such highly diastereoselective cyclization reactions of 
the indolyl nucleus onto N-acyliminium intermediates 
are now well established,4a,d,e,g,o and the usual rational-
5a 
2M HCI, EtOH 
RT 
Scheme 4. Access to the manadomanzamine core. 
5b 
2M HCI, EtOH 
RT 
Scheme 5. Cyclization of 5b. 
Appendix 
ization of the observed stereochemical induction holds 
true in this particular case. The stereocontrol arises from 
a preferred conformation, 7a, having minimal A(I,3) 
strain between the H-atom at the stereogenic centre of 
the tryptophanol moiety and the lactam carbonyl group 
in the transition state.9 Cyclization of the indolyl 
nucleus thus takes place from a pro-equatorial orienta-
tion, leading to a seemingly preferred axial orientation 
of all three H-substituents at positions Col, 10 and 24 
in compound Sb, matching the natural product stereo-
chemistry at these three contiguous asymmetric centres. 
In the case of lactam substrate Sb, as outlined in Scheme 
5, cyclization proceeded in comparable (75%) yield to 
give a single product diastereoisomer, which was 
subsequently determined (NOE) to have the relative 
stereochemistry shown in structure 8b.1O Again the 
stereocontrol arises through the preferred conformation 
7b, minimizing the A(I,3) strain between the H-atom at 
the stereo genic centre of the tryptophanol moiety and 
the lactam carbonyl group, despite the fact that the tran-
sition state must lead to a pro-axial attack onto the 
iminium species by the indolyl nucleus. 
In summary, we report the first highly asymmetric syn-
thesis of the pentacyclic core of the manadomanzamine 
alkaloids in only two linear synthetic steps from readily 
available reagents. Our route allows the controlled for-
mation of the correct relative and absolute stereochem-
istries at the three contiguous chiral centres at positions 
Col, C-lO, and C-24 of the heterocyclic skeleton. 
Although not described in this Letter, we have estab-
lished and reported several routes for removal of the 
hydroxymethyl auxiliary group from similar heterocy-
clic templates.4d.f Our current work is devoted to the 
development of this synthetic route to allow access to 
more highly functionalized intermediates and thus to a 
total synthesis of the manadomanzamines and their syn-
thetic analogues, and will be reported in due course. 
Cyclization 
Cyclizalion 
o 
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